ketoconazole has been researched along with itraconazole in 836 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 150 (17.94) | 18.7374 |
| 1990's | 390 (46.65) | 18.2507 |
| 2000's | 160 (19.14) | 29.6817 |
| 2010's | 109 (13.04) | 24.3611 |
| 2020's | 27 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Emami, S; Keighobadi, M; Tavangar, P | 1 |
| Cheng, M; Hao, C; Jiang, X; Su, X; Wei, P; Wu, M; Zhang, X; Zhao, D; Zhao, L; Zhao, S | 1 |
| Wang, SQ; Wang, YF; Xu, Z | 1 |
| Braga, SS | 1 |
| Gao, F; Huang, G; Xiao, J | 1 |
| Cheng, M; Su, X; Sun, N; Sun, Y; Tian, L; Yin, W; Zhang, C; Zhao, D; Zhao, L; Zhao, S; Zheng, Y | 1 |
| Cheng, M; Cui, H; Jiang, H; Li, S; Liu, L; Su, X; Sun, Y; Wu, T; Yin, W; Zhang, Y; Zhao, D; Zhao, L; Zheng, Y | 1 |
| Guengerich, FP; Hargrove, TY; Lepesheva, GI; Nes, WD; Rachakonda, G; Villalta, F; Wawrzak, Z | 1 |
| Emami, S; Ghobadi, E; Saednia, S | 1 |
| Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
| Driscoll, MD; Lafite, P; Levy, C; Leys, D; Mast, N; McLean, KJ; Munro, AW; Pikuleva, IA; Rigby, SE | 1 |
| Algueró, M; Bartroli, J; Boncompte, E; Forn, J; García-Rafanell, J; Turmo, E; Vericat, ML | 1 |
| Kukla, MJ; Liu, L; Marichal, P; Odds, F; Saha, AK; Simoneaux, RL | 1 |
| Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
| Casciano, CN; Clement, RP; Johnson, WW; Wang, EJ | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Casciano, CN; Clement, RP; Johnson, WW; Lew, K; Wang, EJ | 1 |
| Fischer, H; Huwyler, J; Poli, S; Schwab, D; Tabatabaei, A | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ji, H; Jiang, Q; Lü, J; Miao, Z; Sheng, C; Song, Y; Xu, H; Yao, J; Zhang, M; Zhang, W; Zhou, Y; Zhu, J | 1 |
| Abonía, R; Delgado, P; Enriz, RD; Garibotto, FM; Insuasty, B; Juárez, S; Nogueras, M; Quiroga, J; Rodero, L; Sortino, M; Zacchino, SA | 1 |
| Bergès, T; Bouchara, JP; Chabasse, D; Hennequin, C; Tronchin, G; Vandeputte, P | 1 |
| Ekins, S; Harwood, HJ; Hoover, DJ; Lawton, MP; Mankowski, DC; Treadway, JL | 1 |
| Guengerich, FP; Isin, EM | 1 |
| Cheng, S; Clancy, CJ; Clapp, W; Nguyen, KT; Nguyen, MH | 1 |
| Cao, YB; Jiang, YY; Sun, QY; Wu, QY; Xu, JM; Zhang, DZ; Zhang, J; Zhang, WN; Zhao, HQ | 1 |
| Alvarado-Ramírez, E; Torres-Rodríguez, JM | 1 |
| Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA | 1 |
| Herrmann, JV; Miltenberger, R; Müller, FM; Salvenmoser, S; Staudigel, A; Tredup, A | 1 |
| Deising, HB; Serfling, A; Wohlrab, J | 1 |
| Cao, Y; Chen, J; Ji, H; Jiang, Y; Li, Y; Liang, R; Lü, J; Tang, H; Yao, B; Zheng, C; Zhou, Y; Zhu, J | 1 |
| Enriz, RD; Freile, M; Gupta, MP; Kouznetsov, VV; Sortino, M; Vargas Méndez, LY; Vásquez, Y; Zacchino, SA | 1 |
| Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C | 1 |
| Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Gutierrez, MO; Rodriguez-Tudela, JL | 1 |
| Azor, M; Cano, J; Fothergill, AW; Gené, J; Guarro, J; Rinaldi, MG; Sutton, DA | 1 |
| Jiang, Y; Jin, Y; Li, P; Liu, P; Sun, P; Sun, Q; Wu, Q; Xie, W; Yang, X; Zhang, D; Zhang, Y; Zhu, S | 1 |
| Artico, M; Botta, M; Caporuscio, F; Cirilli, R; D'Auria, FD; De Melo, NR; Kelly, SL; La Regina, G; La Torre, F; Lamb, DC; Nencioni, L; Olla, S; Palamara, AT; Piscitelli, F; Silvestri, R; Tafi, A | 1 |
| Kelly, DE; Kelly, SL; Manning, NJ; Merkamm, M; Parker, JE; Pompon, D | 1 |
| Cannon, RD; Holmes, AR; Lamping, E; Nakamura, K; Niimi, K; Niimi, M; Ranchod, A; Tyndall, JD | 1 |
| Jackson, CJ; Kelly, DE; Kelly, SL; Lamb, DC; Marczylo, TH; Parker, JE; Warrilow, AG | 1 |
| Chai, X; Dan, Z; Hu, H; Jiang, Y; Sun, Q; Wu, Q; Yu, S; Zhang, J | 1 |
| Cheng, A; Lou, H; Sun, L; Sun, S; Wu, X; Zhang, Y | 1 |
| Alexopoulos, EC; Antonopoulou, S; Aoun, M; Baka, S; Grigoriou, O; Kalambokas, T; Kouskouni, E; Logothetis, E; Papadias, K; Velegraki, A; Zannos, A | 1 |
| Rahkhoodaee, F; Raymond, M; Tsao, S | 1 |
| Chai, X; Dan, Z; Hu, H; Wu, Q; Yu, S; Zhang, D; Zhang, J; Zhao, Q; Zou, Y | 1 |
| Ambudkar, SV; Manoharlal, R; Prasad, R; Prasad, T; Puri, N; Sharma, M; Shukla, S | 1 |
| Gao, C; Pang, G; Sun, S; Wang, B; Xu, Y; Zhao, D; Zhou, L | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bader, O; Gross, U; Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Warrilow, AG; Weig, M | 1 |
| Chai, X; Guan, Z; Hu, H; Sun, Q; Wu, Q; Yan, Y; Yu, S; Zou, Y | 1 |
| Bader, O; Gross, U; Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, N; Warrilow, AG; Weig, M | 1 |
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Xu, J; Yu, S; Zhang, D; Zhang, J; Zou, Y | 1 |
| Juvonen, RO; Koskiranta, J; Ollakka, R; Rahnasto-Rilla, M; Raunio, H; Ritvanen, A; Salminen, KA; Tani, N; Wittekindt, C | 1 |
| Chai, X; Hu, H; Liao, J; Wu, Q; Xu, M; Yu, S; Zhao, Q; Zou, Y | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chai, X; Ding, H; Li, L; Wang, B; Wu, Q; Yu, S; Zou, Y | 1 |
| Chai, X; Hu, H; Huang, T; Li, R; Li, X; Wu, M; Wu, Q; Yu, S; Zhao, Q; Zou, Y | 1 |
| Gerwick, WH; Kurtán, T; Liu, B; Mándi, A; Sun, P; Tang, H; Wang, ZW; Xu, DX; Zhang, W | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cheng, M; Hao, C; Liu, C; Su, X; Sun, B; Wei, P; Zhang, X; Zhao, D; Zhao, L; Zhao, S | 1 |
| Cheng, M; Hao, C; Liu, C; Su, X; Wei, P; Wu, M; Zhang, X; Zhao, D; Zhao, L; Zhao, S | 1 |
| Benhamou, RI; Dorot, O; Elias, R; Fridman, M; Jaber, QZ; Oved, K; Pichinuk, E; Zada, SL | 1 |
| Denning, DW; Hanson, LH; Perlman, AM; Stevens, DA | 1 |
| Cauwenbergh, G | 2 |
| Bhandari, V; Narang, A | 1 |
| Carbon, C; Gillardin, JM; Joly, V; Le Conte, P; Saint-Julien, L; Yeni, P | 1 |
| Rex, J | 1 |
| Abel, SM; Back, DJ; Tjia, JF | 1 |
| Breckenridge, A | 1 |
| Granger, SE; Loo, P; Tobin, JM | 1 |
| Blume, KG; Denning, DW; Stepan, DE; Stevens, DA | 1 |
| Badcock, NR; Thompson, PJ; Watkins, DN | 1 |
| Kalin, M | 1 |
| Chaffanjon, P; Delbeke, E; Lafeuillade, A; Quilichini, R | 1 |
| de Gans, J; Eeftinck Schattenkerk, JK; Portegies, P; Stam, J; Tiessens, G; van Boxtel, CJ; van Ketel, RJ | 1 |
| Cauwenbergh, G; De Doncker, P; Janssen, PA; Lachapelle, JM; Tennstedt, D | 1 |
| Gedde, S; Head, WS; O'Day, DM; Robinson, RD; Williams, TE | 1 |
| Bodey, GP | 1 |
| Bradsher, RW | 3 |
| Wheat, LJ | 1 |
| Denning, DW; Graybill, JR; Hanson, LH; Pappagianis, D; Rinaldi, MG; Sharkey, PK; Stevens, DA; Tucker, RM | 1 |
| Chiewchanvit, S; Hirunsri, P; Nelson, KE; Sirisanthana, T; Supparatpinyo, K; Uthammachai, C | 1 |
| Chapman, SW; Cleary, JD; Taylor, JW | 1 |
| Carlson, AN; Foulks, GN; Kim, JH; Perfect, JR | 1 |
| Cauwenbergh, G; De Doncker, P; Heykants, J; Roseeuw, D; Van Cutsem, J; Van de Velde, V; Willems, J; Willemsen, M; Woestenborghs, R | 1 |
| Barnes, M; Burdon, JG; Harris, A | 1 |
| Andrade, J; Armstrong, D; Edwards, F; Niki, Y; Schmitt, HJ | 1 |
| Hiller, EJ | 1 |
| Gallin, JI; Kwon-Chung, KJ; Williamson, PR | 1 |
| Bhiraleus, P; Dusitsin, N; Pupaibul, K; Roongpisuthipong, A; Sentrakul, P; Sukroongreung, S | 1 |
| Baran, R | 1 |
| Cajot, MA; Gosselin, B; Goullard, L; Koussa, A; Marquette, F; Pol, A; Roux, JP; Soots, G; Warembourg, H | 1 |
| Denning, DW; Hostetler, JS; Stevens, DA | 1 |
| van't Wout, JW | 1 |
| Bayles, MA | 2 |
| Van Cutsem, J | 5 |
| Viviani, MA | 2 |
| Bloom, PA; Easty, DL; Laidlaw, DA; Warnock, DW | 1 |
| Shannon, D | 1 |
| Basugi, N; Eguchi, M; Matsuno, A; Yoshida, S | 1 |
| Azanza, JR; Catalán, M; Herreros, J; López-Ocariz, A | 1 |
| Lanigan, SW | 1 |
| Carbon, C; Eloy, O; Ghnassia, JC; Joly, V; Yeni, P | 1 |
| Forbes, NA; Goudswaard, MF; Simpson, GN | 1 |
| Chotmongkol, V; Jitpimolmard, S | 2 |
| Noppakun, N; Phuphaibool, K | 1 |
| Atkinson, K; Enno, A; Walsh, M; White, L | 1 |
| Bhakoo, ON; Bhandari, V; Kumar, B; Nair, PM; Narang, A; Singh, M | 1 |
| Blomqvist, K; Brandt, H; Havu, V; Hollmen, A; Kohtamäki, K; Lehtonen, L; Piepponen, T; Turjanmaa, K | 1 |
| Garg, AK; Hamir, Z; Padhye, AA; Sekhon, AS | 1 |
| Castro, LG | 1 |
| van den Anker, JN | 1 |
| Guyotat, D; Marzullo, C; Persat, F; Piens, MA; Rochet, MJ | 1 |
| Lesher, JL | 1 |
| Hendriks, WD; Sizoo, W | 1 |
| Bava, AJ; Negroni, R | 1 |
| Bender, HG; Laufer, B | 1 |
| Borgers, M; Jansen, T; Odds, FC; Xhonneux, B | 1 |
| Belghiti, J; Benhamou, JP; Bernuau, J; Degott, C; Dupont, B; Durand, F; Sauvanet, A | 1 |
| Büchner, T; Roos, N | 1 |
| Jones, PD; See, J | 1 |
| Lode, H; Schaberg, T | 1 |
| Aerts, F; Cools, M; Van Wauwe, J | 1 |
| Bordignon, GF; Cauwenbergh, G; Fillus, JN; Lameira, RP; Purim, KS; Queiroz-Telles, F; Van Cutsem, J | 1 |
| Bowles-Patton, C; Bradsher, RW; Chapman, SW; Cloud, GC; Dismukes, WE; George, RB; Girard, WM; Kauffman, CA; Saag, MS; Stevens, DA | 1 |
| Bagnasco, FA; Kauffman, CA | 1 |
| al-Abedeen Jamjoom, Z; al-Hedaithy, S; Jamali, A; Jamjoom, A; Malabarey, T | 1 |
| Chaidemenos, G; Chatzopoulou, E; Kalogeropoulou, A; Karakatsanis, G; Kousidou, T; Michailidis, D; Panagiotidou, D; Teknetzis, A | 1 |
| Masclans, JR; Pérez, A; Planas, M; Tenorio, L | 1 |
| Collignon, P; McGregor, A; McNicol, D | 1 |
| Bunting, W; Greatorex, FB; Jones, W; Pether, JV | 1 |
| Fong, IW | 1 |
| Bhagavathula, PR; Brummer, E; Hanson, LH; Stevens, DA | 1 |
| Lozano, MC; Martín, E; Parras, P | 1 |
| Crevits, B; Kint, A; Naeyaert, JM; Van der Straeten, E; Van Hecke, E | 1 |
| Chotmongkol, V; Techasuknirun, A | 1 |
| Chotmongkol, V; Sookprasert, A | 1 |
| Baosoung, V; Chaimongkol, B; Chiewchanvit, S; Hirunsri, P; Sirisanthana, T; Supparatpinyo, K; Uthammachai, C | 1 |
| Balmus, KJ; Lavrijsen, AP; Nugteren-Huying, WM; Roldaan, AC; Stricker, BH; van't Wout, JW | 1 |
| Gazzard, BG; Smith, D; van de Velde, V; Woestenborghs, R | 1 |
| Kujala, P; Ruutu, P | 1 |
| Adibzadeh, M; Friccius, H; Pawelec, G; Pohla, H; Schenk, A; Siegels-Hübenthal, P | 1 |
| Kajita, M; Niimi, T; Saito, H | 1 |
| Bissonnette, KW; Davis, B; Dykstra, MH; Kaufman, L; Padhye, AA; Robertson, IR; Sharp, NJ | 1 |
| Dunn, JF; Fetchick, RJ; Graybill, JR; Hardin, TC; Rinaldi, MG; Sharkey, PK | 1 |
| Ehninger, G; Jaschonek, K; Pawelec, G; Rehbein, A; Schaudt, K | 1 |
| Ruffin, RE | 1 |
| Aoki, K; Matsuzaka, A; Uchida, K; Yamaguchi, H | 1 |
| Aoki, K; Hosaka, J; Uchida, K; Yamaguchi, H | 1 |
| Hiratani, T; Yamaguchi, H | 1 |
| Shibuya, K; Uchida, K; Yamaguchi, H | 1 |
| Durmaz, B | 1 |
| Bellamy, J | 1 |
| Bots, GT; de Beer, FC; Ottenhoff, TM; Peters-Christodoulou, MN; Thompson, J; van 't Wout, JW | 1 |
| Lamey, PJ; Lewis, MA; Samaranyake, LP | 1 |
| Cruz, S; de Hoyos, LA; Diaz, M; Puente, R | 1 |
| Denning, DW; Lewiston, NJ; Stevens, DA; Van Wye, JE | 1 |
| Berry, G; Denning, DW; Kramer, MR; Lewiston, NJ; Marshall, SE; Ross, DJ; Stevens, DA; Theodore, J | 1 |
| Cobbs, CG; Dismukes, WE; Lank, KM; Smith, KR | 1 |
| Kloss, S; Lamprecht, J; Schroten, H; Schuster, A; Wahn, V | 1 |
| Barton, SE; Gazzard, BG; Kell, PD; Midgley, J; Samarasinghe, PL; Smith, DE | 1 |
| Honda, A; Kamei, K; Kohno, N; Kuriyama, T; Miyaji, M; Nagao, K; Tabeta, H; Unno, H; Yamaguchi, T | 1 |
| Ancarani, F; Arzeni, D; Barchiesi, F; Scalise, G | 1 |
| Hiruma, M; Kawada, A; Kukita, A; Shimizu, T | 1 |
| Arenas, R; Domínguez, L; Fernández, G | 1 |
| Back, DJ; Tjia, JF | 1 |
| Avril, MF; Dupont, B; Paul, C; Pialoux, G; Pradinaud, R | 1 |
| Borgers, MJ; Jansen, TM; Odds, FC; Van Cutsem, JM; Van de Ven, MA | 1 |
| Hendriks, WD; Sizoo, W; Thunnissen, PL | 1 |
| Chakrabarti, A; Kaur, I; Kumar, B; Sharma, VK | 1 |
| Amann, F; Korting, HC; Lukacs, A; Peuser, R; Schäfer-Korting, M | 1 |
| Ehninger, G; Jaschonek, K; Pawelec, G | 1 |
| Bradford, CR; Copplestone, JA; Prentice, AG; Warnock, DW | 1 |
| Allan, M; Connolly, GM; Gazzard, BG; Midgley, J; Smith, DE | 1 |
| al Saleh, QA; al-Fouzan, AS; Najem, NM; Rostom, AI | 1 |
| de Pauw, BE; Fibbe, WE; Novakova, I; van der Meer, JW; van't Wout, JW; Verhagen, CA | 2 |
| Denning, DW | 2 |
| Hostetler, JS; Stevens, DA | 1 |
| Banham, SW; Campbell, JH; Richardson, MD; Shankland, GS; Winter, JH | 1 |
| Bor, A; Elad, D; Golomb, P; Orgad, U; Perl, S; Shenkler, S; Trainin, R; Tsur, I; Yakobson, B | 1 |
| Fuhrer, J; Heller, HM | 1 |
| Cauwenbergh, G; De Doncker, P; Dockx, P; Janssen, PA; Matthieu, L; van de Velde, V; Woestenborghs, R | 1 |
| Bolzinger, T; Pradinaud, R | 1 |
| Baraggino, E; Orsetti, G; Pecorari, D; Ribaric, G; Wiesenfeld, V | 1 |
| Brasseur, R; Duquenoy, PH; Goormaghtigh, E; Marichal, P; Ruysschaert, JM; Vanden Bossche, H | 1 |
| Andrade, L; Francisca, A; Silva-Cruz, A; Sobral, L | 1 |
| Barnes, M; Burdon, J; Harris, A | 1 |
| Didier, ES; Held, KS; Martinez, JA; Shadduck, JA; Tio, FO; Yee, RW | 1 |
| Dietlein, J; Fiscella, R; Peyman, GA; Schulman, JA | 1 |
| Gollapudi, S; Gupta, S; Kim, J | 1 |
| Alberico, G; Cotilli, G; Goitre, M; Puiatti, P; Salvai, M | 1 |
| Allenmark, S; Edebo, A; Lindgren, K | 1 |
| Aricò, M; Burgio, GR; Caselli, D; Cavanna, C; Michelone, G; Nespoli, L | 1 |
| St-Germain, G | 1 |
| Cilli, P; Difonzo, EM; Panconesi, E | 1 |
| Cauwenbergh, G; De Doncker, P | 1 |
| Graybill, JR; Sharkey, PK | 1 |
| Coussement, W; De Coster, R; Lampo, A; Marsboom, R; Van Cauteren, H; Vandenberghe, J; Vanparys, P | 2 |
| Cauwenbergh, G; Heykants, J; Lavrijsen, K; Meuldermans, W; Van Peer, A; Woestenborghs, R | 1 |
| Wesel, S | 1 |
| Merkus, JM; Van Heusden, AM | 2 |
| Shindo, K | 1 |
| Akoun, G; Dupont, B; Koeger, A; Lebreton, C; Milleron, B; Roger, V; Roux, P | 1 |
| Stangerup, M; Svejgaard, E; Walsøe, I | 1 |
| Borgers, M; Faergemann, J | 1 |
| Fraimow, HS; Moore, JH; Ost, D; Paluzzi, RG; Sachs, MK | 1 |
| Blomley, M; de Belder, A; Teare, EL; Thway, Y; Weston, M | 1 |
| Denning, DW; Dupont, B; Stevens, DA; Tucker, RM | 1 |
| Hommura, S; Ishibashi, Y; Ishii, K; Kabata, T; Matsumoto, Y; Watanabe, R; Yasuraoka, K | 1 |
| Behrendt, H; Heykants, J; Korting, HC; Lukacs, A; Schäfer-Korting, M | 1 |
| Hay, RJ; Mehentee, JF | 1 |
| Raven, EJ; van 't Wout, JW; van der Meer, JW | 1 |
| Arning, M; Scharf, RE; Schneider, W; Wolf, HH | 1 |
| Ringel, SM | 1 |
| Jacobs, PH; Nall, L | 1 |
| Badcock, NR | 1 |
| Hector, RF; Yee, E | 1 |
| Defaveri, J; Graybill, JR; Sun, SH | 1 |
| Kint, RT; Mertens, RL; Peremans, W; Roseeuw, D; Van Cutsem, J; Willemsen, M | 1 |
| Bailey, EM; Krakovsky, DJ; Rybak, MJ | 1 |
| Gomez, I; Munera, MI; Naranjo, MS; Restrepo, A; Restrepo, P; Trujillo, M | 1 |
| Baba, M; Iwata, K; Naito, N; Ohsumi, M; Taki, A; Yamada, N; Yamashita, T | 1 |
| Andreassian, B; Bouttier, S; Branger, C; Elzaabi, M; Icard, P; Nussaume, O | 1 |
| Defaveri, J; Graybill, JR | 1 |
| Linde, I; Mattie, H; Meynaar, I; Poell, R; Van 't Wout, JW; Van Furth, R | 1 |
| Denning, DW; Galgiani, JN; Keogh, AM; Kramer, MR; Lewiston, NJ; Marshall, SE; Stevens, DA; Theodore, J; Tucker, RM | 1 |
| Kühn, AG; Lamprecht, J; Sauer, S | 1 |
| Alfaham, M; Clement, MJ; Edwards, JH; Fifield, R; Goodchild, MC; Philpot, C | 1 |
| Guinet, R; Marlier, H | 2 |
| Campbell, C; Gazzard, B; Midgley, J; Nelson, M; Rowe, I; Youle, M | 1 |
| Larsen, RA | 1 |
| Cloud, GA; Dismukes, WE; Galgiani, JN; Graybill, JR; Stevens, DA | 1 |
| Easty, DL; Hart, JC; Ragge, NK; Tyers, AG | 1 |
| Greene, CE; Medleau, L; Rakich, PM | 1 |
| Boudghène-Stambouli, O; Mérad-Boudia, A | 1 |
| Delescluse, J | 1 |
| Bonifaz, A; Saul, A | 1 |
| Esola-Macre, J; Legendre, R | 1 |
| Clayton, YM; Hay, RJ; Midgely, G; Moore, MK | 2 |
| Blatchford, NR | 1 |
| Counts, GW; Frenkel, L; Graybill, JR; Greer, DL; Hoeprich, PD; Peterie, JD; Rinaldi, MG; Sharkey, PK; Stevens, DA; Tucker, RM | 1 |
| Assaisso, ML; Cristina, S; Farina, C; Gubertini, G; Minetti, B; Pagano, A; Suter, F; Tortorano, AM; Vigevani, GM; Viviani, MA | 1 |
| Arathoon, EG; Denning, DW; Rinaldi, MG; Stevens, DA; Tucker, RM | 1 |
| Denning, DW; Hanson, LH; Stevens, DA; Tucker, RM | 2 |
| Dupont, B | 4 |
| Otcenásek, M | 1 |
| Roesler, J | 1 |
| Arrese Estrada, J; Piérard, GE; Piérard-Franchimont, C; Rurangirwa, A | 1 |
| Richardson, C; Soo, SC; Summerton, C; Yeh, J | 1 |
| Denning, DW; Hanson, LH; Stevens, DA | 1 |
| Perfect, JR; Ritter, W; Wright, KA | 1 |
| Milburn, PB; Tuffanelli, L | 1 |
| Barnett, JM; Scher, RK | 1 |
| Dupont, B; Hennequin, C; Pialoux, G; Ravisse, P | 1 |
| Broestler, J; Brown, D; Golden, J; Piper, JP | 1 |
| Meunier, F | 1 |
| Mundell, AC | 1 |
| Denning, DW; Haq, Y; Stevens, DA; Tucker, RM | 1 |
| König, HJ; Mühldorfer, SM | 1 |
| Pechère, JC; Ponce, E | 1 |
| De Beuckelaere, S; De Beule, K; De Greve, J; Impens, N; Meysman, M; Schandevyl, W | 1 |
| Ballard, SA; Ellis, SW; Kelly, SL; Troke, PF | 2 |
| Mai, GT; McCormack, JG; Seow, WK; Thong, YH; Vuddhakul, V | 1 |
| Aneja, N; Dogra, J; Lal, BB; Mishra, SN | 1 |
| Badcock, NR; Davies, A | 1 |
| Damanhouri, Z; Gumbleton, M; Nicholls, PJ; Shaw, MA | 1 |
| Dunker, H; Kaben, U; Westphal, HJ; Zimmermann, R | 1 |
| Antoine, GA; Raterink, MH | 1 |
| Bortolotti, U; Chiominto, B; Faggian, G; Gallucci, V; Livi, U; Mazzucco, A; Stellin, G; Vivani, MA | 1 |
| Almaviva, M; Cristina, S; De Maria, R; Ferrazzi, P; Fiocchi, R; Langer, M; Negri, C; Scoccia, S; Tortorano, AM; Viviani, MA | 1 |
| Clissold, SP; Grant, SM | 1 |
| Mattie, H; van Furth, R; Van t Wout, JW | 1 |
| Hart, DT; Lauwers, WJ; Opperdoes, FR; Vanden Bossche, H; Willemsens, G | 1 |
| Arechavala, A; Negroni, R; Robles, AM; Taborda, A | 1 |
| Gasparini, R; Gauwenbergh, G; Heykants, J; Van Peer, A; Woestenborghs, R | 1 |
| Clark, J; Manzella, JP | 1 |
| Bava, AJ; Finquelievich, JL; Iovannitti, C; Negroni, R | 2 |
| Kobayashi, GS; Spitzer, ED | 1 |
| Graybill, JR | 2 |
| Goldberg, DJ; Green, ST; Kennedy, DH; McGuire, W; Nathwani, D | 1 |
| Burke, J; Johnson, EM; Pracharktam, R; Warnock, DW | 1 |
| Fransen, J; Janssen, PA; Van Cutsem, J; Van Gerven, F | 1 |
| Bush, EN; De, B; Diaz, G; Jae, HS; Johnson, ES; Perun, TJ; Plattner, JJ | 1 |
| Cavanna, C; Gramegna, G; Lombardi, G; Marangoni, E; Michelone, G; Poma, G | 1 |
| Bastide, JM; Bastide, M; Jouvert, S; Mallie, M; Montes, B | 1 |
| Denning, DW; Hamilton, JR; Hanson, LH; Stevens, DA; Tucker, RM | 1 |
| Warnock, DW | 1 |
| Albanese, G; Crippa, D; Giorgetti, P; Sala, G; Santagostino, L | 1 |
| Baker, JH; Goodpasture, HC; Kuhns, HR; Rinaldi, MG | 1 |
| Burke, WA | 1 |
| de Muinck Keizer-Schrama, SM; Dzoljic-Danilovic, G; Frenkel, J; Meradji, M; Neijens, HJ; van Dongen, JJ | 1 |
| Flores, V; Galimberti, RL; Gonzalez Ramos, MC; Villalba, LI | 1 |
| Cumming, D; Elliott, JA; Milne, LJ | 1 |
| Blancard, A; Goudard, M; Mary, C; Quilici, M; Regli, P | 1 |
| Jacquemin, JL; Lacroix, C; Rabot, MH; Rovira, JC; Villard, C | 1 |
| Ehninger, G; Einsele, H; Jaschonek, K; Roth, HJ; Steinhilber, D | 1 |
| Boogaerts, MA; De Beule, K; Demuynck, H; Verbist, L; Verhoef, GE; Zachee, P | 1 |
| Arathoon, EG; Brummer, E; Stevens, DA | 1 |
| Bellens, D; Coene, MC; Gorrens, J; Janssen, PA; Marichal, P; Moereels, H; Roels, I; Vanden Bossche, H; Willemsens, G | 1 |
| Borgers, M; Van de Ven, MA | 1 |
| Cauwenbergh, G; Heykants, J; Lavrijsen, K; Meuldermans, W; Van Cutsem, J; Van de Velde, V; Van Peer, A; Van Rooy, P; Woestenborghs, R | 1 |
| Bradford, GR; Prentice, AG | 1 |
| Gwiezdziński, Z; Nierebińska, E; Urbanowski, S | 1 |
| Cauwenbergh, G; Cornu, G; De Beule, K; Ninane, J; Sluysmans, T; Vermylen, C; Woestenborghs, R | 1 |
| Freeman, S; Tam, M | 1 |
| De Laurenzi, A | 1 |
| Polak, A | 1 |
| Aste, N; Biggio, P; Pau, M | 1 |
| Robertson, LI | 1 |
| Longman, LP; Martin, MV | 1 |
| Finquelievich, JL; Gosis, AS; Negroni, R | 1 |
| Barnard, PG; Bloch, B; Burger, GD; Meyer, JS; Parkes, JR; Smythe, E | 1 |
| Janssen, PA; Van Cutsem, J; Van Gerven, F | 1 |
| de Gans, J; Eeftinck Schattenkerk, JK; van Ketel, RJ | 1 |
| Cauwenbergh, G; Degreef, H; Haeverans, K; Heykants, J; Van Rooy, P; Woestenborghs, R | 1 |
| Dismukes, WE; Saag, MS | 1 |
| Calderon, RA; Goodfellow, A; Hay, RJ; Mayou, SC | 1 |
| Burke, J; Turner, A; Warnock, DW | 1 |
| Angtuaco, EJ; Bradsher, RW; Jay, WM; LeMay, B; Snyderman, N | 1 |
| Cervetti, O; Forte, M | 1 |
| Walsh, TJ | 1 |
| Andrade, L; Oliveira, JE; Silva Cruz, A; Sobral, JL | 1 |
| Borghys, AM; Cauwenbergh, G; Degreef, H; Dupré, K; Mariën, K | 1 |
| Difonzo, EM; Palleschi, GM; Panconesi, E; Vannini, P | 1 |
| Tortorano, AM; Viviani, MA | 1 |
| Cannistraci, C; Cristaudo, A; Santucci, B | 1 |
| Hanifin, JM; Tofte, SJ | 1 |
| Arechavala, A; Finquelievich, JL; Negroni, R | 1 |
| Dismukes, WE | 1 |
| D'Auria, FD; Lucchetti, G; Simonetti, N; Strippoli, V | 1 |
| Coulaud, JP; Ngo Van, P | 1 |
| Abraham, DJ; Kalavathy, CM; Rajasekaran, J; Thomas, PA | 1 |
| Faergemann, J | 5 |
| Pizzo, A; Walsh, TJ | 1 |
| Gordon, MA; Lapa, EW; Passero, PG | 1 |
| Beach, DH; Goad, LJ; Holz, GG | 1 |
| Klech, H; Losch, S; Pohl, W | 1 |
| Endo, T; Hommura, S; Ishibashi, Y; Ishii, K; Koyama, T; Matsumoto, Y; Watanabe, R; Yagita, K; Yasuraoka, K | 1 |
| Boelaert, J; Daneels, R; De Beule, K; Heykants, J; Matthys, E; Schurgers, M; van Peer, A; Woestenborghs, R | 1 |
| Cohen, O; De Pauw, BE; De Vries, F; De Witte, T; Donnelly, JP; Schattenberg, A | 1 |
| Engelhard, D; Leibovici, V; Naparstek, E; Or, R | 1 |
| Fetchick, R; Graybill, JR; Hardin, TC; Kuhn, JG; Rinaldi, MG; Woestenborghs, R | 1 |
| Blatchford, N; Cauwenbergh, G; Chwetzoff, E; Daunas, J; De Beule, K; De Doncker, P; Koster, M; Legendre, R | 1 |
| Chá Torea, JC; Negroni, R; Palmieri, OJ | 1 |
| Bauters, F; Delcambre, B; Duquesnoy, B; Gluckman, E; Hardouin, P; Thevenon, A; Vannimenus, PY; Walter, MP | 1 |
| Geerts, H; Gorrens, J; Janssen, PA; Marichal, P; Vanden Bossche, H | 1 |
| Cauwenbergh, G; Van Cutsem, J | 1 |
| Arathoon, EG; Stevens, DA; Tucker, RM; Williams, PL | 1 |
| Arango, M; de Bedout, C; Gomez, I; Gonzalez, A; Restrepo, A | 1 |
| Hay, RJ | 2 |
| Stevens, DA | 1 |
| Lucchetti, G; Retico, A; Simonetti, N; Strippoli, V | 1 |
| Canafax, DM; Dombrovskis, D; Remmel, RP | 1 |
| Van Cutsem, J; Van Hecke, E | 1 |
| D'Antuono, A; Morganti, L; Negosanti, M; Patrizi, A; Pizzino, D; Varotti, C | 1 |
| Abraham, DJ; Joseph, PC; Kalavathy, CM; Rajasekaran, J; Thomas, PA | 1 |
| Bennett, JE; Kan, VL | 1 |
| Janssen, PA; Vanden Bossche, H; Willemsens, G | 1 |
| Bending, MR; Davidson, DG; Eisinger, AJ; Foxall, PJ; Kwan, JT | 1 |
| Gumbleton, M; Nicholls, PJ; Shaw, MA | 1 |
| Boezeman, J; de Pauw, B; de Witte, T; Donnelly, P; Nováková, I; Veltman, G | 1 |
| Birnbaum, D; Brett, W; Jähnchen, E; Trenk, D | 1 |
| Gorrens, J; Marichal, P; Vanden Bossche, H | 1 |
| Heyl, T | 1 |
| Ackerbauer, H; Meingassner, JG; Mieth, H | 1 |
| Espinel-Ingroff, A; Gebhart, RJ; Shadomy, S | 2 |
| Ahrens, J; Graybill, JR | 2 |
| Durack, DT; Perfect, JR | 1 |
| Abbott, AB; Cockayne, A; Hayward, J; Odds, FC | 1 |
| Araujo, FG; McCabe, RE; Remington, JS | 1 |
| Rippon, JW | 1 |
| Gómez, I; Gutiérrez, R; Restrepo, A; Robledo, J; Tabares, AM | 1 |
| Durack, DT; Perfect, JR; Savani, DV | 2 |
| Aerts, F; De Brabander, M; Van Cutsem, J | 1 |
| Heykants, J; Lavrijsen, K; Meuldermans, W; Thijs, D; Van Houdt, J | 2 |
| Cauwenbergh, G; Degreef, H; Delescluse, J | 1 |
| Hopwood, V; Johnson, EM; Kennedy, CT; Smith, KJ; Van Cutsem, J; Vanden Bossche, H; Warnock, DW | 1 |
| Blaschke, TF; Brummer, E; McEwen, JG; Perlman, AM; Peters, GR; Restrepo, A; Stevens, DA | 1 |
| Abruzzo, GK; Bulmer, GS; Fromtling, RA | 1 |
| Borgers, M; Cauwenbergh, G; del Palacio Hernanz, A; Frias-Iniesta, J; Gonzalez-Valle, O; van Cutsem, J | 1 |
| Meingassner, JG; Schaude, M | 1 |
| Douglas, CJ; Johnson, EM; Richardson, MD; Warnock, DW | 1 |
| Borgers, M; Cauwenbergh, G; Vanden Bossche, H | 1 |
| Cauwenbergh, G; Cilli, P; Heykants, J; Larosa, E; Woestenborghs, R | 1 |
| Almaviva, M; Arici, C; Crocchiolo, P; Giani, PC; Goglio, A; Tortorano, AM; Viviani, MA | 1 |
| Fransen, J; Janssen, PA; Van Cutsem, J | 1 |
| Heykants, J; Lorreyne, W; Woestenborghs, R | 1 |
| Cobo, LM; Durack, DT; Perfect, JR; Savani, DV | 1 |
| Gorrens, J; Marichal, P; Van Cutsem, J; Van Gerven, F; Vanden Bossche, H | 1 |
| Galgiani, JN; Yozwiak, ML | 1 |
| Dunn, JF; Fetchick, R; Graybill, JR; Phillips, P | 1 |
| Cauwenbergh, G; Tortorano, AM; Viviani, MA; Woenstenborghs, R | 1 |
| Abruzzo, GK; Fromtling, RA; Giltinan, DM; Turnbull, TA | 1 |
| Wishart, JM | 1 |
| Muller, G; Sobel, JD | 1 |
| Abbott, AB; Odds, FC; Webster, CE | 1 |
| Borgers, M; Janssen, PA; Van Cutsem, J; Van de Ven, MA; Van Gerven, F | 1 |
| Backx, LJ; Heeres, J; Van Cutsem, J | 1 |
| Asgari, M; Back, DJ | 1 |
| Wenig, JA | 2 |
| Galloway, AM; O'Boyle, DA; Robins, GM; Watt, PR | 1 |
| Just-Nübling, G | 1 |
| Brasini, S; De Luca, C; Fabbri, AA; Fanelli, C; Passi, S | 1 |
| Baldwin, BC; Corran, A; Kelly, SL; Kwon-Chung, J; Lamb, DC | 1 |
| Hahn, K; Scheven, Ch; Scheven, M; Senf, A | 1 |
| Hoeprich, PD | 1 |
| Huang, G; Li, J; Nong, H | 1 |
| Ahearn, DG; Kalya, AV | 1 |
| Buffet, P; Caumes, E; Gentilini, M | 1 |
| Cross, JT; Hickerson, SL; Yamauchi, T | 1 |
| Barchiesi, F; Colombo, AL; McGough, DA; Rinaldi, MG | 1 |
| Benveniste, P; Chaubet, N; Gigot, C; Grausem, B; Loper, JC | 1 |
| Denning, DW; Law, D; Mason, C; Moore, CB; Wardle, HM | 1 |
| Andreu, A; Arévalo, MP; Arias, A; Rodríguez, C; Sierra, A | 1 |
| Venugopal, PV; Venugopal, TV | 2 |
| Wheat, J | 1 |
| Kivistö, KT; Klotz, U; Neuvonen, PJ | 1 |
| Bergman, W; Rutten, FF | 1 |
| Ancarani, F; Arzeni, D; Barchiesi, F; Del Poeta, M; Marinucci, G; Morbiducci, V; Scalise, G | 1 |
| Bartlett, MS; Queener, SF; Richardson, JD; Shaw, MM; Smith, JW | 1 |
| Neuvonen, PJ; Olkkola, KT; Varhe, A | 1 |
| Blanche, S; Brauner, R; Donadieu, J; Fischer, A; Griscelli, C; Levron, JC; Mouy, R; Veber, F | 1 |
| Ali, KB; Goh, CL; Koh, MT; Seow, CS; Tay, YK | 1 |
| Pohjola-Sintonen, S | 1 |
| Abriola, KP; Greer, DL; Hernandez, RL; Hoadley, DJ; Witzig, RS | 1 |
| DeDoncker, PR; Degreef, HJ | 1 |
| Roberts, DT | 1 |
| Bickers, DR | 1 |
| Gerritsen, J; Mannes, GP; van Aalderen, WM; van der Heide, S | 1 |
| O'Dell, CA; Symonds, JM | 1 |
| Hudson, M; Lim, SG; Pounder, RE; Sawyerr, AM; Sercombe, J | 1 |
| Backman, JT; Neuvonen, PJ; Olkkola, KT | 1 |
| Arikian, SR; Einarson, TR; Kobelt-Nguyen, G; Schubert, F | 1 |
| Arendorf, TM; van der Bijl, P | 1 |
| Edwards, JE; Filler, SG; Swerdloff, JN | 1 |
| Drew, RH | 1 |
| Breeling, JL; Weinstein, L | 1 |
| Balmus, KJ; Lavrijsen, AP; Nugteren-Huying, WM; Roldaan, AC; Stricker, BH; van 't Wout, JW | 1 |
| Jacobs, AE | 1 |
| Sangueza, OP; Shupack, JL; Stiller, MJ | 1 |
| Mummaw, N; Stein, GE | 1 |
| Acuña, G; Brengues, C; Cuny, G; Labarca, J; Muñoz, S; Oddó, D; Saavedra, H; Sepúlveda, C; Solari, A; Veas, F | 1 |
| Neuvonen, P; Pohjola-Sintonen, S; Toivonene, L; Viitasalo, M | 1 |
| Bannatyne, RM; Fong, IW; Wong, P | 1 |
| Cuevas, M; Martin, JA; Pacheco, A | 1 |
| Briggs, N; Connolly-Stringfield, P; Hafner, R; Hamill, R; Murphy, R; Owens, S; Powderly, W; Rinaldi, M; Saag, M; Spencer, P; Squires, K; Wheat, J; Wong, B; Wulfsohn, M | 1 |
| Blanchard, LM; Green, PJ; Sachs, MK | 1 |
| Berman, JD; Grogl, M; Soto-Mancipe, J | 1 |
| Ambroise-Thomas, P; Blanc, M; Grillot, R; Lebeau, B; Leclercq, P; Manquat, G; Pelloux, H | 1 |
| Meyer, C | 1 |
| Byard, RW; Ellis, DH; Moore, L; Suppiah, R; Toogood, IR | 1 |
| Barone, JA; Bierman, RH; Colaizzi, JL; Gaffar, MC; Koh, JG; Mechlinski, W; Moskovitz, BL; Swanson, KA; Van de Velde, V | 1 |
| Barker, JN; Hay, RJ; Smith, CH | 1 |
| George, F; Hernigou, A; Kazatchkine, MD; Lavarde, V; Piketty, C; Weiss, L | 1 |
| Cunningham, J; Holt, RI; Kwan, JT; Sefton, AM | 1 |
| Cox, NJ; Stolk-Engelaar, MV | 1 |
| Erskine, D; Gazzard, BG; Nelson, MR; Smith, D | 1 |
| Altés, A; Ausina, V; Brunet, S; Domingo-Albós, A; Martino, R; Nomdedéu, J | 1 |
| Johnson, EM; Warnock, DW; White, DJ | 1 |
| Ilavarasi, S; Ramakrishna, ES; Venugopal, PV; Venugopal, TV | 1 |
| Calcagno, AM; San-Blas, F; San-Blas, G | 1 |
| Fetchick, R; Graybill, JR; Sharkey-Mathis, PK; Velez, J | 1 |
| Klauss, V; Lund, OE; Miño de Kaspar, H | 1 |
| Goh, CL | 1 |
| De Doncker, P; Roseeuw, D | 1 |
| Geha, DJ; Goldberg, SL; Hoagland, HC; Inwards, DJ; Marshall, WF | 1 |
| Altman, A; Giller, R; Lanza, L; Menezes, AH; Peters, C; Sato, Y; Smith, RJ; Trigg, ME | 1 |
| Degreef, H | 1 |
| Cadranel, J; Dupont, B; Lortholary, O; Meyohas, MC; Peyramond, D; Salmon-Ceron, D; Simonin, D | 1 |
| Odds, FC | 2 |
| Barge, RM; Buiting, AG; van 't Wout, JW; Visser, LG | 1 |
| Cloud, G; Dismukes, WE; Graybill, JR; Hostetler, JS; Kauffman, CA; Sharkey-Mathis, PK; Stevens, DA | 1 |
| de Pauw, BE; Raemaekers, JM; van Dijke, BJ; Vreugdenhil, G | 1 |
| Catalin, J; Durand, A; Lacarelle, B; Rajaonarison, JF; Sampol, E | 1 |
| de Repentigny, L; Dion, C; Espinel-Ingroff, A; Ratelle, J; St-Germain, G | 1 |
| Canel, MA; Danis, M; Datry, A; Nozais, JP | 1 |
| Oster, G; Thompson, D | 1 |
| Johnson, EM; Warnock, DW | 1 |
| Karvonen, J; Ruutu, P | 1 |
| Eichmann, A; Schär, G | 1 |
| Cunha, BA; Klein, NC | 1 |
| Chen, SC; Gilbert, GL; Gordon, S; O'Donnell, ML | 1 |
| Adachi, A; Kanbe, T; Matsumoto, Y; Ohashi, M; Shibata, M; Tanaka, K | 1 |
| Rodríguez, MA; Salinas, MC; Welsh, O | 1 |
| Bolmström, A; Messer, SA; Odds, FC; Pfaller, MA; Rex, JH | 1 |
| Inoue, I; Kitajima, Y; Osada, K; Seishima, M | 1 |
| Bolmström, A; Lancaster, M; Odds, FC; Pfaller, MA; Rex, JH; Rinaldi, MG | 1 |
| Clark, FS; Gow, NA; Hitchcock, CA; Parkinson, T | 1 |
| Caldarola, G; Cauda, R; Morace, G; Ortona, L; Posteraro, B; Tacconelli, E; Tumbarello, M | 1 |
| Moreno, MI; Zaror, L | 1 |
| Goldman, M; Lee, YP | 1 |
| Friedman, HL; Greenblatt, DJ; Karsov, D; Schmider, J; Shader, RI; Vena, R; von Moltke, LL | 1 |
| Cuenca, M; Gadea, I; Gegúndez, MI; Soriano, F; Valero, ML; Zapardiel, J | 1 |
| Gøtzsche, PC; Johansen, HK | 1 |
| Carver, PL; Kauffman, CA | 1 |
| Adeyemi-Doro, FA; Chan, RC; Cheng, AF; Cheung, SW; Ng, TK | 1 |
| White, TC | 1 |
| Evans, S; Leake, H; Ustianowski, AP | 1 |
| Barbuch, R; Bard, M; Gachotte, D; Koegel, C; Lees, ND; Pierson, CA | 1 |
| Hecker, D | 1 |
| Cartledge, JD; Gazzard, BG; Midgley, J; Petrou, M; Shanson, D | 1 |
| Laurijssens, L; Vanden Bossche, H; Vermuyten, K | 1 |
| Cartledge, JD; Gazzard, BG; Midgley, J | 1 |
| Klimke, K; Schäfer-Korting, M | 1 |
| Hofmann, H; Metzger, S | 1 |
| Burgaleta, C | 1 |
| Bouza, E; Muñoz, P | 1 |
| Hernanz Hermosa, JM; Lázaro Ochaita, P | 1 |
| Berenguer Berenguer, J | 1 |
| Casali, AK; Hamdan, JS | 1 |
| Kadowaki, K; Komaki, H; Mikami, Y; Tanaka, Y; Thomson, KS; Yazawa, K | 1 |
| Andrew, SE; Brooks, DE; Dillavou, CL; Ellis, G; Kubilis, PS | 1 |
| Cabral, JM; Massa, A; Velho, GC | 1 |
| Chapman, SW; Rinaldi, MG; Rogers, PD; Sullivan, DC | 1 |
| Ghannoum, MA; Hawser, SP; Jessup, CJ; Norris, H | 1 |
| Demitrovicova, A; Kralovicova, K; Krcmery, V; Krupova, I; Kukuckova, E; Kunova, A; Mrazova-Studena, M; Oravcova, E; Spanik, S; Stopkova-Grey, K; Trupl, J | 1 |
| Balaña-Fouce, R; Cubría, JC; Ordóñez, D; Reguera, RM | 1 |
| Juhakoski, A; Lukkari, E; Pelkonen, O; Taavitsainen, P | 1 |
| Beatty, DW; Daubenton, JD | 1 |
| Kitada, M; Kiuchi, M; Nakamura, H; Nakasa, H; Ohmori, S; Ono, S; Tsutsui, M | 1 |
| Iga, T; Ishizuka, H; Kawahara, Y; Matsuo, H; Miyama, T; Naito, M; Sawada, Y; Takanaga, H; Tsuruo, T; Yamamoto, K; Yamano, K | 1 |
| Elewski, BE | 1 |
| Ten Broeke, R; Walenkamp, G | 1 |
| McLachlan, AJ; Tett, SE | 1 |
| Arceneaux, KA; Hosgood, G; Taboada, J | 1 |
| Jimenez, T; López-Jodra, O; Madrenys-Brunet, N; Siddat, M; Torres-Rodríguez, JM | 1 |
| Nguyen, MH; Yu, CY | 1 |
| Casal, M; Linares, MJ; Muñoz, JF; Rodríguez, FC; Solís, F; Valero, A | 1 |
| Bogaerts, M; Roodhooft, J; van Rens, G; Vermander, JM | 1 |
| Gano, DL; Guzek, JP; Roosenberg, JM; Wessels, IF | 1 |
| Care, SB; Lacey, SH | 1 |
| Counihan, M; Durol, AL; Graf, JA; Greenblatt, DJ; Harmatz, JS; Mertzanis, P; Roth-Schechter, B; Shader, RI; von Moltke, LL | 1 |
| Buri, P; Ganem-Quintanar, A; Kalia, YN; Quintanar-Guerrero, D; Tapia-Olguín, P | 1 |
| Burattini, MN; Colombo, AL; Costa, PR; Fischmann, O; Kallás, EG; Milan, EP | 1 |
| Araj, GF; Daher, NK; Tabbarah, ZA | 1 |
| Espinel-Ingroff, A; Ghannoum, MA; Killian, S; Knapp, CC; Messer, SA; Norris, HA; Pfaller, M | 1 |
| Terrell, CL | 1 |
| Iga, T; Kotaki, H; Sawada, Y; Yamamoto, K; Yamano, K | 1 |
| Frieden, IJ; Howard, RM | 1 |
| Bonnet, D; Cuguillière, A; Guigay, J; Jancovici, R; L'Her, P; Le Vagueresse, R; Lonjon, T; Miltgen, J; Natali, E; Vaylet, F | 1 |
| Dhindsa, MK; Naidu, J; Singh, SM | 1 |
| Kelly, DE; Kelly, SL; Lamb, DC; Rozman, D; Stromstedt, M; Waterman, MR | 1 |
| Ambroise-Thomas, P; Brion, JP; Grillot, R; Lebeau, B; Pavese, P | 1 |
| Desmet, P; Raes-Wuytack, C; Swinne, D; Van Looveren, K | 1 |
| Dalton, LM; McBain, J; Reidarson, TH | 1 |
| Alonso-Vargas, R; Arévalo, P; Bornay-Llinares, FJ; Carrillo-Muñoz, AJ; del Valle, O; Gasser, I; Quindós, G; Ruesga, MT; Santos, P; Tur-Tur, C | 1 |
| Backman, JT; Kivistö, KT; Neuvonen, PJ; Taavitsainen, P; Wang, JS; Wen, X | 1 |
| Balian, JD; Flockhart, DA; Yuan, R | 1 |
| Romano, C | 1 |
| Capone, D; de Noronha Andrade, G; do Valle, AC; Lazéra, MS; Londero, AT; Monteiro, PC; Moreno, AM; Wanke, B | 1 |
| Korting, HC; Niewerth, M | 1 |
| Faergemann, J; Gupta, AK; Kohli, Y; Li, A; Summerbell, RC | 1 |
| Hahn, RC; Hamdan, JS | 1 |
| Gibson, PG; Wark, P; Wilson, AW | 2 |
| Del Rosso, JQ; Gupta, AK | 1 |
| Apfalter, P; Hirschl, AM; Makristathis, A; Rotter, M; Seibold, M; Willinger, B | 1 |
| Smith, EB | 1 |
| Kibbler, CC; McWhinney, PH; Paterson, PJ; Potter, M; Prentice, HG | 1 |
| Ellepola, AN; Samaranayake, LP | 2 |
| Bodey, GP; Chatzinikolaou, I; Hajiioannou, I; Kontoyiannis, DP; Maraki, S; Rolston, KV; Samonis, G | 1 |
| Chambliss, ML; DeSpain, J; Johnston, KL | 1 |
| Barchiesi, F; Cogliati, M; Di Francesco, LF; Scalise, G; Tortorano, AM; Viviani, MA | 1 |
| Fernández-Ballart, J; Guarro, J; Pujol, I | 1 |
| King, S; McGeer, A; Richardson, S; Walmsley, S; Ye, Y | 1 |
| Barr, D; Smart, T | 1 |
| Brooks, JT; Wheat, LJ | 1 |
| Briand, V; Lortholary, O | 1 |
| Carrillo, AJ; Del Palacio, A; Fernández-Torres, B; Guarro, J; Martín, E; Moore, MK; Serrano, M; Valverde, A | 1 |
| Bonito, AJ; Patton, LL; Shugars, DA | 1 |
| Crego, AL; Gómez, J; Lavandera, JL; Marina, ML | 1 |
| Torres-Rodríguez, JM; Vivas, JR | 1 |
| Bruserud, O | 1 |
| Arrese, JE; Piérard, GE; Piérard-Franchimont, C | 2 |
| Fernández-Torres, B; Guarro, J; Pereiro, M | 1 |
| Kantarjiev, TB; Kuzmanov, AH; Zissova, LG | 1 |
| Alcântara, AP; Carvalho, MT; Colombo, AL; Ferreira, MS; Martinez, R; Milan, EP; Queiroz-Telles, F; Sant'Ana, Pde L | 1 |
| Bell-Syer, SE; Brunt, E; Crawford, F; Godfrey, C; Hart, R; Russell, I; Young, P | 1 |
| Capilla, J; Fernández-Torres, B; Guarro, J; Ortoneda, M; Pujol, I | 1 |
| Alvarado, D; Díaz, MC; Silva, V | 2 |
| Ichihara, S; Murasaki, C; Ohwada, J; Shimma, N; Umeda, I; Yamazaki, T | 1 |
| Marrazzo, J | 2 |
| Andrade, DR; Barone, AA; Benard, G; Del Negro, GM; Gryschek, RC; Higaki, Y; Hoo, S; Segurado, AA; Shikanai-Yasuda, MA; Vaccari, EH | 1 |
| Meneses-García, A; Morales-de la Luz, R; Mosqueda-Taylor, A; Rivera, LM | 1 |
| Engelen, M; Rochette, F; Vanden Bossche, H | 1 |
| Nikkels, AF; Piérard, GE | 1 |
| Brewster, M; Kempen, D; Peeters, J; Six, K; Van den Mooter, G; Verreck, G; Weuts, I | 1 |
| Usatine, RP | 1 |
| del Palacio, A; Garau, M; Pereiro, M | 1 |
| Alvareda, D; Silva, V; Zepeda, G | 1 |
| Gibson, PG; Wark, PA; Wilson, AJ | 2 |
| Gupta, AK; Kohli, Y | 1 |
| Gupta, AK; Ryder, JE | 1 |
| Fehér, J; Lengyel, G | 1 |
| Godoy, H; Reichart, PA | 1 |
| González-Monroy, J; Hernández-Hernández, F; López-Martínez, R; Manzano-Gayosso, P; Méndez-Tovar, LJ | 1 |
| Gangneux, JP; Guiguen, C; Preney, L; Théraud, M | 1 |
| Ausma, J; Borgers, M; Heeres, J; Meerpoel, L; Odds, F; Van Gerven, F; Vanden Bossche, H; Woestenborghs, F | 1 |
| Maertens, JA | 1 |
| Seebacher, C | 1 |
| Al Hedaithy, SS; Fotedar, R | 1 |
| Andrade, TS; Castro, LG; Cury, AE; Gimenes, VM; Nunes, RS | 1 |
| Akkar, A; Blaut, M; Müller, RH; Namsolleck, P | 1 |
| Della Torre, PK; Kluger, EK; Krockenberger, MB; Malik, R; Martin, P | 1 |
| Balaji, P; Chakrabarti, A; Panda, NK; Reddy, CE; Sharma, SC | 1 |
| Anagnostopolous, I; Gleissner, B; Schilling, A; Siehl, I; Thiel, E | 1 |
| Wark, P | 1 |
| Andreoni, S; Faggi, E; Farina, C; Fazii, P; Lombardi, G; Manso, E; Mazzoni, A; Nanetti, A; Pini, G | 1 |
| Chang, CL; Choi, JC; Kim, HH; Lee, EY; Lee, JN; Shin, JH | 1 |
| Spence, D | 2 |
| Antal, Z; Dóczi, I; Dósa, E; Kredics, L; Nagy, E; Varga, J | 1 |
| Carrillo-Muñoz, AJ; Casals, J; del Valle, O; Guardià, C; Guglietta, A; Palacín, C; Quindós, G; Rodríguez, V | 1 |
| Chimishkian, KL; Minenko, SV; Ptushkin, VV; Sokolova, EN; Zhukov, NV | 1 |
| Aeschlimann, C; Dunmire, D; Freedman, TB; Gal, J; Gerber, JG; Nafie, LA | 1 |
| Yasuda, MA | 1 |
| Ayangil, D; Cankaya, S; Ferahbaş, A; Koc, AN; Silici, S | 1 |
| Suh, MK | 1 |
| Alía-Aponte, C; Baró-Tomás, T; Jiménez-Cabello, T; Lázera, MS; Morera-López, Y; Torres-Rodríguez, JM | 1 |
| Niwa, T; Shiraga, T; Takagi, A | 1 |
| Braun, JJ; de Blay, F; Pauli, G | 1 |
| Bagg, J; Coulter, WA; Kuriyama, T; Lewis, MA; Ready, D; Williams, DW | 1 |
| Hector, RF | 1 |
| Arikan, S; Ayhan, M; Karaduman, A; Sancak, B | 1 |
| Dietrich, UM; Moore, PA; Ritchie, BW; Sanchez, S; Weinstein, WL; Wooley, RE | 1 |
| Crawford, F; Ferrari, J | 2 |
| Fontes, CJ; Menezes, VM; Soares, BG | 1 |
| Das, H; Deb, M; Khanal, B; Kumar, S; Panda, A | 1 |
| Atkins, WM; Hill, JJ; Isoherranen, N; Kunze, KL; Pearson, JT; Swank, J | 1 |
| Hamimah, H; Ng, KP; Rohani, MY; Tanty Haryanty, T; Tay, ST | 1 |
| Camacho, FM; Herrera, A; Ruiz de Casas, A; Suárez, AI | 1 |
| Choczaj-Kukuła, A; Kwaśniewska, J | 1 |
| San Filippo, J | 1 |
| Cepero de García, MC; Espinel-Ingroff, A; Rincón, S | 1 |
| Rott, T; Rylander, R; Tercelj, M | 1 |
| Khachemoune, A; Lichon, V | 1 |
| Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
| Barros, ME; Hamdan, JS; Santos, Dde A | 1 |
| Costa, CR; de Araujo, CR; de Fátima Lisboa Fernandes, O; do Rosário Rodrigues Silva, M; Miranda, KC; Passos, XS | 1 |
| Brocks, DR; El-Kadi, AO; Korashy, HM; Shayeganpour, A | 1 |
| da Silva Barros, ME; de Assis Santos, D; Soares Hamdan, J | 1 |
| Hatai, K; Kamei, K; Murata, Y; Nishimura, K; Sakaeyama, S; Sano, A | 1 |
| Carod, JF; Ramarozatovo, L; Randrianasolo, P; Randrianirina, F; Rapelanoro, FR; Ratsima, E | 1 |
| Gupta, A; Mao, Q; Unadkat, JD | 1 |
| de Assis Santos, D; Figueiredo, VT; Hamdan, JS; Resende, MA | 1 |
| Domínguez, M; Fernández-Torres, B; López-Aracil, V; Mayayo, E; Mayayo, R | 1 |
| Ahmed, AO; Coppens, J; de Kat, J; Fahal, A; van Belkum, A; van de Sande, WW; Verbrugh, H | 1 |
| Korting, HC; Schmid-Wendtner, MH | 1 |
| Brocks, DR; El-Kadi, AO; Korashy, HM | 1 |
| Abou-Auda, HS; Al-Humayyd, MS; Mustafa, AA | 1 |
| Carrillo-Muñoz, AJ; Casals, JB; del Valle, O; Estivill, MD; Ezkurra, PA; Giusiano, G; Quindós, G; Santos, P | 1 |
| Hernández-Hernández, F; López-Martínez, R; Manzano-Gayosso, P; Méndez-Tovar, LJ; Millan-Chiu, B; Mondragón-González, R; Velásquez-Hernández, V | 1 |
| Jordan, RM; Kosseifi, SG; Nassour, DN; Peiris, AN; Sarubbi, FA; Shaikh, MA | 1 |
| Kornienko, II; Kul'ko, AB; Litvinov, VI; Lovacheva, OV; Slogotskaia, LV | 1 |
| Bate, A; Edwards, IR; Norén, GN; Sundberg, R | 1 |
| Baines, SJ; Knights, CB; Lee, K; Patterson-Kane, JC; Rycroft, AN | 1 |
| Bulmer, GS; Pu, XM; Yi, LX | 1 |
| Balci, DD; Cetin, M | 1 |
| Shin, S; Sim, Y | 1 |
| Adibpour, N; Daneshtalab, M; Khalaj, A; Rezaee, S | 1 |
| Anderson, R; Steel, HC; Tintinger, GR | 1 |
| Antal, I; Klebovich, I; Kovács, K; Ludányi, K; Stampf, G | 1 |
| Islam, N; Islam, T; Kamal, M; Muhammad, N; Shafiquzzaman, M | 1 |
| Camizotti, LA; Cotrim, PC; Yamashiro-Kanashiro, EH | 1 |
| Celik, AD; Kantarcioglu, S; Mert, A; Ozaras, R; Ozturk, R; Tabak, F | 1 |
| Ambudkar, SV; Gaur, M; Prasad, R; Puri, N; Sharma, M; Shukla, S | 1 |
| Billack, B; Lau-Cam, C; Santoro, M | 1 |
| Brilhante, RS; Cordeiro, Rde A; de Camargo, ZP; de Lima, RA; Medrano, DJ; Monteiro, AJ; Rocha, MF; Sidrim, JJ; Tavares, JL | 1 |
| Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S | 1 |
| Accoceberry, I; Bernadou, JM; Breilh, D; Gordien, JB; Pigneux, A; Rouault, A; Saux, MC; Tabrizi, R; Vigouroux, S | 1 |
| Aoki, FH; de Almeida, EA; Guariento, ME; Pedro, Rde J; Silva, EL | 1 |
| Capoor, MR; Dhawan, J; Khanna, G; Ramam, M; Ramesh, V; Sugandhan, S | 1 |
| Figueiredo, FB; Gremião, ID; Monteiro, PC; Passos, SR; Pereira, SA; Schubach, TM; Silva, JN; Teixeira, JL | 1 |
| Millikan, LE | 1 |
| Kelly, DE; Kelly, SL; Lamb, DC; Martel, CM; Melo, N; Nes, WD; Parker, JE; Warrilow, AG | 1 |
| Heeres, J; Lewi, P; Meerpoel, L | 1 |
| Nakashima, K; Yamada, N; Yamamoto, O; Yoshida, Y | 1 |
| Calahorra, M; Lozano, C; Peña, A; Sánchez, NS | 1 |
| Hasegawa, A; Kamata, H; Kano, R; Nagata, M; Nijima, M | 1 |
| Fahal, AH; van Belkum, A; van de Sande, WW | 1 |
| Arslan, U; Fındık, D; Solgun, G; Türk Dağı, H | 1 |
| Alves, SH; Azevedo, MI; Botton, SA; Dutra, V; Jesus, FP; Lautert, C; Machado, ML; Mahl, DL; Santurio, JM; Zanette, RA | 1 |
| Abliz, P; Cheng, W; Deng, S; Hu, H; Li, R; Wan, Z; Wang, A | 1 |
| Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY | 1 |
| Cafarchia, C; Figueredo, LA; Iatta, R; Montagna, MT; Otranto, D | 1 |
| Duhem, N; Gohy, JF; Guillet, P; Jérome, C; Préat, V; Riva, R; Rolland, J; Schumers, JM | 1 |
| Hasegawa, A; Itoi, S; Kamata, H; Kano, R | 1 |
| Chen, TC; Chen, YC; Chen, YH; Lu, PL | 1 |
| Hu, C; Li, S; Sun, X; Zhang, H; Zhang, X; Zhang, Y; Zhang, Z | 1 |
| Abdel-Rahman, ME; El Hassan, TA; Fahal, AH; Mahgoub, el S; Zein, HA | 1 |
| Chang, W; Cheng, A; Li, Y; Liu, Y; Lou, H; Zhang, L | 1 |
| Curfs-Breuker, I; Fahal, AH; Kloezen, W; Meis, JF; van de Sande, WW | 1 |
| Donoso, MD; Haskell, RJ; Schartman, RR | 1 |
| Kelly, DE; Kelly, SL; Parker, JE; Warrilow, AG | 1 |
| Gärtner, P; Knoth, H; Petry, T | 1 |
| Helou, J; Maatouk, I; Moutran, R; Obeid, G | 1 |
| Abouhafsse, A; Agoumi, A; Al Hamany, Z; Benouchen, T; Malihi, A; Nacir, A; Razouk, S; Sebbani, S; Tligui, H | 1 |
| Chang, SY; Grubb, MF; Isoherranen, N; Peng, CC; Rodrigues, AD; Shirasaka, Y; Thummel, KE | 1 |
| Han, A; Hu, G; Kan, X; Lin, G; Qiu, X; Wang, C; Wang, Z; Xu, T | 1 |
| Bulut, Y; Tunçoğlu, E; Yenişehirli, A; Yenişehirli, G | 1 |
| Barbosa de Paulo, LF; Francisco Durighetto, A; Silva de Faria, L | 1 |
| Barbério, GS; Bueno, MG; da Silva, WJ; Neppelenbroek, KH; Pinto, L; Porto, VC; Urban, VM | 1 |
| Chen, C; Hasegawa, A; Hwang, CY; Kamata, H; Kano, R; Koike, A; Nagata, M; Watanabe, S | 1 |
| Li, S; Liu, J; Sun, X; Wang, K; Xie, B; Yu, X; Zhang, H; Zhou, F | 1 |
| Cuenca-Estrella, M; Escribano, P; Guinea, J; Martín-Mazuelos, E; Pemán, J; Sánchez-Reus, F; Zaragoza, Ó | 1 |
| Hall, SD; Higgins, JW; Ke, AB; Zamek-Gliszczynski, MJ | 1 |
| Ahmed, SA; de Hoog, GS; Duncanson, F; Fahal, AH; Kloezen, W; van de Sande, WW; Zijlstra, EE | 1 |
| Arioli Filho, JN; Bueno, MG; de Almeida, AL; Giannini, M; Lima, TF; Neppelenbroek, KH; Urban, VM | 1 |
| Higgins, JW; Ke, AB; Zamek-Gliszczynski, MJ | 1 |
| Li, L; Yuli, K; Zhang, Q; Zhao, Y; Zhu, J; Zhu, M | 1 |
| Cheung, BP; Samaranayake, LP; Samaranayake, YH; Yau, JY; Yeung, KW | 1 |
| Ahmed, SA; de Hoog, GS; Fahal, AH; Kloezen, W; van de Sande, WW | 1 |
| Babu Singh, YR; Galgóczy, L; Homa, M; Kredics, L; Manikandan, P; Mythili, A; Narendran, V; Panneerselvam, K; Priya, R; Shobana, CS; Vágvölgyi, C | 1 |
| Fong, PH; Lee, VH; Seneviratne, CJ; Wong, SS | 1 |
| Krüger, C; Mayser, P; Nenoff, P | 1 |
| Ramírez Soto, MC | 1 |
| Bello, A; Dresser, MJ; Heald, D; Komjathy, SF; Liu, L; O'Mara, E; Robertson, SM; Rogge, M; Stoch, SA | 1 |
| Adrjanowicz, K; Kaminska, E; Kamiński, K; Madejczyk, O; Paluch, M; Pionteck, J; Tarnacka, M | 1 |
| Bulanda, M; Jagielski, T; Skóra, M | 1 |
| Chen, X; Jin, C; Li, S; Liu, H; Sun, X; Wang, K; Zhang, Z | 1 |
| Buettner, B; Knoth, H; Scriba, GK | 1 |
| Aburub, A; Chen, X; Fadda, HM; Mishra, D; Pinal, R | 1 |
| Ravenstijn, P; Sensenhauser, C; Snoeys, J; Templeton, I | 1 |
| Abbas, MA; Ahmed, SA; Al-Hatmi, AM; de Hoog, GS; Jouvion, G; Kolecka, A; Mahgoub, el S | 1 |
| Buckley, DB; Isringhausen, CD; Ogilvie, BW; Vermeer, LM | 1 |
| Bumroongthai, K; Chetanachan, P; Niyomtham, W; Prapasarakul, N; Yurayart, C | 1 |
| Alves, GS; Bentes, Ados S; de Souza, JV; Freire, AK; Jackisch-Matsuura, AB; Matsuura, T; Pinheiro, JF; Wanke, B | 1 |
| Garvey, EP; Hoekstra, WJ; Kelly, DE; Kelly, SL; Nes, WD; Parker, JE; Price, CL; Schotzinger, RJ; Warrilow, AG | 1 |
| Bennett, C; Chen, X; González, U; Hua, X; Jiang, X; Lin, X; Xue, S; Yang, M; Zhang, M | 1 |
| Holman, TR; Hughes, DD; Kelly, DE; Kelly, SL; Nes, WD; Parker, JE; Price, CL; Rolley, NJ; Smyrniotis, CJ; Thoss, V; Warrilow, AG | 1 |
| Hase, M; Sei, Y; Shimoyama, H; Suzuki, C | 1 |
| Brown, MS; Das, A; De Brabander, JK; Goldstein, JL; Li, X; Liang, Q; Lu, F; Trinh, MN | 1 |
| Chen, C; Han, HS; Kano, R; Noli, C | 1 |
| Adégbidi, H; Adéyé, A; Atadokpédé, F; Chabasse, D; Chauty, A; Dégboé, B; Dieng, MT; do-Ango-Padonou, F; Gnossikè, J; Koeppel, MC; Koudoukpo, C; Saint-André, JP; Sissinto-Savi de Tovè, Y; Yedomon, HG | 1 |
| Fahal, AH | 1 |
| Friesen, DT; Grass, ME; Morgen, MM; Mudie, DM; Stewart, AM; Vodak, DT | 1 |
| Almeida-Paes, R; Brito-Santos, F; Figueiredo-Carvalho, MHG; Gutierrez-Galhardo, MC; Machado, ACS; Oliveira, MME; Pereira, SA; Zancopé-Oliveira, RM | 1 |
| Garvey, EP; Hoekstra, WJ; Kelly, DE; Kelly, SL; Nes, WD; Parker, JE; Price, CL; Schotzinger, RJ; Warrilow, AGS; Wiederhold, NP | 1 |
| Daali, Y; Desmeules, JA; Marsousi, N; Rudaz, S | 1 |
| Abdalla, SMH; Bamal, HD; Gront, D; Kgosiemang, IKR; Manume, NA; Mashele, SS; Matowane, RG; Syed, K; Van Wyk, M; Wieteska, L | 1 |
| Cota, GF; Galvão, EL; Rabello, A | 1 |
| Almeida, ALPF; Galitesi, LL; Hotta, J; Lima, JFM; Neppelenbroek, KH; Urban, VM | 1 |
| Canedo, P; Catão-Dias, JL; Esperón, F; Ewbank, AC; Reisfeld, L; Sacristán, C; Schwarz, B | 1 |
| Friedlander, SF; Gupta, AK; Mays, RR; Piguet, V; Piraccini, BM; Shear, NH; Tosti, A; Versteeg, SG | 1 |
| Aguiar, L; Araújo, GDS; Brilhante, RSN; Castelo-Branco, DSCM; Cordeiro, RA; España, JDA; Guedes, GMM; Oliveira, JS; Paiva, MAN; Pereira-Neto, WA; Pinheiro, AQ; Rocha, MFG; Rocha, MGD; Sales, JA; Sidrim, JJC | 1 |
| McComiskey, KPM; Tajber, L | 1 |
| Fabbrocini, G; Greco, V; Luciano, MA; Megna, M | 1 |
| Milanezi, ACM; VAN DER Sand, ST; Witusk, JPD | 1 |
| Bao, SS; Chen, MC; Chen, RJ; Cui, X; Dong, YY; Hu, GX; Lou, D; Pan, WH; Sun, W; Wang, Z | 1 |
| Kaypetch, R; Lapirattanakul, J; Muadcheingka, T; Tantivitayakul, P | 1 |
| Cho, JY; Jang, IJ; Kim, AH; Kim, B; Lee, J; Lee, S; Yi, S; Yoon, SH; Yu, KS | 1 |
| Choi, MS; Kang, SJ; Kim, S; Oh, JH; Park, SM; Yoon, S | 1 |
| Chen, M; Chen, R; Chen, Y; Hu, G; Huang, C; Sun, W; Wang, Z; Zhang, X | 1 |
| Lima, EO; Lima, MIO; Pereira, FO; Ponte, HAS | 1 |
| Mandras, N; Roana, J; Scalas, D; Tullio, V | 1 |
| Dastgheib, L; Ghasemi, N; Jowkar, F; Nouraei, H; Pakshir, K; Zomorodian, K | 1 |
| Afsarian, MH; Ahmadi, B; Ansari, S; Ansari, Z; Lotfali, E; Norouzi, M; Rezaei-Matehkolaei, A | 1 |
| Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K | 1 |
| Cai, T; Chen, Z; Liao, Y; Qiu, X; Zhu, Y | 1 |
| Dickinson, GL; Hall, SD; Kulanthaivel, P; Morse, BL; Posada, MM; Turner, PK | 1 |
| Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M | 1 |
| Aneke, CI; Cafarchia, C; Otranto, D; Rhimi, W | 1 |
| Almeida-Paes, R; Boechat, JS; de Oliveira, MME; de Sá Machado, AC; Gremião, IDF; Pereira, SA; Viana, PG; Zancopé-Oliveira, RM | 1 |
| Fan, B; Ke, A; Le, K; Prakash, C; Yang, H | 1 |
| Cheng, G; Huang, L; Li, T; Luo, X; Xue, X; Zhang, Y | 1 |
| Aman, AT; Ambara, A; Annisa, L; Darma, S; Nuryastuti, T; Wibawa, T | 1 |
| Chen, RJ; Cheng, C; Cui, X; Huang, CK; Sun, W; Wang, J; Wang, Y; Wang, Z | 1 |
| Alessandro, R; Arena, GO; Bella, MAD; Cascioferro, SM; Cirrincione, G; Corbeil, D; Diana, P; Fontana, S; Huang, K; Huynh, T; Karbanová, J; Lorico, A; Moschetti, M; Parrino, B; Pope, MR; Rappa, G; Santos, MF; Vistoli, G; Woo, G | 1 |
| Amidon, GE; Kataoka, M; Minami, K; Takagi, T; Yamashita, S | 1 |
| Araújo, RPC; Deegan, KR; Fonseca, MS; Machado, BAS; Meyer, R; Portela, RW; Sokolonski, AR; Umsza-Guez, MA | 1 |
| Abastabar, M; Aghili, SR; Badali, H; Haghani, I; Hedayati, MT; Javidnia, J; Khojasteh, S; Meis, JF; Moazeni, M; Nargesi, S; Nosratabadi, M; Shabanzadeh, S; Shokohi, T; Zaedi, A | 1 |
| Alegre, L; Giusiano, G; Latorre, W; Mussin, J; Rojas, FD; Sosa, MLÁ | 1 |
| Buapeth, KO; Chaisut, M; Chanchayanon, B; Indoung, S; Jantrakajorn, S; Morteh, R | 1 |
| Alves, AI; Bezerra, JD; Buonafina-Paz, MD; Leal, MC; Leite-Andrade, MC; Lima-Neto, RG; Neves, RP; Pape, PL; Robert, E; Santos, FA | 1 |
| Bragulat, MR; Cabañes, FJ; Castellá, G; Díaz, L | 1 |
| Murakami, M; Niwa, T; Suzuki, A; Tani, M | 1 |
146 review(s) available for ketoconazole and itraconazole
| Article | Year |
|---|---|
An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy.
Topics: 14-alpha Demethylase Inhibitors; Antiprotozoal Agents; Azoles; Humans; Leishmania; Molecular Structure; Sterol 14-Demethylase | 2017 |
Tetrazole hybrids and their antifungal activities.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Mycoses; Pyridines; Pyrimidines; Quinolines; Structure-Activity Relationship; Tetrazoles | 2019 |
Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing.
Topics: Amphotericin B; Antifungal Agents; Drug Repositioning; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leishmaniasis; Molecular Targeted Therapy; Phosphorylcholine; Sterol 14-Demethylase; Triazoles; Voriconazole | 2019 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
Synthetic approaches and structural diversity of triazolylbutanols derived from voriconazole in the antifungal drug development.
Topics: Antifungal Agents; Drug Development; Fungi; Voriconazole | 2022 |
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Skin kinetics of azole antifungal drugs.
Topics: Administration, Oral; Administration, Topical; Animals; Antifungal Agents; Humans; Itraconazole; Ketoconazole; Skin; Skin Absorption; Tissue Distribution | 1992 |
Clinical significance of interactions with antifungal agents.
Topics: Antifungal Agents; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Fluconazole; Humans; Itraconazole; Ketoconazole | 1992 |
[Rapid increase in the incidence of respiratory aspergillosis. Improved diagnosis and more aggressive treatment for better prognosis].
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Incidence; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Prognosis; Radiography; Respiratory Tract Diseases; Sweden | 1992 |
Azole antifungal agents.
Topics: Animals; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses | 1992 |
Blastomycosis.
Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Disease Outbreaks; Humans; Itraconazole; Ketoconazole; United States | 1992 |
Histoplasmosis in Indianapolis.
Topics: Amphotericin B; Disease Outbreaks; Fluconazole; Histoplasmosis; Humans; Indiana; Itraconazole; Ketoconazole | 1992 |
Itraconazole in antifungal therapy.
Topics: Antifungal Agents; Fungi; Humans; Itraconazole; Ketoconazole; Meta-Analysis as Topic; Mycoses | 1992 |
Successful treatment of Paecilomyces varioti infection in a patient with chronic granulomatous disease and a review of Paecilomyces species infections.
Topics: Amphotericin B; Antifungal Agents; Child; Drug Therapy, Combination; Follow-Up Studies; Granulomatous Disease, Chronic; Heel; Humans; Interferon-gamma; Itraconazole; Ketoconazole; Male; Mycoses; Paecilomyces; Treatment Outcome | 1992 |
[Primary Aspergillus endocarditis. Apropos of a case and review of the international literature].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Drug Therapy, Combination; Endocarditis; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Recurrence; Reoperation | 1992 |
[Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Opportunistic Infections | 1992 |
[Current developments in antimycotic therapy in gynecology and obstetrics].
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Dose-Response Relationship, Drug; Female; Fluconazole; Humans; Infant, Newborn; Itraconazole; Ketoconazole; Mycoses; Pregnancy; Pregnancy Complications, Infectious | 1992 |
Antifungal treatment strategy in leukemia patients.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Leukemia; Mycoses; Tomography, X-Ray Computed | 1992 |
[Therapy of pulmonary mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Blastomycosis; Coccidioidomycosis; Cryptococcosis; Fluconazole; Flucytosine; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal | 1992 |
[Systemic antifungal drugs].
Topics: Amphotericin B; Animals; Antifungal Agents; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Mycoses; Rabbits | 1991 |
[Importance of the new triazoles in antifungal therapy].
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses | 1991 |
Diagnosis and treatment of oral candidosis.
Topics: Antifungal Agents; Candidiasis, Oral; Chronic Disease; Fluconazole; HIV Infections; Humans; Immune Tolerance; Itraconazole; Ketoconazole; Opportunistic Infections | 1991 |
Disseminated sporotrichosis in patients with AIDS: case report and review of the literature.
Topics: Acquired Immunodeficiency Syndrome; Biopsy; Bisexuality; HIV-1; Humans; Itraconazole; Ketoconazole; Male; Sporotrichosis | 1991 |
[Preliminary clinical study of the use of itraconazole in the treatment of vulvovaginal candidiasis].
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Evaluation; Female; Humans; Itraconazole; Ketoconazole; Middle Aged | 1991 |
Laboratory monitoring of antifungal chemotherapy. British Society for Antimicrobial Chemotherapy Working Party.
Topics: Adult; Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Drug Resistance; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Immunodiffusion; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses | 1991 |
Management of fungal skin infections with 15 days itraconazole treatment: a worldwide review.
Topics: Antifungal Agents; Dermatomycoses; Humans; Itraconazole; Ketoconazole | 1990 |
Fungal infections and their management.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Naphthalenes; Terbinafine; Triazoles | 1990 |
Oral and parenteral treatment with itraconazole in various superficial and systemic experimental fungal infections. Comparisons with other antifungals and combination therapy.
Topics: Animals; Antifungal Agents; Disease Models, Animal; Itraconazole; Ketoconazole; Mycoses | 1990 |
Safety aspects of oral antifungal agents.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Antifungal Agents; Endocrine Glands; Humans; Hypercholesterolemia; Itraconazole; Ketoconazole; Liver | 1990 |
Pharmacokinetics of oral antifungals and their clinical implications.
Topics: Absorption; Administration, Oral; Animals; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Tissue Distribution | 1990 |
Chronic vulvovaginal candidosis: the role of oral treatment.
Topics: Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Female; Humans; Itraconazole; Ketoconazole; Recurrence | 1990 |
[Semi-invasive aspergillosis with involvement of the thoracic wall cured by itraconazole].
Topics: Antifungal Agents; Aspergillosis; Carcinoma, Bronchogenic; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Lung Neoplasms; Male; Middle Aged; Ribs; Sternum; Thoracic Diseases | 1990 |
Fluconazole and itraconazole for vulvo-vaginal candidosis.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Itraconazole; Ketoconazole | 1990 |
New antifungal agents for the systemic mycoses.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Molecular Structure; Mycoses | 1990 |
The triazole antifungal agents: a review of itraconazole and fluconazole.
Topics: Antifungal Agents; Aspergillus; Candida albicans; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Cryptococcus neoformans; Fluconazole; Half-Life; Humans; Itraconazole; Ketoconazole; Metabolic Clearance Rate | 1990 |
Azoles and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ketoconazole; Meningitis; Mycoses; Opportunistic Infections | 1990 |
Itraconazole in tinea versicolor: a review.
Topics: Antifungal Agents; Humans; Itraconazole; Ketoconazole; Tinea Versicolor | 1990 |
Itraconazole in common dermatophyte infections of the skin: fixed treatment schedules.
Topics: Antifungal Agents; Dermatomycoses; Drug Administration Schedule; Humans; Itraconazole; Ketoconazole | 1990 |
Treatment of oral candidosis with itraconazole: a review.
Topics: Antifungal Agents; Candidiasis, Oral; Humans; Itraconazole; Ketoconazole | 1990 |
Treatment of chromoblastomycosis.
Topics: Antifungal Agents; Chromoblastomycosis; Drug Administration Schedule; Humans; Itraconazole; Ketoconazole; Male; Middle Aged | 1990 |
[Systemic mycotic infections].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses | 1990 |
New therapeutic agents in veterinary dermatology.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Cat Diseases; Cats; Chlorambucil; Clofazimine; Dog Diseases; Dogs; Itraconazole; Ivermectin; Ketoconazole; Skin Diseases | 1990 |
Bipolaris: a serious new fungal pathogen of the paranasal sinus.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Humans; Immunosuppression Therapy; Itraconazole; Ketoconazole; Male; Mitosporic Fungi; Mycoses; Paranasal Sinus Diseases | 1989 |
Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.
Topics: Animals; Antifungal Agents; Humans; Itraconazole; Ketoconazole; Mycoses | 1989 |
Testing of organisms for susceptibility to triazoles: is it justified?
Topics: Antifungal Agents; Drug Resistance, Microbial; Fluconazole; Fungi; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Triazoles | 1989 |
New antifungal agents.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antifungal Agents; Azoles; Echinocandins; Fluconazole; Fungi; Humans; Itraconazole; Ketoconazole; Mycoses; Peptides; Peptides, Cyclic; Triazoles | 1989 |
Itraconazole and fluconazole: new drugs for deep fungal infection.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses | 1989 |
Biochemical approaches to selective antifungal activity. Focus on azole antifungals.
Topics: Animals; Antifungal Agents; Azoles; Humans; Imidazoles; Itraconazole; Ketoconazole | 1989 |
Mode of action of itraconazole: morphological aspects.
Topics: Animals; Antifungal Agents; Fungi; Humans; Itraconazole; Ketoconazole | 1989 |
Toxicological profile and safety evaluation of antifungal azole derivatives.
Topics: Abnormalities, Drug-Induced; Animals; Antifungal Agents; Endocrine Glands; Fluconazole; Humans; Itraconazole; Ketoconazole; Liver | 1989 |
The clinical pharmacokinetics of itraconazole: an overview.
Topics: Absorption; Antifungal Agents; Half-Life; Humans; Itraconazole; Ketoconazole; Tissue Distribution | 1989 |
Azole antifungal agents: emphasis on new triazoles.
Topics: Animals; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Triazoles | 1988 |
Recent advances in the treatment of systemic fungal infections.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1987 |
Azole antifungal drugs: old and new.
Topics: Animals; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Triazoles | 1988 |
Treatment of systemic fungal infections: recent progress and current problems.
Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1988 |
New oral treatments for dermatophytosis.
Topics: Administration, Oral; Antifungal Agents; Dermatomycoses; Fluconazole; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine; Triazoles | 1988 |
The pharmacology of agents used in the treatment of pulmonary mycoses.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Flucytosine; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Miconazole | 1986 |
The systemic treatment of onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1995 |
[Therapy of candidiasis and cryptococcosis in AIDS].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Candidiasis, Oral; Cryptococcosis; Fluconazole; Humans; Itraconazole; Ketoconazole | 1994 |
Can we prevent azole resistance in fungi?
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole | 1995 |
Antifungal chemotherapy.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Morpholines; Naphthalenes; Terbinafine | 1995 |
[Treatment of localized cutaneous leishmaniasis].
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Humans; Itraconazole; Ketoconazole; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine | 1994 |
Antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Child; Child, Preschool; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses | 1995 |
Histoplasmosis: recognition and treatment.
Topics: Amphotericin B; Fluconazole; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Serologic Tests | 1994 |
Inhibition of terfenadine metabolism. Pharmacokinetic and pharmacodynamic consequences.
Topics: Cytochrome P-450 Enzyme System; Drug Interactions; Fluconazole; Heart; Humans; Itraconazole; Ketoconazole; Prodrugs; Terfenadine | 1994 |
[Treatment with terfenadine and ketoconazole or itraconazole can cause torsades de pointes ventricular tachycardia].
Topics: Drug Interactions; Humans; Itraconazole; Ketoconazole; Terfenadine; Torsades de Pointes | 1993 |
Current therapy of dermatophytosis.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Administration, Topical; Allylamine; Antifungal Agents; Dermatomycoses; Drug Administration Schedule; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Morpholines; Time Factors; Tolnaftate | 1994 |
Oral therapeutic agents in fungal nail disease.
Topics: Administration, Oral; Allylamine; Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine; Time Factors; Treatment Outcome | 1994 |
Antifungal therapy: potential interactions with other classes of drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Fluconazole; Flucytosine; Griseofulvin; Humans; Itraconazole; Ketoconazole; Mycoses | 1994 |
Is there a correlation between serum antifungal drug concentration and clinical outcome?
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Humans; Injections, Intravenous; Itraconazole; Ketoconazole; Liver; Microbial Sensitivity Tests; Mycoses; Piperazines; Risk Factors; Treatment Outcome | 1994 |
A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. The Onychomycosis Study Group.
Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Foot Dermatoses; Griseofulvin; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Models, Econometric; Naphthalenes; Onychomycosis; State Medicine; Terbinafine | 1994 |
A clinician's view of blastomycosis.
Topics: Adult; Amphotericin B; Blastomycosis; Child; Female; Humans; Itraconazole; Ketoconazole; Male | 1993 |
Itraconazole and fluconazole in oropharyngeal candidiasis.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Oral; Fluconazole; Humans; Itraconazole; Ketoconazole; Pharyngeal Diseases | 1993 |
Pharmacotherapy of disseminated histoplasmosis in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fluconazole; Histoplasmosis; Humans; Itraconazole; Ketoconazole; United States | 1993 |
Systemic drugs in the treatment of dermatophytoses.
Topics: Antifungal Agents; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Molecular Structure | 1993 |
Onychomycosis. Agents of choice.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Candidiasis, Cutaneous; Fluconazole; Foot Dermatoses; Griseofulvin; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1993 |
New approaches to the treatment of onychomycosis.
Topics: Adult; Antifungal Agents; Humans; Itraconazole; Ketoconazole; Male; Naphthalenes; Onychomycosis; Terbinafine | 1993 |
[New antifungal agents in the treatment of superficial dermatomycoses].
Topics: Administration, Topical; Antifungal Agents; Azoles; Dermatomycoses; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine; Tolnaftate | 1993 |
Intraconazole--a new oral antifungal agent with a very broad spectrum of activity in superficial and systemic mycoses.
Topics: Administration, Oral; Animals; Antifungal Agents; Guinea Pigs; Humans; Itraconazole; Ketoconazole; Mycoses; Rabbits; Rats | 1993 |
[Oral antifungal drugs].
Topics: Administration, Oral; Antifungal Agents; Dermatomycoses; Drug Administration Schedule; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1995 |
New antifungal drugs for pulmonary mycoses.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal | 1996 |
Treatment of eumycetoma and actinomycetoma.
Topics: Actinomycetales; Amphotericin B; Antifungal Agents; Humans; Itraconazole; Ketoconazole; Mycetoma; Nocardia; Streptomyces | 1995 |
Management of scalp ringworm.
Topics: Antifungal Agents; Child; Child, Preschool; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine; Tinea Capitis; United Kingdom | 1996 |
The role of azole antifungal agents for systemic antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Drug Costs; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole | 1997 |
Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Neoplasms; Neutropenia; Randomized Controlled Trials as Topic | 1997 |
Use of azoles for systemic antifungal therapy.
Topics: Antifungal Agents; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1997 |
Therapy of blastomycosis.
Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Dose-Response Relationship, Drug; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Recurrence; Treatment Outcome | 1997 |
Current trends in onychomycosis therapy: a literature review.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
[Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Candidiasis, Chronic Mucocutaneous; Clinical Trials as Topic; Cryptococcosis; Double-Blind Method; Fluconazole; Humans; Itraconazole; Ketoconazole; Mucormycosis; Mycoses; Neutropenia; Nystatin; Primary Prevention; Recurrence; Retrospective Studies | 1995 |
[Prevention and treatment of fungal infections in solid-organ transplant recipients].
Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fluconazole; Heart Transplantation; Humans; Itraconazole; Ketoconazole; Kidney Transplantation; Liver Transplantation; Lung Transplantation; Multicenter Studies as Topic; Mycoses; Pancreas Transplantation; Risk Factors; Transplantation | 1995 |
[Superficial mycoses in immunosuppressed patients].
Topics: Adult; Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Child; Dermatitis, Seborrheic; Dermatomycoses; Female; Fluconazole; Humans; Imidazoles; Immunosuppression Therapy; Itraconazole; Ketoconazole; Male; Morpholines; Onychomycosis; Tinea; Tinea Versicolor; Transplantation; Triazoles | 1995 |
[Antifungal agent resistance of yeasts of clinical significance].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Yeasts | 1995 |
[Commonly used antifungal agents in the treatment of systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Topic; Coccidioidomycosis; Cryptococcosis; Fluconazole; Flucytosine; Hematologic Diseases; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Kidney; Mycoses; Thrombophlebitis | 1995 |
The pharmacology of leishmaniasis.
Topics: Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Drug Design; Humans; Itraconazole; Ketoconazole; Leishmania; Leishmaniasis; Paromomycin; World Health Organization | 1998 |
Onychomycosis: pathogenesis, diagnosis, and management.
Topics: Adult; Antifungal Agents; Child; Diagnosis, Differential; Female; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Male; Nails; Naphthalenes; Onychomycosis; Terbinafine | 1998 |
Antifungal agents. Part II. The azoles.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Drug Interactions; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Ketoconazole | 1999 |
Dermatophyte infections in children.
Topics: Antifungal Agents; Arthrodermataceae; Child; Child, Preschool; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microsporum; Naphthalenes; Terbinafine; Tinea; Trichophyton | 1999 |
[Exotic pulmonary mycoses].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Diagnosis, Differential; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Paracoccidioidomycosis; Penicillium; Sporotrichosis; Sulfadiazine; Travel; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
[American pulmonary histoplasmosis caused by Histoplasma capsulatum].
Topics: Africa; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Asia; Australia; Bronchoalveolar Lavage Fluid; Diagnosis, Differential; Histoplasma; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Latin America; Lung Diseases, Fungal; Radiography, Thoracic; Tomography, X-Ray Computed; United States | 1998 |
Pharmacokinetic and pharmacodynamic consequences of metabolism-based drug interactions with alprazolam, midazolam, and triazolam.
Topics: Alprazolam; Anti-Anxiety Agents; Data Collection; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Humans; Itraconazole; Ketoconazole; Midazolam; Triazolam | 1999 |
Azoles for allergic bronchopulmonary aspergillosis.
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Controlled Clinical Trials as Topic; Humans; Itraconazole; Ketoconazole | 2000 |
An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Dermatomycoses; Drug Administration Schedule; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2000 |
The treatment of dermatophytosis: safety considerations.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Dermatomycoses; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine | 2000 |
Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Clotrimazole; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Nystatin; Virulence | 2000 |
Clinical inquiries. What is the best oral antifungal medication for tinea capitis?
Topics: Administration, Oral; Adult; Antifungal Agents; Child; Evidence-Based Medicine; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine; Tinea Capitis; Treatment Outcome; Trichophyton | 2001 |
A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, Oral; Clotrimazole; Databases as Topic; Fluconazole; HIV Seropositivity; Humans; Itraconazole; Ketoconazole; Nystatin; Oropharynx; Pharyngeal Diseases; Randomized Controlled Trials as Topic; Research Design; Statistics as Topic; Treatment Outcome | 2001 |
Azoles for allergic bronchopulmonary aspergillosis associated with asthma.
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Asthma; Controlled Clinical Trials as Topic; Humans; Itraconazole; Ketoconazole | 2001 |
A plea to bridge the gap between antifungals and the management of onychomycosis.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2001 |
Oral candidal infections and antimycotics.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles | 2000 |
Oral treatments for toenail onychomycosis: a systematic review.
Topics: Administration, Oral; Antifungal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Evidence-Based Medicine; Female; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Ketoconazole; Male; Naphthalenes; Onychomycosis; Prognosis; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Terbinafine; Treatment Outcome | 2002 |
Vulvovaginal candidiasis.
Topics: Administration, Intravaginal; Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Imidazoles; Itraconazole; Ketoconazole; Nystatin; Recurrence; Sexual Partners | 2002 |
Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.
Topics: Animals; Antifungal Agents; Clotrimazole; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Griseofulvin; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Natamycin; Nystatin; Terbinafine; Thiabendazole; Tolnaftate; Veterinary Drugs | 2003 |
Framing the future of antifungals in atopic dermatitis.
Topics: Antifungal Agents; Dermatitis, Atopic; Fluconazole; Forecasting; Humans; Itraconazole; Ketoconazole; Treatment Outcome | 2003 |
Azoles for allergic bronchopulmonary aspergillosis associated with asthma.
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Asthma; Controlled Clinical Trials as Topic; Humans; Itraconazole; Ketoconazole | 2003 |
The use of oral antifungal agents to treat onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Drug Interactions; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2003 |
[Therapeutic safety of antimycotics in the treatment of systemic fungal infections].
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Liver; Mycoses | 2003 |
History of the development of azole derivatives.
Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Pyrimidines; Triazoles; Voriconazole | 2004 |
Azoles for allergic bronchopulmonary aspergillosis associated with asthma.
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Asthma; Humans; Itraconazole; Ketoconazole; Randomized Controlled Trials as Topic | 2004 |
Improved outcome of zygomycosis in patients with hematological diseases?
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Deoxycholic Acid; Ethmoid Sinusitis; Female; Hematologic Diseases; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Liposomes; Lymphoma, Large B-Cell, Diffuse; Male; Maxillary Sinusitis; Middle Aged; Mucor; Mucormycosis; Multiple Myeloma; Nose Diseases; Opportunistic Infections; Prognosis; Treatment Outcome; Zygomycosis | 2004 |
Candidiasis (vulvovaginal).
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Nystatin; Sexual Partners | 2003 |
The systemic treatment of onychomycosis.
Topics: Antifungal Agents; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2004 |
Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment.
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Azoles; Evidence-Based Medicine; Forecasting; Humans; Itraconazole; Ketoconazole; Pyrimidines; Triazoles; Voriconazole | 2004 |
Candidiasis (vulvovaginal).
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Nystatin; Secondary Prevention; Sexual Partners | 2003 |
Pharmacological management of paracoccidioidomycosis.
Topics: Amphotericin B; Central Nervous System Fungal Infections; Drug Resistance; Fluconazole; Follow-Up Studies; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Paracoccidioidomycosis; Pyrimidines; Sulfonamides; Triazoles; Voriconazole | 2005 |
Phaeohyphomycosis in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Dermatomycoses; Exophiala; Female; Fluconazole; Humans; Hyphae; Itraconazole; Ketoconazole; Male; Middle Aged; Subcutaneous Tissue | 2005 |
[Drug-drug interaction of antifungal drugs].
Topics: Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microsomes, Liver; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2005 |
An overview of antifungal drugs and their use for treatment of deep and superficial mycoses in animals.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Candida; Fluconazole; Griseofulvin; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Severity of Illness Index | 2005 |
Fungal nail infections.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2005 |
Candidiasis (vulvovaginal).
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Nystatin; Secondary Prevention | 2005 |
Drugs for treating paracoccidioidomycosis.
Topics: Antifungal Agents; Humans; Itraconazole; Ketoconazole; Paracoccidioidomycosis; Randomized Controlled Trials as Topic; Sulfadiazine | 2006 |
[Current possibilities of using antimyocotic drugs in the treatment of various skin disorders].
Topics: Animals; Antifungal Agents; Dermatitis, Atopic; Dermatitis, Seborrheic; Dermatomycoses; Female; Humans; Itraconazole; Ketoconazole; Male; Naphthalenes; Skin Diseases; Terbinafine; Treatment Outcome | 2004 |
Chronic mucocutaneous candidiasis associated with malignant thymoma and systemic lupus erythematosus with hypergammaglobulinemia: a case report and literature review.
Topics: Adult; Antifungal Agents; Candidiasis, Chronic Mucocutaneous; Humans; Hypergammaglobulinemia; Itraconazole; Ketoconazole; Lupus Erythematosus, Systemic; Male; Thymoma; Thymus Neoplasms | 2006 |
Fungal toenail infections.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2006 |
Mycetoma : a review.
Topics: Actinomycetales Infections; Antifungal Agents; Diagnosis, Differential; Fungi; Humans; Itraconazole; Ketoconazole; Mycetoma | 2006 |
Effective treatment for dermatophytoses of the foot: effect on restoration of depressed cell-mediated immunity.
Topics: Animals; Antifungal Agents; Fluconazole; Foot Dermatoses; Humans; Immunity, Cellular; Itraconazole; Ketoconazole; Mycoses; Naphthalenes; Terbinafine | 2007 |
Nodular pulmonary histoplasmosis in Cushing's disease: a case report and literature review.
Topics: Adenoma; Aminoglutethimide; Dexamethasone; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Lung Diseases; Male; Middle Aged; Pituitary ACTH Hypersecretion; Pituitary Neoplasms | 2007 |
Spondylodiscitis due to an emergent fungal pathogen: Blastoschizomyces capitatus, a case report and review of the literature.
Topics: Aged; Amphotericin B; Antifungal Agents; Dipodascus; Discitis; Fluconazole; Humans; Itraconazole; Ketoconazole; Lumbar Vertebrae; Male; Microbial Sensitivity Tests; Naphthalenes; Opportunistic Infections; Radiography; Terbinafine; Treatment Outcome | 2009 |
Conazoles.
Topics: Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Miconazole; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole | 2010 |
[The subcutaneous mucormycosis due to Lichtheimia corymbifera: A case report in an immunocompetent child].
Topics: Antifungal Agents; Biopsy; Child; Diagnostic Errors; Edema; Humans; Immunocompetence; Itraconazole; Ketoconazole; Leg; Male; Mucorales; Mucormycosis; Opportunistic Infections; Subcutaneous Tissue; Tuberculosis, Cutaneous | 2012 |
[Cutaneous Malassezia infections and Malassezia associated dermatoses: An update].
Topics: Antifungal Agents; Dermatitis, Atopic; Dermatitis, Seborrheic; Itraconazole; Ketoconazole; Malassezia; Tinea Versicolor | 2015 |
Sporotrichosis: The Story of an Endemic Region in Peru over 28 Years (1985 to 2012).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Endemic Diseases; Female; Geography; Humans; Infant; Itraconazole; Ketoconazole; Male; Middle Aged; Peru; Sporotrichosis; Young Adult | 2015 |
Best practices for the use of itraconazole as a replacement for ketoconazole in drug-drug interaction studies.
Topics: Antifungal Agents; Clinical Trials as Topic; Drug Interactions; Humans; Itraconazole; Ketoconazole | 2016 |
Systemic antifungal therapy for tinea capitis in children.
Topics: Antifungal Agents; Child; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Randomized Controlled Trials as Topic; Terbinafine; Tinea Capitis | 2016 |
Efficacy of azole therapy for tegumentary leishmaniasis: A systematic review and meta-analysis.
Topics: Administration, Cutaneous; Administration, Mucosal; Antifungal Agents; Azoles; Databases, Factual; Humans; Itraconazole; Ketoconazole; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous | 2017 |
Tinea capitis in children: a systematic review of management.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Child; Drug Therapy, Combination; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microsporum; Specimen Handling; Terbinafine; Tinea Capitis; Trichophyton | 2018 |
60 trial(s) available for ketoconazole and itraconazole
| Article | Year |
|---|---|
Treatment of vaginal candidosis: a comparative study of the efficacy and acceptability of itraconazole and clotrimazole.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Itraconazole; Ketoconazole; Patient Acceptance of Health Care; Patient Compliance; Single-Blind Method | 1992 |
Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis, Cryptococcal; Middle Aged; Opportunistic Infections; Prospective Studies; Survival Analysis | 1992 |
Itraconazole compared with griseofulvin in the treatment of tinea corporis/cruris and tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Griseofulvin; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Tinea | 1992 |
Itraconazole in neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Humans; Itraconazole; Ketoconazole; Mycoses; Neutropenia | 1992 |
Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Cryptococcosis; Double-Blind Method; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Opportunistic Infections; Oropharynx; Pilot Projects | 1992 |
Itraconazole in the treatment of cryptococcal meningitis.
Topics: Adolescent; Adult; Antifungal Agents; Cerebrospinal Fluid; Female; Humans; Itraconazole; Ketoconazole; Male; Meningitis, Cryptococcal | 1992 |
Treatment of dermatophytosis with new systemic antifungal agent, itraconazole.
Topics: Adolescent; Adult; Antifungal Agents; Dermatomycoses; Female; Hospitals, University; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Outpatient Clinics, Hospital | 1992 |
Efficacy and safety of itraconazole in the long-term treatment of onychomycosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Arthrodermataceae; Dermatomycoses; Drug Administration Schedule; Female; Griseofulvin; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Onychomycosis; Single-Blind Method | 1992 |
Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Chromoblastomycosis; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mitosporic Fungi; Skin; Time Factors | 1992 |
Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Blastomycosis; Female; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Prospective Studies; Treatment Outcome | 1992 |
A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Griseofulvin; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Species Specificity; Tinea; Trichophyton | 1992 |
The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal candidiasis.
Topics: Administration, Oral; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Itraconazole; Ketoconazole; Middle Aged; Prospective Studies; Recurrence; Treatment Outcome | 1992 |
Onychomycosis treated with itraconazole or griseofulvin alone with and without a topical antimycotic or keratolytic agent.
Topics: Administration, Topical; Adult; Antifungal Agents; Drug Therapy, Combination; Emollients; Female; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Keratolytic Agents; Ketoconazole; Male; Middle Aged; Onychomycosis; Prospective Studies | 1991 |
Comparison of the multiple dose pharmacokinetics of two formulations of itraconazole during remission induction for acute myeloblastic leukaemia.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Humans; Itraconazole; Ketoconazole; Leukemia, Myeloid, Acute; Middle Aged; Polyethylene Glycols; Powders; Remission Induction; Solutions | 1991 |
Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Oral; Double-Blind Method; Esophageal Diseases; Female; HIV Infections; Humans; Itraconazole; Ketoconazole; Male; Opportunistic Infections; Recurrence | 1991 |
Cutaneous leishmaniasis in Kuwait. Clinical experience with itraconazole.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Capsules; Child; Female; Humans; Itraconazole; Ketoconazole; Kuwait; Leishmaniasis, Cutaneous; Male; Middle Aged; Placebos | 1991 |
[Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].
Topics: Adolescent; Agranulocytosis; Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Candidiasis; Humans; Itraconazole; Ketoconazole; Male; Mycoses | 1991 |
[Preliminary clinical study of the use of itraconazole in the treatment of vulvovaginal candidiasis].
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Evaluation; Female; Humans; Itraconazole; Ketoconazole; Middle Aged | 1991 |
Itraconazole versus placebo in the management of vaginal candidiasis.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Double-Blind Method; Drug Evaluation; Female; Humans; Itraconazole; Ketoconazole; Leukorrhea; Middle Aged; Pruritus; Vulvovaginitis | 1991 |
The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B.
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Candidiasis; Drug Therapy, Combination; Female; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Neutropenia; Prospective Studies | 1991 |
Antifungal chemoprophylaxis in cancer children: a prospective randomized controlled study.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Feces; Female; Humans; Infant; Itraconazole; Ketoconazole; Male; Mycoses; Neoplasms; Pharynx; Prospective Studies | 1990 |
Itraconazole: a single-day oral treatment for acute vulvovaginal candidosis.
Topics: Acute Disease; Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Itraconazole; Ketoconazole | 1990 |
Itraconazole in onychomycosis. Open and double-blind studies.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Double-Blind Method; Female; Follow-Up Studies; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Onychomycosis; Random Allocation; Recurrence | 1990 |
Itraconazole therapy for chronic coccidioidal meningitis.
Topics: Adolescent; Adult; Aged; Antibodies, Fungal; Antifungal Agents; Chronic Disease; Coccidioidomycosis; Female; Humans; Itraconazole; Ketoconazole; Leukocyte Count; Male; Meningitis; Middle Aged; Multicenter Studies as Topic; Prospective Studies | 1990 |
Itraconazole in the treatment of superficial mycoses--a double-blind study vs. placebo.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Clinical Trials as Topic; Dermatomycoses; Double-Blind Method; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Tinea Versicolor | 1990 |
The triazole antifungal agents: a review of itraconazole and fluconazole.
Topics: Antifungal Agents; Aspergillus; Candida albicans; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Cryptococcus neoformans; Fluconazole; Half-Life; Humans; Itraconazole; Ketoconazole; Metabolic Clearance Rate | 1990 |
Itraconazole therapy in aspergillosis: study in 49 patients.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Administration Schedule; Encephalitis; Female; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Maxillary Sinusitis; Middle Aged; Recurrence | 1990 |
Adverse events associated with itraconazole in 189 patients on chronic therapy.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Humans; Itraconazole; Ketoconazole; Male; Miconazole; Middle Aged; Mycoses | 1990 |
Cutaneous leishmaniasis in India. Clinical experience with itraconazole (R51 211 Janssen).
Topics: Adolescent; Adult; Animals; Female; Humans; India; Itraconazole; Ketoconazole; Leishmania tropica; Leishmaniasis; Male; Middle Aged; Rural Health | 1990 |
Itraconazole in human histoplasmosis.
Topics: Adult; Aged; Antifungal Agents; Clinical Trials as Topic; Female; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Male; Middle Aged | 1989 |
The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects.
Topics: Administration, Oral; Adult; Antifungal Agents; Dose-Response Relationship, Drug; Food; Humans; Itraconazole; Ketoconazole; Male; Random Allocation; Reference Values | 1989 |
Prophylaxis of fungal infections with itraconazole during remission-induction therapy.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Humans; Itraconazole; Ketoconazole; Leukemia; Lymphoma; Male; Middle Aged; Multicenter Studies as Topic; Mycoses; Prospective Studies; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies | 1989 |
Itraconazole versus ketoconazole for the prophylaxis of fungal infection in neutropenic children: results of two consecutive nonrandomized studies.
Topics: Adolescent; Agranulocytosis; Antifungal Agents; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Infant; Itraconazole; Ketoconazole; Male; Mycoses; Neutropenia | 1989 |
Itraconazole in the treatment of acute vaginal candidiasis.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Evaluation; Female; Humans; Itraconazole; Ketoconazole; Middle Aged; Prospective Studies; Random Allocation | 1988 |
An open assessment of three different treatment regimens of itraconazole for the management of vaginal candidosis.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Itraconazole; Ketoconazole | 1988 |
Itraconazole therapy for recalcitrant dermatophyte infections.
Topics: Adult; Clinical Trials as Topic; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Recurrence; Tinea | 1988 |
Treatment of pityriasis versicolor with itraconazole: a double-blind placebo controlled study.
Topics: Adult; Antifungal Agents; Double-Blind Method; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Tinea Versicolor | 1988 |
The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987).
Topics: Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Chronic Disease; Clinical Trials as Topic; Dermatomycoses; Granuloma; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Necrosis | 1988 |
Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manuum.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Griseofulvin; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Tinea; Tinea Pedis | 1988 |
Itraconazole therapy in lymphangitic and cutaneous sporotrichosis.
Topics: Adolescent; Adult; Animals; Antifungal Agents; Child; Clinical Trials as Topic; Dermatomycoses; Female; Guinea Pigs; Humans; Iodides; Itraconazole; Ketoconazole; Lymphatic Diseases; Male; Middle Aged; Sporotrichosis; Time Factors | 1986 |
Itraconazole therapy in pityriasis versicolor.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Random Allocation; Tinea Versicolor | 1986 |
The influence of food on the pharmacokinetics of itraconazole in patients with superficial fungal infection.
Topics: Adolescent; Adult; Dermatomycoses; Eating; Female; Humans; Itraconazole; Ketoconazole; Kinetics; Male; Middle Aged; Random Allocation | 1987 |
Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole.
Topics: Administration, Oral; Adult; Analysis of Variance; Cytochrome P-450 Enzyme System; Double-Blind Method; Drug Synergism; Female; Half-Life; Humans; Itraconazole; Ketoconazole; Male; Reference Values; Triazolam | 1994 |
Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease.
Topics: Administration, Oral; Aspergillosis; Child; Child, Preschool; Female; Follow-Up Studies; Granulomatous Disease, Chronic; Humans; Incidence; Infant; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Prospective Studies; Retrospective Studies; Time Factors; Treatment Outcome | 1994 |
Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.
Topics: Adult; Analysis of Variance; Cytochrome P-450 Enzyme Inhibitors; Double-Blind Method; Drug Synergism; Female; Humans; Itraconazole; Ketoconazole; Male; Midazolam; Psychomotor Performance; Reference Values | 1994 |
Placebo-controlled trial of itraconazole for treatment of acute vaginal candidiasis.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Double-Blind Method; Female; Humans; Itraconazole; Ketoconazole | 1993 |
Lack of in vitro resistance of Candida albicans to ketoconazole, itraconazole and clotrimazole in women treated for recurrent vaginal candidiasis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Clotrimazole; Drug Resistance; Female; Humans; Itraconazole; Ketoconazole; Middle Aged; Prospective Studies; Recurrence | 1993 |
Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antigens, Fungal; Female; Histoplasma; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Patient Compliance; Prospective Studies; Recurrence | 1993 |
Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Colombia; Follow-Up Studies; Humans; Injections, Intramuscular; Itraconazole; Ketoconazole; Leishmaniasis, Cutaneous; Male; Meglumine; Pentamidine; Treatment Outcome | 1993 |
Itraconazole and multidrug resistance: possible effects on remission rate and disease-free survival in acute leukemia.
Topics: Adolescent; Adult; Drug Resistance; Female; Humans; Itraconazole; Ketoconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Rate | 1993 |
Ketoconazole and itraconazole susceptibility of Candida albicans isolated from patients infected with HIV.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Double-Blind Method; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Predictive Value of Tests; Prospective Studies | 1995 |
Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Reference Values; Risk Factors | 1996 |
Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole.
Topics: Administration, Oral; Adult; Antifungal Agents; Cross-Over Studies; Double-Blind Method; Female; Fluconazole; Half-Life; Humans; Hypnotics and Sedatives; Itraconazole; Ketoconazole; Male; Pyridines; Reference Values; Zolpidem | 1998 |
Randomized trial with itraconazole, ketoconazole and sulfadiazine in paracoccidioidomycosis.
Topics: Adolescent; Adult; Antifungal Agents; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Paracoccidioidomycosis; Sulfadiazine; Treatment Outcome | 2002 |
Antifungal treatment in sarcoidosis--a pilot intervention trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antifungal Agents; Drug Therapy, Combination; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Pilot Projects; Sarcoidosis; Treatment Outcome | 2007 |
A study to evaluate the efficacy and safety of oral fluconazole in the treatment of tinea versicolor.
Topics: Adolescent; Adult; Antifungal Agents; Bangladesh; Female; Fluconazole; Humans; Incidence; Itraconazole; Ketoconazole; Male; Middle Aged; Prevalence; Risk Factors; Tinea Versicolor; Treatment Outcome; Young Adult | 2009 |
Response to azolic antifungal agents for treating feline sporotrichosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Appetite; Cat Diseases; Cats; Diarrhea; Female; Itraconazole; Kaplan-Meier Estimate; Ketoconazole; Logistic Models; Male; Sporotrichosis; Treatment Outcome; Vomiting | 2010 |
A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China.
Topics: Adolescent; Antifungal Agents; Arthrodermataceae; Child; Child, Preschool; China; Female; Griseofulvin; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Microsporum; Naphthalenes; Terbinafine; Tinea Capitis; Treatment Outcome; Trichophyton | 2011 |
A physiologically based pharmacokinetic modeling approach to predict drug-drug interactions between domperidone and inhibitors of CYP3A4.
Topics: Adolescent; Adult; Caco-2 Cells; Computer Simulation; Cytochrome P-450 CYP3A Inhibitors; Domperidone; Dopamine Antagonists; Drug Interactions; Erythromycin; Female; Humans; Itraconazole; Ketoconazole; Male; Microsomes, Liver; Middle Aged; Models, Biological; Young Adult | 2016 |
Quantitative prediction of hepatic CYP3A activity using endogenous markers in healthy subjects after administration of CYP3A inhibitors or inducers.
Topics: Adult; Biomarkers; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Healthy Volunteers; Humans; Itraconazole; Ketoconazole; Male; Midazolam; Rifampin; Young Adult | 2019 |
632 other study(ies) available for ketoconazole and itraconazole
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Design, synthesis and evaluation of benzoheterocycle analogues as potent antifungal agents targeting CYP51.
Topics: Antifungal Agents; Aspergillus fumigatus; Binding Sites; Candida albicans; Catalytic Domain; Cryptococcus neoformans; Drug Design; Drug Resistance, Fungal; Drug Stability; Fluconazole; Fungal Proteins; Gas Chromatography-Mass Spectrometry; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Isoforms; Sterol 14-Demethylase; Sterols; Structure-Activity Relationship; Triazoles | 2018 |
Improving the metabolic stability of antifungal compounds based on a scaffold hopping strategy: Design, synthesis, and structure-activity relationship studies of dihydrooxazole derivatives.
Topics: Antifungal Agents; Drug Design; Humans; Molecular Structure; Structure-Activity Relationship | 2021 |
Design, synthesis and evaluation of novel 5-phenylthiophene derivatives as potent fungicidal of Candida albicans and antifungal reagents of fluconazole-resistant fungi.
Topics: Antifungal Agents; Candida albicans; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Fungal; Fluconazole; Fungicides, Industrial; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Thiophenes | 2021 |
Relaxed Substrate Requirements of Sterol 14α-Demethylase from
Topics: 14-alpha Demethylase Inhibitors; Ligands; Naegleria fowleri; Sterol 14-Demethylase; Substrate Specificity | 2021 |
Structural and biochemical characterization of Mycobacterium tuberculosis CYP142: evidence for multiple cholesterol 27-hydroxylase activities in a human pathogen.
Topics: Cholesterol; Crystallography, X-Ray; Cytochrome P-450 Enzyme System; Host-Pathogen Interactions; Humans; Hydroxylation; Mycobacterium tuberculosis; Oxidation-Reduction; Protein Structure, Tertiary | 2010 |
Synthesis and antifungal activity of new azole derivatives containing an N-acylmorpholine ring.
Topics: Animals; Antifungal Agents; Azoles; Candidiasis; Female; Male; Mice; Microbial Sensitivity Tests; Rats; Rats, Wistar; Stereoisomerism; Structure-Activity Relationship | 1995 |
Novel antifungals based on 4-substituted imidazole: a combinatorial chemistry approach to lead discovery and optimization.
Topics: Antifungal Agents; Candida; Combinatorial Chemistry Techniques; Drug Design; Ergosterol; Fungi; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2000 |
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors.
Topics: 3T3 Cells; Adrenergic Uptake Inhibitors; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Biological Transport, Active; Cell Line; Cell Separation; Cell Survival; Flow Cytometry; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Mice; Protein Binding; Reserpine; Spectrometry, Fluorescence; Substrate Specificity; Time Factors | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Interaction of common azole antifungals with P glycoprotein.
Topics: 3T3 Cells; Adenosine Triphosphate; Animals; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azoles; Cell Line; Hydrolysis; Mice | 2002 |
Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Drug Evaluation, Preclinical; Fluoresceins; Fluorescent Dyes; Humans; Indicators and Reagents; Mice; Models, Molecular; Rhodamines; Species Specificity; Swine | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking.
Topics: Antifungal Agents; Azoles; Binding Sites; Databases, Factual; Fungi; Hydrogen Bonding; In Vitro Techniques; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship | 2006 |
Synthesis and antifungal activity of (Z)-5-arylidenerhodanines.
Topics: Antifungal Agents; Computer Simulation; Drug Design; Microbial Sensitivity Tests; Microwaves; Mitosporic Fungi; Molecular Structure; Rhodanine; Sensitivity and Specificity; Stereoisomerism; Structure-Activity Relationship; Yeasts | 2007 |
Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; DNA Primers; Genes, Fungal; Genetic Complementation Test; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Phenotype; Polyenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Fungal; RNA, Messenger; Sterols | 2007 |
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors.
Topics: Amides; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; Indoles; Models, Molecular; Oxidoreductases; Quantitative Structure-Activity Relationship; Sterol 14-Demethylase | 2007 |
Multiple sequential steps involved in the binding of inhibitors to cytochrome P450 3A4.
Topics: Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Humans; Kinetics; Ligands; Models, Chemical; Pharmaceutical Preparations; Protein Binding; Recombinant Proteins; Spectrum Analysis; Thermodynamics; Titrimetry | 2007 |
A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Drug Resistance, Fungal; Fluconazole; Microbial Sensitivity Tests; Mutation; Oxidative Phosphorylation; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2007 |
Synthesis of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase (CYP51).
Topics: Antifungal Agents; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Triazoles | 2007 |
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Sporothrix; Sporotrichosis; Triazoles; Voriconazole | 2007 |
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Oral; Drug Resistance, Fungal; Environmental Microbiology; Fungicides, Industrial; Germany; HIV Infections; HIV-1; Humans; Microbial Sensitivity Tests; Oropharynx; Vitis | 2007 |
Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy.
Topics: Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Colletotrichum; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fungi; Fungicides, Industrial; Humans; In Vitro Techniques; Lipopeptides; Microbial Sensitivity Tests; Microscopy, Fluorescence; Nystatin; Plant Diseases; Skin; Triazoles | 2007 |
Synthesis and antifungal activities of novel 2-aminotetralin derivatives.
Topics: Administration, Intravaginal; Animals; Antifungal Agents; Binding Sites; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fluconazole; Microbial Sensitivity Tests; Models, Molecular; Oxidoreductases; Protein Binding; Rats; Sterol 14-Demethylase; Structure-Activity Relationship; Tetrahydronaphthalenes; Vaginal Diseases | 2007 |
Antifungal and cytotoxic activities of some N-substituted aniline derivatives bearing a hetaryl fragment.
Topics: Aniline Compounds; Antifungal Agents; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Imines; Microbial Sensitivity Tests; Molecular Structure; National Cancer Institute (U.S.); United States | 2008 |
In vitro antifungal susceptibilities of five species of sporothrix.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis | 2008 |
Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Culture Media; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Reproducibility of Results; Yeasts | 2008 |
In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Fusarium; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Naphthalenes; Sequence Analysis, DNA; Terbinafine; Triazoles; Tubulin | 2008 |
Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents.
Topics: Antifungal Agents; Candida albicans; Fluconazole; Humans; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole; Yeasts | 2008 |
1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies.
Topics: Antifungal Agents; Arthrodermataceae; Candida albicans; Cell Line, Tumor; Cell Survival; Computer Simulation; Humans; Imidazoles; Models, Molecular; Molecular Structure; Stereoisomerism; Structure-Activity Relationship | 2008 |
Differential azole antifungal efficacies contrasted using a Saccharomyces cerevisiae strain humanized for sterol 14 alpha-demethylase at the homologous locus.
Topics: Antifungal Agents; Azoles; Base Sequence; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Genes, Fungal; Humans; Molecular Sequence Data; Recombinant Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Species Specificity; Sterol 14-Demethylase | 2008 |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Cell Membrane; Chromosomes, Fungal; Drug Resistance, Fungal; Endoplasmic Reticulum; Humans; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae | 2009 |
Identification, characterization, and azole-binding properties of Mycobacterium smegmatis CYP164A2, a homolog of ML2088, the sole cytochrome P450 gene of Mycobacterium leprae.
Topics: Amino Acid Motifs; Amino Acid Sequence; Azoles; Base Sequence; Cloning, Molecular; Conserved Sequence; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Genes, Bacterial; Hydrogen-Ion Concentration; Molecular Sequence Data; Molecular Structure; Molecular Weight; Mycobacterium leprae; Mycobacterium smegmatis; Osmolar Concentration; Recombinant Proteins; Sequence Homology, Amino Acid; Sodium Chloride | 2009 |
Design, synthesis, and biological evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Enzyme Inhibitors; Protein Binding; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2009 |
In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans.
Topics: Antifungal Agents; Azoles; Candida albicans; Fluconazole; Itraconazole; Ketoconazole; Lichens; Microbial Sensitivity Tests; Triterpenes | 2009 |
Fenticonazole activity measured by the methods of the European Committee on Antimicrobial Susceptibility Testing and CLSI against 260 Candida vulvovaginitis isolates from two European regions and annotations on the prevalent genotypes.
Topics: Adult; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Cluster Analysis; DNA Fingerprinting; Drug Resistance, Fungal; Europe; Female; Fluconazole; Genotype; Humans; Imidazoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Prevalence | 2009 |
Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida albicans; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Rhodamines | 2009 |
Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols.
Topics: Antifungal Agents; Catalytic Domain; Chemistry, Pharmaceutical; Computer Simulation; Crystallography, X-Ray; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Models, Chemical; Propanols; Protein Binding; Triazoles | 2009 |
Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals.
Topics: Anisomycin; Antifungal Agents; Biological Transport; Candida albicans; Curcumin; Cycloheximide; Drug Synergism; Enzyme Inhibitors; Fluconazole; Itraconazole; Ketoconazole; Methotrexate; Miconazole; Multidrug Resistance-Associated Proteins; Pyrimidines; Rhodamines; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2009 |
In vitro activity of thimerosal against ocular pathogenic fungi.
Topics: Alternaria; Amphotericin B; Antifungal Agents; Aspergillus; Eye Infections, Fungal; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Natamycin; Thimerosal | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Drug Resistance, Fungal; Fungal Proteins; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction | 2010 |
Synthesis and antifungal evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Fungi; Humans; Models, Molecular; Mycoses; Sterol 14-Demethylase; Triazoles | 2010 |
Identification and characterization of four azole-resistant erg3 mutants of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Drug Resistance, Fungal; Ergosterol; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mutation; Oxidoreductases; Pyrimidines; Triazoles; Voriconazole | 2010 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives.
Topics: Antifungal Agents; Candida albicans; Catalytic Domain; Cryptococcus neoformans; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Piperazines; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles; Voriconazole | 2011 |
Antifungal activities of novel non-azole molecules against S. cerevisiae and C. albicans.
Topics: Antifungal Agents; Candida albicans; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Liver; Models, Molecular; Nitriles; Protein Conformation; Saccharomyces cerevisiae; Sterol 14-Demethylase; User-Computer Interface | 2012 |
New triazole derivatives as antifungal agents: synthesis via click reaction, in vitro evaluation and molecular docking studies.
Topics: Antifungal Agents; Catalysis; Catalytic Domain; Click Chemistry; Computer Simulation; Copper; Fungi; Humans; Microbial Sensitivity Tests; Triazoles | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Synthesis and evaluation of novel azoles as potent antifungal agents.
Topics: Antifungal Agents; Azoles; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2014 |
Synthesis, antifungal activities and molecular docking studies of novel 2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl dithiocarbamates.
Topics: Aspergillus fumigatus; Candida; Carbamates; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Docking Simulation | 2014 |
Polyhydroxy cyclohexanols from a Dendrodochium sp. fungus associated with the sea cucumber Holothuria nobilis Selenka.
Topics: Animals; Antifungal Agents; Cryptococcus neoformans; Cyclohexanols; Holothuria; Humans; Microbial Sensitivity Tests; Molecular Structure; Oceans and Seas; Trichophyton | 2014 |
Discovery of biphenyl imidazole derivatives as potent antifungal agents: Design, synthesis, and structure-activity relationship studies.
Topics: Antifungal Agents; Biphenyl Compounds; Candida albicans; Cryptococcus neoformans; Dose-Response Relationship, Drug; Drug Discovery; Imidazoles; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2017 |
Design, synthesis and evaluation of aromatic heterocyclic derivatives as potent antifungal agents.
Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Cryptococcus neoformans; Dose-Response Relationship, Drug; Drug Design; Heterocyclic Compounds; Hydrocarbons, Aromatic; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2017 |
Antifungal activity, mode of action variability, and subcellular distribution of coumarin-based antifungal azoles.
Topics: Antifungal Agents; Azoles; Candida; Cell Survival; Coumarins; Dose-Response Relationship, Drug; HEK293 Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Optical Imaging; Structure-Activity Relationship | 2019 |
In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Azoles; Drug Antagonism; Drug Resistance, Microbial; Drug Synergism; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 1992 |
Oral itraconazole therapy for disseminated candidiasis in low birth weight infants.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Humans; Infant, Newborn; Infant, Premature, Diseases; Itraconazole; Ketoconazole | 1992 |
Drugs for treatment of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses; Opportunistic Infections | 1992 |
Tissue distribution and antifungal effect of liposomal itraconazole in experimental cryptococcosis and pulmonary aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Cryptococcosis; Cryptococcus neoformans; Drug Carriers; Itraconazole; Ketoconazole; Liposomes; Lung; Lung Diseases, Fungal; Male; Mice; Mice, Inbred DBA; Microbial Sensitivity Tests; Spleen; Tissue Distribution | 1992 |
Itraconazole-digoxin interaction.
Topics: Aged; Antifungal Agents; Digoxin; Drug Interactions; Humans; Itraconazole; Ketoconazole; Male | 1992 |
Azoles, allylamines and drug metabolism.
Topics: Antifungal Agents; Azoles; Cyclosporine; Dose-Response Relationship, Drug; Humans; Hydrocortisone; In Vitro Techniques; Itraconazole; Ketoconazole; Microsomes, Liver; Naphthalenes; Terbinafine | 1992 |
Control of invasive pulmonary aspergillosis with oral itraconazole in a bone marrow transplant patient.
Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Female; Graft vs Host Disease; Hepatitis B; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Myelodysplastic Syndromes | 1992 |
Itraconazole concentrations in airway fluid and tissue.
Topics: Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Bronchoalveolar Lavage Fluid; Humans; Itraconazole; Ketoconazole; Lung; Male | 1992 |
Maintenance itraconazole for visceral leishmaniasis in HIV infection.
Topics: Adult; Antifungal Agents; Female; HIV Infections; Humans; Itraconazole; Ketoconazole; Leishmaniasis, Visceral; Opportunistic Infections; Pentamidine | 1992 |
The evaluation of therapeutic responses in experimental keratomycosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colony Count, Microbial; Disease Models, Animal; Eye Infections, Fungal; Fluconazole; Itraconazole; Keratitis; Ketoconazole; Observer Variation; Rabbits | 1992 |
Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.
Topics: Adult; Aged; Antifungal Agents; Azoles; Carbamazepine; Coccidioides; Cryptococcus neoformans; Drug Interactions; Drug Therapy, Combination; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Malassezia; Male; Middle Aged; Mycoses; Phenytoin; Rifampin | 1992 |
Penicillium marneffei infection in patients infected with human immunodeficiency virus.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; HIV Infections; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mycoses; Opportunistic Infections; Penicillium; Retrospective Studies; Thailand; Treatment Outcome | 1992 |
Fungal scleritis after cataract surgery. Successful outcome using itraconazole.
Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Aspergillus flavus; Cataract Extraction; Eye Infections, Fungal; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Postoperative Complications; Scleritis; Treatment Outcome; Visual Acuity | 1992 |
Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis.
Topics: Antifungal Agents; Capsules; Chromatography, High Pressure Liquid; Drug Evaluation; Female; Fingers; Humans; Itraconazole; Ketoconazole; Male; Nails; Onychomycosis; Remission Induction; Time Factors; Toes | 1992 |
Treatment of pulmonary aspergilloma with itraconazole.
Topics: Antifungal Agents; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Mycetoma | 1992 |
Comparison of azoles against aspergilli in vitro and in an experimental model of pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Disease Models, Animal; Itraconazole; Ketoconazole; Male; Rats; Rats, Inbred Strains; Triazoles | 1992 |
Aspergillosis.
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Child; Cystic Fibrosis; Humans; Itraconazole; Ketoconazole; Male; Prednisolone; Radiography | 1992 |
Itraconazole in the treatment of acute vaginal candidosis.
Topics: Acute Disease; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Itraconazole; Ketoconazole; Middle Aged | 1992 |
[New treatments of onychomycoses].
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Ciclopirox; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Morpholines; Onychomycosis; Pyridones | 1992 |
US experience with itraconazole in Aspergillus, Cryptococcus and Histoplasma infections in the immunocompromised host.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Cryptococcosis; Histoplasmosis; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; United States | 1992 |
Tropical mycoses.
Topics: Adult; Aged; Antifungal Agents; Blastomycosis; Chromoblastomycosis; Drug Therapy, Combination; Female; Flucytosine; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mycetoma; Mycoses; South Africa; Sporotrichosis | 1992 |
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Guinea Pigs; Immunocompromised Host; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Sporotrichosis | 1992 |
Treatment failure in a case of fungal keratitis caused by Pseudallescheria boydii.
Topics: Antifungal Agents; Eye Infections, Fungal; Humans; Itraconazole; Keratitis; Keratoplasty, Penetrating; Ketoconazole; Male; Miconazole; Middle Aged; Pseudallescheria | 1992 |
Treatment with itraconazole of penguins suffering from aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Bird Diseases; Birds; Itraconazole; Ketoconazole; Lung Diseases, Fungal | 1992 |
[Sphenoid sinus aspergillosis presenting abducens nerve palsy and visual field impairment; a case report].
Topics: Abducens Nerve; Aged; Antifungal Agents; Aspergillosis; Cranial Nerve Diseases; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Paralysis; Paranasal Sinus Diseases; Sphenoid Sinus; Visual Fields | 1992 |
[Itraconazole++-induced neurotoxicity].
Topics: Aged; Antifungal Agents; Aspergillosis; Cerebellar Diseases; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male | 1992 |
Cutaneous Alternaria infection treated with itraconazole.
Topics: Aged; Alternaria; Antifungal Agents; Dermatomycoses; Female; Humans; Itraconazole; Ketoconazole | 1992 |
Diagnosis of avian aspergillosis and treatment with itraconazole.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bird Diseases; Birds; Itraconazole; Ketoconazole | 1992 |
Fungal Pseudoallescheria boydii lung infiltrates unresponsive to amphotericin B in leukaemic patients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Humans; Itraconazole; Ketoconazole; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudallescheria | 1992 |
Itraconazole therapy for disseminated candidiasis in a very low birthweight neonate.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Humans; Infant, Low Birth Weight; Infant, Newborn; Itraconazole; Ketoconazole; Male | 1992 |
Effects of culture media on the in vitro susceptibility of selected opportunistic fungi to fluconazole and itraconazole.
Topics: Alternaria; Antifungal Agents; Aspergillus; Candida; Culture Media; Fluconazole; Fungi; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Pseudallescheria | 1992 |
Chromomycosis: a therapeutic challenge.
Topics: Antifungal Agents; Chromoblastomycosis; Humans; Itraconazole; Ketoconazole | 1992 |
Treatment of neonatal Candida albicans septicemia with itraconazole.
Topics: Antifungal Agents; Candidiasis; Fungemia; Humans; Infant, Newborn; Itraconazole; Ketoconazole; Male | 1992 |
Plasma itraconazole concentrations in neutropenic patients after repeated high-dose treatment.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Bone Marrow Transplantation; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Itraconazole; Ketoconazole; Leukemia; Middle Aged; Neutropenia | 1992 |
New antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine | 1992 |
Possible failure of itraconazole in preventing fungal infection in a neutropenic leukaemia patient.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Aspergillus niger; Humans; Itraconazole; Ketoconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia | 1992 |
Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mice, Inbred BALB C; Triazoles | 1992 |
Effects of itraconazole on phagocytosis and killing of Candida glabrata by polymorphonuclear leucocytes from guinea pigs.
Topics: Animals; Antifungal Agents; Candida; Deoxycholic Acid; Feces; Guinea Pigs; Humans; In Vitro Techniques; Injections, Intraperitoneal; Itraconazole; Ketoconazole; Leukemia, Experimental; Male; Neutrophils; Phagocytosis | 1992 |
Aspergillus intraabdominal abscess after liver transplantation successfully treated with itraconazole.
Topics: Abdomen; Abscess; Adult; Antifungal Agents; Aspergillosis; Female; Humans; Itraconazole; Ketoconazole; Liver Transplantation; Peritoneal Diseases | 1992 |
Penicillium marneffei infection in patients infected with human immunodeficiency virus: late presentation in an area of nonendemicity.
Topics: Adult; AIDS-Related Opportunistic Infections; Dermatomycoses; Humans; Itraconazole; Ketoconazole; Male; Penicillium | 1992 |
Lack of immunosuppression by ketoconazole and itraconazole.
Topics: Animals; Antibody Formation; Antifungal Agents; DNA; Female; Hypersensitivity, Delayed; Immunosuppressive Agents; Itraconazole; Ketoconazole; Lymphocyte Activation; Mice | 1992 |
Digoxin toxicity associated with itraconazole therapy.
Topics: Aged; Antifungal Agents; Aspergillosis; Digoxin; Drug Interactions; Female; Humans; Itraconazole; Ketoconazole | 1992 |
Ventriculitis and hydrocephalus caused by Candida albicans successfully treated by antimycotic therapy and cerebrospinal fluid shunting.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Brain Abscess; Candidiasis; Cerebral Ventricles; Cerebrospinal Fluid; Combined Modality Therapy; Drug Therapy, Combination; Female; Flucytosine; Humans; Hydrocephalus; Itraconazole; Ketoconazole; Ventriculoperitoneal Shunt | 1992 |
[The use of itraconazole in liver transplantation].
Topics: Antifungal Agents; Aspergillosis; Humans; Itraconazole; Ketoconazole; Liver Transplantation; Lung Diseases, Fungal; Male; Middle Aged; Postoperative Complications | 1992 |
Aspergillus-induced discitis. A role for itraconazole in therapy?
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Discitis; Humans; Itraconazole; Ketoconazole; Lumbar Vertebrae; Male | 1992 |
Acute pyogenic Pseudallescheria boydii foot infection sequentially treated with miconazole and itraconazole.
Topics: Acute Disease; Antifungal Agents; Foot Diseases; Humans; Itraconazole; Ketoconazole; Male; Miconazole; Middle Aged; Mycetoma; Pseudallescheria | 1992 |
Synergy of itraconazole with macrophages in killing Blastomyces dermatitidis.
Topics: Animals; Antifungal Agents; Blastomyces; Blastomycosis; Cell Adhesion; Culture Media; Drug Synergism; Immunity, Cellular; Itraconazole; Ketoconazole; Lymphocytes; Macrophages; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peritoneal Cavity; Time Factors | 1992 |
In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Species Specificity | 1992 |
[Chronic aspergillosis in familial chronic granulomatosis].
Topics: Adult; Antifungal Agents; Aspergillosis; Dermatomycoses; Fingers; Granulomatous Disease, Chronic; Humans; Itraconazole; Ketoconazole; Male | 1992 |
Superior division paresis of the oculomotor nerve caused by cryptococcal meningitis.
Topics: Adolescent; Antifungal Agents; Blepharoptosis; Eye Infections, Fungal; Female; Humans; Itraconazole; Ketoconazole; Meningitis, Cryptococcal; Oculomotor Nerve Diseases; Visual Acuity | 1992 |
Itraconazole in cryptococcal meningitis in pregnancy: a case report.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Flucytosine; Humans; Infant, Newborn; Itraconazole; Ketoconazole; Meningitis, Cryptococcal; Pregnancy; Pregnancy Complications, Infectious | 1992 |
An efficacy study of itraconazole in the treatment of Penicillium marneffei infection.
Topics: Adolescent; Adult; Antifungal Agents; Female; HIV Seropositivity; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mycoses; Penicillium | 1992 |
Hepatic injury associated with itraconazole.
Topics: Aged; Antifungal Agents; Chemical and Drug Induced Liver Injury; Female; Humans; Itraconazole; Ketoconazole; Liver Diseases; Male; Middle Aged | 1992 |
The pharmacokinetics of oral itraconazole in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Antifungal Agents; Humans; Itraconazole; Ketoconazole; Male; Middle Aged | 1992 |
The effects of the antifungal azoles itraconazole, fluconazole, ketoconazole and miconazole on cytokine gene expression in human lymphoid cells.
Topics: Antifungal Agents; Cells, Cultured; Cyclosporine; Cytokines; Fluconazole; Gene Expression; Humans; Itraconazole; Ketoconazole; Lymphocytes; Miconazole; Tacrolimus | 1992 |
Necrotizing bronchial aspergillosis in a patient receiving neoadjuvant chemotherapy for non-small cell lung carcinoma.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus fumigatus; Bronchi; Bronchial Diseases; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Itraconazole; Ketoconazole; Lung Neoplasms; Mitomycin; Mitomycins; Necrosis; Vindesine | 1991 |
Nasal and retrobulbar mass in a cat caused by Pythium insidiosum.
Topics: Animals; Antibodies, Fungal; Antifungal Agents; Cat Diseases; Cats; Fluorescent Antibody Technique; Immunodiffusion; Itraconazole; Ketoconazole; Male; Mycoses; Nasopharyngeal Diseases; Nose Diseases; Orbital Diseases; Pythium; Spores, Fungal; Tomography, X-Ray Computed | 1991 |
High-dose itraconazole in the treatment of severe mycoses.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Antifungal Agents; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mycoses | 1991 |
Comparison of the immunosuppressive activities of the antimycotic agents itraconazole, fluconazole, ketoconazole and miconazole on human T-cells.
Topics: Antifungal Agents; Cytokines; Fluconazole; Humans; Immunosuppressive Agents; In Vitro Techniques; Interleukin-2; Itraconazole; Ketoconazole; Lymphocyte Activation; Miconazole; T-Lymphocytes | 1991 |
Itraconazole and aspergilloma.
Topics: Antifungal Agents; Aspergillosis; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal | 1991 |
[In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Mycoses; Trichosporon | 1991 |
[In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with dermatomycoses].
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Dermatomycoses; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 1991 |
[In vitro antifungal activity of itraconazole: a comparative study with ketoconazole].
Topics: Antifungal Agents; Candida albicans; Humans; Itraconazole; Ketoconazole; Mycoses | 1991 |
[The therapeutic effects of itraconazole, a new triazole antifungal agent, for experimental fungal infections].
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Cryptococcus neoformans; Female; Guinea Pigs; Itraconazole; Ketoconazole; Male; Mice; Mice, Inbred ICR; Mycoses; Trichophyton | 1991 |
[Aspergillosis with involvement of the thoracic wall].
Topics: Antifungal Agents; Aspergillosis; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Pneumonectomy; Thoracic Diseases | 1991 |
Treatment of postoperative Aspergillus fumigatus spondylodiscitis with itraconazole.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Debridement; Discitis; Humans; Itraconazole; Ketoconazole; Lumbar Vertebrae; Male; Middle Aged; Surgical Wound Infection | 1991 |
Itraconazole in the treatment of coccidioidomycosis.
Topics: Adult; Antifungal Agents; Coccidioidomycosis; Female; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Prospective Studies; Recurrence | 1991 |
Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Asthma; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Prednisone | 1991 |
Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Biopsy; Bronchi; Bronchitis; Female; Humans; Itraconazole; Ketoconazole; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Trachea; Tracheitis; Ulcer | 1991 |
In vitro comparison of cilofungin alone and in combination with other antifungal agents against clinical isolates of Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Drug Therapy, Combination; Echinocandins; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic | 1991 |
Control of proven pulmonary and suspected CNS aspergillus infection with itraconazole in a patient with chronic granulomatous disease.
Topics: Antifungal Agents; Aspergillosis; Brain Diseases; Child; Granulomatous Disease, Chronic; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Magnetic Resonance Imaging; Male | 1991 |
Disseminated histoplasmosis in an AIDS patient treated with itraconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Blood; Histoplasma; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Macrophages; Male; Opportunistic Infections | 1991 |
[The treatment of pulmonary aspergilloma with itraconazole].
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Drug Evaluation; Female; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Middle Aged | 1991 |
Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative study.
Topics: Antifungal Agents; Candida; Cryptococcus; Fluconazole; Fungi; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1991 |
Tinea of the eyebrow showing kerion celsi reaction: report of one case.
Topics: Antifungal Agents; Diagnosis, Differential; Eyebrows; Female; Hair Diseases; Humans; Itraconazole; Ketoconazole; Middle Aged; Tinea | 1991 |
Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes.
Topics: Adult; Antifungal Agents; Cyclosporine; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Microsomes, Liver; Naphthalenes; Terbinafine | 1991 |
Chromoblastomycosis with malignant transformation and cutaneous-synovial secondary localization. The potential therapeutic role of itraconazole.
Topics: Aged; Antifungal Agents; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Chromoblastomycosis; Guyana; Humans; Itraconazole; Ketoconazole; Male; Skin Neoplasms; Synovial Cyst | 1991 |
Fungal morphology after treatment with itraconazole as a single oral dose in experimental vaginal candidosis in rats.
Topics: Administration, Oral; Animals; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Female; Itraconazole; Ketoconazole; Microscopy, Electron; Rats; Rats, Inbred Strains | 1991 |
Safety and efficacy of itraconazole in prevention of fungal infections in neutropenic patients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mycoses; Neutropenia; Nystatin; Prospective Studies | 1991 |
Treatment of deep mycoses with itraconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Antitubercular Agents; Aspergillosis; Child; Chromoblastomycosis; Drug Resistance, Microbial; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mucormycosis | 1991 |
Influence of albumin on itraconazole and ketoconazole antifungal activity: results of a dynamic in vitro study.
Topics: Antifungal Agents; Candida albicans; Culture Media; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Protein Binding; Serum Albumin | 1991 |
The anti-fungal agent itraconazole exerts immunosuppressive effects on alloreactivity but not on natural immunity in vitro.
Topics: Antifungal Agents; Fluconazole; Humans; Immunity; Immunity, Innate; Immunosuppressive Agents; In Vitro Techniques; Itraconazole; Ketoconazole; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Lymphocyte Culture Test, Mixed | 1991 |
[Tropical mycoses].
Topics: Antifungal Agents; Blastomycosis; Chromoblastomycosis; Clinical Trials as Topic; Female; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Male; Mycetoma; Mycoses; Paracoccidioidomycosis; South Africa; Sporotrichosis | 1991 |
[Mycoses as opportunistic infections in AIDS patients].
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Humans; Itraconazole; Ketoconazole; Mycoses; Opportunistic Infections; Recurrence | 1991 |
[Itraconazole in systemic fungal infections].
Topics: Antifungal Agents; Humans; Itraconazole; Ketoconazole; Mycoses | 1991 |
[In-vitro and in-vivo activity of itraconazole].
Topics: Animals; Antifungal Agents; Drug Synergism; Drug Therapy, Combination; Fungi; Guinea Pigs; Itraconazole; Ketoconazole; Mycoses | 1991 |
[The treatment of aspergillosis, cryptococcosis and histoplasmosis in immunocompromised patients. Report of experience in the United States].
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Cryptococcosis; Histoplasmosis; HIV Infections; Immunocompromised Host; Itraconazole; Ketoconazole | 1991 |
Treatment of pulmonary aspergilloma with itraconazole.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Immunoglobulin G; Itraconazole; Ketoconazole; Lung; Lung Diseases, Fungal; Male; Middle Aged; Radiography | 1991 |
Eumycetoma caused by Curvularia lunata in a dog.
Topics: Animals; Dog Diseases; Dogs; Granuloma; Itraconazole; Ketoconazole; Male; Microscopy, Electron, Scanning; Mitosporic Fungi; Mycetoma | 1991 |
Itraconazole penetrates the nail via the nail matrix and the nail bed--an investigation in onychomycosis.
Topics: Adult; Aged; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Nails; Onychomycosis | 1991 |
Treatment of chromoblastomycosis.
Topics: Antifungal Agents; Chromoblastomycosis; Drug Combinations; Flucytosine; Humans; Itraconazole; Ketoconazole | 1991 |
Lipid-itraconazole interaction in lipid model membranes.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Calorimetry, Differential Scanning; Itraconazole; Ketoconazole; Lipids; Membranes, Artificial; Molecular Conformation; Phospholipids; Spectrophotometry, Infrared | 1991 |
[Itraconazole and Ketoconazole cream--new concepts in antimycotic therapy. Paris, 26 January 1991].
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Dermatomycoses; Humans; Itraconazole; Ketoconazole | 1991 |
Itraconazole for pulmonary mycetoma.
Topics: Antifungal Agents; Drug Administration Schedule; Female; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Middle Aged; Mycetoma | 1991 |
Resolution of microsporidial epithelial keratopathy in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Antifungal Agents; Corneal Diseases; Cryptococcosis; Encephalitozoon cuniculi; Eye Infections, Parasitic; HIV Seropositivity; Humans; Itraconazole; Ketoconazole; Male; Meningitis; Opportunistic Infections; Protozoan Infections | 1991 |
Ocular toxicity of experimental intravitreal itraconazole.
Topics: Animals; Antifungal Agents; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Electroretinography; Endophthalmitis; Eye; Injections; Itraconazole; Ketoconazole; Rabbits; Retinal Necrosis Syndrome, Acute; Vitreous Body | 1991 |
Reversal of daunorubicin resistance in P388/ADR cells by itraconazole.
Topics: Animals; Cell Line; Daunorubicin; DNA; Dose-Response Relationship, Drug; Drug Resistance; In Vitro Techniques; Itraconazole; Ketoconazole; Membrane Potentials; Mice | 1991 |
Sporotrichoid infection. Two cases.
Topics: Aged; Biopsy; Diagnosis, Differential; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin; Skin Diseases, Infectious; Sporothrix; Sporotrichosis | 1990 |
Determination of itraconazole in serum with high-performance liquid chromatography and fluorescence detection.
Topics: Chromatography, High Pressure Liquid; Humans; Hydrogen-Ion Concentration; Itraconazole; Ketoconazole; Molecular Structure; Quality Control | 1990 |
Effects of pentamidine alone and in combination with ketoconazole or itraconazole on the growth of Candida albicans.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pentamidine | 1990 |
Itraconazole in dermatophyte infections: clinical experience in Italy.
Topics: Antifungal Agents; Dermatomycoses; Humans; Italy; Itraconazole; Ketoconazole | 1990 |
Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis; Miconazole; Middle Aged | 1990 |
The effect of ketoconazole and itraconazole on the filamentous form of Pityrosporum ovale.
Topics: Antifungal Agents; Itraconazole; Ketoconazole; Malassezia; Microscopy, Electron | 1990 |
Amphotericin-resistant aspergillus osteomyelitis controlled by itraconazole.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Microbial; Food, Formulated; Humans; Itraconazole; Ketoconazole; Male; Osteomyelitis | 1990 |
Itraconazole and anti-tuberculosis drugs.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Middle Aged | 1990 |
Oral itraconazole and topical miconazole with débridement for Acanthamoeba keratitis.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Administration, Oral; Administration, Topical; Adult; Animals; Contact Lenses, Hydrophilic; Cornea; Debridement; Female; Humans; Itraconazole; Ketoconazole; Male; Miconazole; Visual Acuity | 1990 |
Chronic recurrent vaginal candidosis: easy to treat, difficult to cure. Results of intermittent treatment with a new oral antifungant.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Drug Administration Schedule; Female; Humans; Itraconazole; Ketoconazole; Menstrual Cycle; Middle Aged; Recurrence | 1990 |
Levels of itraconazole in skin blister fluid after a single oral dose and during repetitive administration.
Topics: Administration, Oral; Adult; Antifungal Agents; Blister; Female; Humans; Itraconazole; Ketoconazole; Male; Time Factors | 1990 |
Effect of antifungal agents on the adherence of Candida albicans to murine gastrointestinal mucosal surfaces.
Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Bacterial Adhesion; Candida albicans; Gastric Mucosa; Hydrogen-Ion Concentration; Intestinal Mucosa; Itraconazole; Jejunum; Ketoconazole; Mice; Microbial Sensitivity Tests | 1990 |
Treatment of invasive aspergillosis with itraconazole in a patient with chronic granulomatous disease.
Topics: Adolescent; Amphotericin B; Aspergillosis; Aspergillus fumigatus; Chromatography, High Pressure Liquid; Granulomatous Disease, Chronic; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Osteomyelitis; Radiography; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
Preliminary results of treatment with itraconazole in patients with systemic fungal infections.
Topics: Acute Disease; Adult; Agranulocytosis; Antifungal Agents; Antineoplastic Agents; Drug Evaluation; Drug Therapy, Combination; Flucytosine; Humans; Itraconazole; Ketoconazole; Leukemia; Liver Function Tests; Middle Aged; Mycoses | 1990 |
Discovering antimycotic drugs: today and tomorrow.
Topics: Antifungal Agents; Azoles; Candidiasis; Dermatomycoses; Female; Humans; Itraconazole; Ketoconazole; Mycoses; Tinea Versicolor; Vaginal Diseases | 1990 |
Micro-scale method for itraconazole in plasma by reversed-phase high-performance liquid chromatography.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Chromatography, High Pressure Liquid; HIV; Hot Temperature; Humans; Itraconazole; Ketoconazole; Microchemistry; Quality Control | 1990 |
Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Disease Models, Animal; Drug Administration Schedule; Evaluation Studies as Topic; Female; Fluconazole; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Meningitis; Mice; Pharmaceutical Vehicles; Rats; Rats, Inbred Strains; Triazoles | 1990 |
Treatment of murine coccidioidal meningitis with SCH39304.
Topics: Animals; Antifungal Agents; Coccidioidomycosis; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Fluconazole; Itraconazole; Ketoconazole; Meningitis; Mice; Mice, Inbred BALB C; Triazoles | 1990 |
Treatment of paracoccidioidomycosis with itraconazole.
Topics: Acute Disease; Adolescent; Adult; Aged; Antifungal Agents; Child; Chronic Disease; Humans; Itraconazole; Ketoconazole; Lung; Male; Middle Aged; Paracoccidioidomycosis; Radiography | 1990 |
Comparative morphological and biological studies on the itraconazole- and ketoconazole-resistant mutants of Cryptococcus neoformans.
Topics: Animals; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Culture Media; Drug Resistance, Microbial; Humans; Itraconazole; Ketoconazole; Male; Mice; Microscopy, Electron; Microscopy, Electron, Scanning; Mutation; Virulence | 1990 |
False aneurysm infected by Aspergillus fumigatus: an unusual complication of aortofemoral bypass graft.
Topics: Amphotericin B; Aneurysm, Infected; Antifungal Agents; Aorta, Abdominal; Aspergillosis; Aspergillus fumigatus; Blood Vessel Prosthesis; Femoral Artery; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Middle Aged | 1990 |
Treatment of chronic murine chromoblastomycosis with the triazole SCH39304.
Topics: Animals; Antifungal Agents; Chromoblastomycosis; Chronic Disease; Disease Models, Animal; Female; Itraconazole; Ketoconazole; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron; Mitosporic Fungi; Skin; Triazoles | 1990 |
Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Cells, Cultured; Colony Count, Microbial; Fluconazole; Itraconazole; Ketoconazole; Macrophages; Mice; Phagocytosis | 1990 |
Cyclosporine and itraconazole interaction in heart and lung transplant recipients.
Topics: Aspergillosis; Coccidiosis; Cyclosporins; Drug Interactions; Heart Transplantation; Heart-Lung Transplantation; Humans; Itraconazole; Ketoconazole; Kidney Diseases; Lung Transplantation; Sporotrichosis | 1990 |
[Aspergillus mastoiditis in infected granulomatosis--a case report].
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Combined Modality Therapy; Granulomatous Disease, Chronic; Humans; Itraconazole; Ketoconazole; Magnetic Resonance Imaging; Male; Mastoid; Mastoiditis; Opportunistic Infections; Tomography, X-Ray Computed | 1990 |
Sequential serological responses to Aspergillus fumigatus in patients with cystic fibrosis. Use of antigen 'stretching' to delineate IgG and IgE activity.
Topics: Adolescent; Adult; Antibodies, Fungal; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Child; Child, Preschool; Cystic Fibrosis; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin E; Immunoglobulin G; Infant; Itraconazole; Ketoconazole; Male; Miconazole; Molecular Weight; Time Factors | 1990 |
[Sensitivity of Aspergillus to ketoconazole and itraconazole using a standardized micromethod].
Topics: Antifungal Agents; Aspergillus; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1990 |
[Comparative sensitivity of yeasts to ketoconazole, itraconazole and fluconazole using a liquid medium standardized micromethod].
Topics: Antifungal Agents; Drug Resistance, Microbial; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Yeasts | 1990 |
Histoplasmosis in a UK patient treated with itraconazole.
Topics: Adult; Histoplasmosis; HIV Seropositivity; Humans; Itraconazole; Ketoconazole; United Kingdom | 1990 |
Itraconazole treatment of coccidioidomycosis. NAIAD Mycoses Study Group.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Bone Diseases; Coccidioidomycosis; Dermatomycoses; Drug Resistance, Microbial; Female; Follow-Up Studies; Humans; Itraconazole; Joint Diseases; Ketoconazole; Lung Diseases, Fungal; Male; Middle Aged; Recurrence; Remission Induction | 1990 |
A case of fungal keratitis caused by Scopulariopsis brevicaulis: treatment with antifungal agents and penetrating keratoplasty.
Topics: Adult; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Eye Infections, Fungal; Humans; Itraconazole; Keratitis; Keratoplasty, Penetrating; Ketoconazole; Male; Mitosporic Fungi | 1990 |
Evaluation of ketoconazole and itraconazole for treatment of disseminated cryptococcosis in cats.
Topics: Animals; Antigens, Fungal; Cat Diseases; Cats; Cryptococcosis; Cryptococcus; Female; Itraconazole; Ketoconazole; Random Allocation; Time Factors | 1990 |
[Antifungal agents in dermatophytic disease: failure of griseofulvin, ketoconazole and itraconazole].
Topics: Adult; Antifungal Agents; Dermatomycoses; Drug Therapy, Combination; Griseofulvin; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Tinea | 1990 |
Clinical use of itraconazole in fungal infections.
Topics: Antifungal Agents; Humans; Itraconazole; Ketoconazole; Mycoses | 1990 |
Itraconazole in the treatment of tinea capitis.
Topics: Antifungal Agents; Child; Female; Follow-Up Studies; Humans; Itraconazole; Ketoconazole; Male; Tinea Capitis | 1990 |
Itraconazole in the management of chronic dermatophytosis.
Topics: Adult; Aged; Antifungal Agents; Chronic Disease; Dermatomycoses; Drug Administration Schedule; Female; Fingers; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Toes | 1990 |
Itraconazole treatment of phaeohyphomycosis.
Topics: Adult; Aged; Antifungal Agents; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses | 1990 |
European experience with itraconazole in systemic mycoses.
Topics: Antifungal Agents; Aspergillosis; Child; Cryptococcosis; Drug Administration Schedule; Humans; Itraconazole; Ketoconazole; Mycoses; Patient Compliance; Recurrence; Remission Induction; Sporotrichosis | 1990 |
Itraconazole therapy for nonmeningeal coccidioidomycosis: clinical and laboratory observations.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Chronic Disease; Coccidioides; Coccidioidomycosis; Drug Administration Schedule; Female; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Recurrence | 1990 |
Itraconazole in opportunistic mycoses: cryptococcosis and aspergillosis.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; Cryptococcosis; Cryptococcus; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Opportunistic Infections; Organ Transplantation; Recurrence; Survival Rate | 1990 |
The in vitro susceptibility of some mycotic agents to a new orally active triazole, itraconazole.
Topics: Administration, Oral; Antifungal Agents; Drug Resistance, Microbial; Fungi; Itraconazole; Ketoconazole; Mycoses; Yeasts | 1990 |
Treatment of invasive Aspergillus infection with itraconazole.
Topics: Antifungal Agents; Aspergillosis; Humans; Infant; Intestinal Absorption; Itraconazole; Ketoconazole; Male | 1990 |
[Cutaneous protothecosis treated with itraconazole].
Topics: Adult; Antifungal Agents; Granuloma; Humans; Infections; Itraconazole; Ketoconazole; Male; Prototheca; Skin Diseases | 1990 |
Potentiation of action of warfarin by itraconazole.
Topics: Antifungal Agents; Drug Synergism; Female; Hemorrhage; Humans; Itraconazole; Ketoconazole; Middle Aged; Warfarin | 1990 |
In vitro activity of saperconazole (R66 905) compared with amphotericin B and itraconazole against Aspergillus species.
Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Azoles; Itraconazole; Ketoconazole; Species Specificity | 1990 |
The pharmacokinetics of BAY R3783 and its efficacy in the treatment of experimental cryptococcal meningitis.
Topics: Animals; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Itraconazole; Ketoconazole; Meningitis; Rabbits; Triazoles | 1990 |
Successful treatment of Aspergillus flavus onychomycosis with oral itraconazole.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Female; Humans; Itraconazole; Ketoconazole; Middle Aged; Nail Diseases | 1990 |
Cutaneous leishmaniasis in an AIDS patient: cure with itraconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Humans; Itraconazole; Ketoconazole; Leishmaniasis | 1990 |
Successful treatment of Scedosporium apiospermum suppurative arthritis with itraconazole.
Topics: Administration, Oral; Antifungal Agents; Arthritis, Infectious; Child; Humans; Itraconazole; Ketoconazole; Knee Joint; Male; Mycoses; Osteomyelitis; Pseudallescheria | 1990 |
Prophylaxis of fungal infections with itraconazole in immunocompromised cancer patients.
Topics: Adult; Aged; Antifungal Agents; Female; Humans; Immune Tolerance; Itraconazole; Ketoconazole; Male; Middle Aged; Mycoses; Neoplasms; Opportunistic Infections | 1990 |
Activity of amphotericin B and intraconazole against intraphagocytic Candida albicans.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Drug Evaluation, Preclinical; Drug Therapy, Combination; Extracellular Space; Female; Itraconazole; Ketoconazole; Macrophages; Mice; Phagocytosis | 1990 |
Oral treatment with itraconazole of aspergilloma in cavitary lung cancer.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Carcinoma, Small Cell; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Lung Neoplasms; Male; Middle Aged | 1990 |
Interaction of microsomal cytochrome P-450 isolated from Aspergillus fumigatus with fluconazole and itraconazole.
Topics: Antifungal Agents; Aspergillus fumigatus; Binding, Competitive; Carbon Monoxide; Cytochrome P-450 Enzyme System; Fluconazole; Itraconazole; Ketoconazole; Microsomes; Spectrophotometry | 1990 |
A novel method for studying ergosterol biosynthesis by a cell-free preparation of Aspergillus fumigatus and its inhibition by azole antifungal agents.
Topics: Antifungal Agents; Aspergillus fumigatus; Autoradiography; Azoles; Chromatography, Thin Layer; Ergosterol; Fluconazole; Gas Chromatography-Mass Spectrometry; Hydrogen-Ion Concentration; Itraconazole; Ketoconazole; Molecular Structure | 1990 |
Suppression of neutrophil and lymphoproliferative responses in vitro by itraconazole but not fluconazole.
Topics: Antifungal Agents; Cells, Cultured; Chemotaxis, Leukocyte; Deoxyglucose; Fluconazole; Humans; Immunosuppressive Agents; Itraconazole; Ketoconazole; Lymphocyte Activation; Neutrophils | 1990 |
Assay of itraconazole in nail clippings by reversed phase, high performance liquid chromatography.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Drug Stability; Humans; Itraconazole; Ketoconazole; Nails; Reproducibility of Results; Sensitivity and Specificity | 1990 |
In-vivo effects of itraconazole on hepatic mixed-function oxidase.
Topics: Animals; Anticonvulsants; Cytochrome P-450 Enzyme System; Dicumarol; Female; Itraconazole; Ketoconazole; Liver; Male; Mice; Mixed Function Oxygenases; Paralysis; Phenytoin; Rats; Tolbutamide | 1988 |
[Cryptococcosis of the skin].
Topics: Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Female; Humans; Itraconazole; Ketoconazole; Kidney Transplantation; Middle Aged; Opportunistic Infections; Skin | 1989 |
Itraconazole therapy for acute invasive pulmonary aspergillosis in heart transplantation.
Topics: Acute Disease; Adult; Aspergillosis; Cyclosporins; Heart Transplantation; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Postoperative Complications | 1989 |
Experience with itraconazole in cryptococcosis and aspergillosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Cryptococcosis; Disease; Heart Transplantation; Humans; Immunosuppression Therapy; Itraconazole; Ketoconazole; Male; Neoplasms; Opportunistic Infections | 1989 |
[Recent antifungal agents].
Topics: Allylamine; Animals; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Morpholines; Mycoses; Triazoles | 1989 |
Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice.
Topics: Agranulocytosis; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Half-Life; Itraconazole; Ketoconazole; Male; Mice; Neutropenia; Triazoles | 1989 |
Perturbation of sterol biosynthesis by itraconazole and ketoconazole in Leishmania mexicana mexicana infected macrophages.
Topics: Acetates; Animals; Antiprotozoal Agents; Cell Division; Cell Line; Cholesterol; Ergosterol; Itraconazole; Ketoconazole; Leishmania mexicana; Macrophages; Sterols | 1989 |
Treatment of invasive aspergillosis with itraconazole.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Drug Evaluation; Female; Humans; Immunologic Deficiency Syndromes; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged | 1989 |
Effects of itraconazole on mitogen stimulated human mononuclear leucocytes.
Topics: Antifungal Agents; Cells, Cultured; Itraconazole; Ketoconazole; Leukocytes, Mononuclear; Lymphocyte Activation; Mitogens | 1989 |
Treatment of disseminated histoplasmosis in hamsters.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Cricetinae; Female; Histoplasma; Histoplasmosis; Itraconazole; Ketoconazole; Liver; Lung; Male; Mesocricetus; Spleen | 1989 |
New triazole antifungal agents (fluconazole and itraconazole) in the treatment of HIV-related gastrointestinal candidiasis.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Fluconazole; Gastrointestinal Diseases; Humans; Itraconazole; Ketoconazole; Triazoles | 1989 |
Effect of methotrexate alone and in combination with antifungal drugs on the growth of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Drug Interactions; Flucytosine; Itraconazole; Ketoconazole; Methotrexate; Microbial Sensitivity Tests; Spores, Fungal; Time Factors | 1989 |
Treatment of experimental zygomycosis in guinea pigs with azoles and with amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Fluconazole; Guinea Pigs; Itraconazole; Ketoconazole; Male; Mucormycosis; Rhizopus; Triazoles | 1989 |
LH-RH antagonists: design and synthesis of a novel series of peptidomimetics.
Topics: Animals; Antifungal Agents; Gonadotropin-Releasing Hormone; Imidazoles; Itraconazole; Ketoconazole; Male; Peptides; Rats; Rats, Inbred Strains; Receptors, LH; Structure-Activity Relationship | 1989 |
Itraconazole vs amphotericin B: in vitro comparative evaluation of the minimal inhibitory concentration (MIC) against clinically isolated yeasts.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus; Cryptococcus neoformans; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1989 |
[In vitro effect of itraconazole against various species of Candida].
Topics: Candida; Candida albicans; Itraconazole; Ketoconazole; Miconazole; Microscopy, Electron, Scanning; Spheroplasts | 1989 |
Itraconazole therapy for cryptococcal meningitis and cryptococcosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Antigens, Fungal; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Microbial; Female; Humans; Itraconazole; Ketoconazole; Male; Meningitis; Middle Aged; Monitoring, Physiologic; Remission Induction; Sputum; Urine | 1989 |
[Treatment of mycoses and new antifungal agents].
Topics: Allylamine; Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine | 1989 |
Cutaneous leishmaniasis. Treatment with itraconazole.
Topics: Adult; Antiprotozoal Agents; Follow-Up Studies; Humans; Itraconazole; Ketoconazole; Leishmaniasis; Male | 1989 |
Fungemia caused by an amphotericin B-resistant isolate of Sporothrix schenckii. Successful treatment with itraconazole.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Sepsis; Sporothrix; Sporotrichosis | 1989 |
Use of itraconazole in a patient with chronic mucocutaneous candidiasis.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Humans; Itraconazole; Ketoconazole; Male | 1989 |
Invasive Aspergillus infection in chronic granulomatous disease: treatment with itraconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus nidulans; Granulomatous Disease, Chronic; Humans; Infant; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male | 1989 |
Cutaneous ulcers due to Candida albicans in an immunocompromised patient--response to therapy with itraconazole.
Topics: Aged; Antifungal Agents; Candidiasis, Cutaneous; Female; Humans; Immunocompetence; Itraconazole; Ketoconazole; Leg Ulcer | 1989 |
Chronic necrotising pulmonary aspergillosis treated with itraconazole.
Topics: Antifungal Agents; Aspergillosis; Chronic Disease; Humans; Itraconazole; Ketoconazole; Lung; Lung Diseases, Fungal; Male; Middle Aged; Radiography; Spondylitis, Ankylosing | 1989 |
[Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine].
Topics: Antifungal Agents; Candida; Drug Synergism; Fluconazole; Flucytosine; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Yeasts | 1989 |
[Severe Aspergillus keratomycosis treated with itraconazole per os].
Topics: Administration, Oral; Adult; Anterior Chamber; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Corneal Diseases; Humans; Itraconazole; Ketoconazole; Male | 1989 |
5-Lipoxygenase inhibition by antifungal azole derivatives: new tools for immunosuppression?
Topics: Antifungal Agents; Arachidonate Lipoxygenases; Fluconazole; Humans; Immunosuppressive Agents; In Vitro Techniques; Itraconazole; Ketoconazole; Lipoxygenase Inhibitors; Neutrophils | 1989 |
Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels.
Topics: Adult; Aged; Agranulocytosis; Antifungal Agents; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mycoses; Neutropenia; Prospective Studies; Remission Induction | 1989 |
Efficacy of itraconazole in blastomycosis in a murine model and comparison with ketoconazole.
Topics: Animals; Antifungal Agents; Blastomycosis; Itraconazole; Ketoconazole; Male; Mice; Mice, Inbred BALB C; Specific Pathogen-Free Organisms | 1989 |
Oral, topical and parenteral antifungal treatment with itraconazole in normal and in immunocompromised animals.
Topics: Administration, Oral; Administration, Topical; Animals; Antifungal Agents; Disease Models, Animal; Female; Guinea Pigs; Immunosuppression Therapy; Injections; Itraconazole; Ketoconazole; Mycoses; Rats; Rats, Inbred Strains | 1989 |
Symposium: Itraconazole and its use in systemic mycoses. Antwerpen, June 22, 1989. Proceedings.
Topics: Animals; Antifungal Agents; Humans; Itraconazole; Ketoconazole; Mycoses | 1989 |
The in-vitro antifungal spectrum of itraconazole.
Topics: Animals; Antifungal Agents; Culture Media; Fungi; Humans; Itraconazole; Ketoconazole | 1989 |
[Effect of itraconazole on the process of mycelial transformation of Candida albicans cells in human serum].
Topics: Antifungal Agents; Blood; Candida albicans; Cell Count; Cell Cycle; Culture Media; Depression, Chemical; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Itraconazole; Ketoconazole | 1989 |
Phaeohyphomycosis due to Phialophora richardsiae.
Topics: Antifungal Agents; Dermatitis, Occupational; Dermatomycoses; Exophiala; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Phialophora; Wood | 1989 |
Aspergillosis in a cardiac transplant patient successfully treated with itraconazole.
Topics: Aspergillosis; Aspergillus fumigatus; Heart Transplantation; Humans; Itraconazole; Ketoconazole; Male; Middle Aged | 1989 |
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Exophiala; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mycoses; Triazoles | 1987 |
[Itraconazole (R 51-211) in the treatment of dermatomycoses. Preliminary results].
Topics: Adolescent; Adult; Antifungal Agents; Child; Dermatomycoses; Drug Administration Schedule; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged | 1987 |
Itraconazole in the treatment of widespread tinea versicolor.
Topics: Adolescent; Adult; Antifungal Agents; Dose-Response Relationship, Drug; Female; Humans; Itraconazole; Ketoconazole; Liver Function Tests; Male; Middle Aged; Tinea Versicolor | 1987 |
A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbit.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Endocarditis; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Rabbits | 1987 |
[Comparative study of the efficiency of itraconazole and ketoconazole in the treatment of experimental paracoccidioidomycosis].
Topics: Animals; Drug Evaluation, Preclinical; Guinea Pigs; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Paracoccidioidomycosis; Rats; Testicular Diseases | 1987 |
[Anti-Candida activity of azoles].
Topics: Animals; Antifungal Agents; Azoles; Candida; Candidiasis; Drug Evaluation, Preclinical; Female; Guinea Pigs; Itraconazole; Ketoconazole; Male; Miconazole; Rats; Rats, Inbred Strains | 1987 |
Itraconazole as maintenance treatment for cryptococcal meningitis in the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Cryptococcosis; Humans; Itraconazole; Ketoconazole; Male; Meningitis; Opportunistic Infections | 1988 |
Pharmacokinetic profile of orally administered itraconazole in human skin.
Topics: Administration, Oral; Adult; Antifungal Agents; Griseofulvin; Humans; Itraconazole; Ketoconazole; Male; Sebaceous Glands; Skin; Sweat Glands; Time Factors; Tissue Distribution | 1988 |
Deep (subcutaneous) dermatophyte infection presenting with unilateral lymphoedema.
Topics: Adolescent; Antifungal Agents; Female; Humans; Immunity, Cellular; Itraconazole; Ketoconazole; Lymphedema; Lymphocyte Activation; Tinea | 1987 |
Comparison of high performance liquid chromatographic and microbiological methods for determination of itraconazole.
Topics: Antifungal Agents; Biological Assay; Candida albicans; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Itraconazole; Ketoconazole | 1988 |
Ocular involvement in mycotic sinusitis caused by Bipolaris.
Topics: Adolescent; Humans; Itraconazole; Ketoconazole; Magnetic Resonance Imaging; Male; Mycoses; Sinusitis; Tomography, X-Ray Computed | 1988 |
[Treatment of dermatomycoses with a new antimycotic: itraconazole. Comparative studies of 2 posologic regimens].
Topics: Adolescent; Adult; Antifungal Agents; Drug Administration Schedule; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Tinea | 1987 |
Experience with itraconazole in treatment of fungal infections.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Dermatomycoses; Drug Evaluation; Female; Humans; Itraconazole; Ketoconazole; Male; Mycoses; Tinea Versicolor | 1987 |
[Treatment of dermatophytoses and pityriasis versicolor with itraconazole].
Topics: Adolescent; Adult; Antifungal Agents; Dermatomycoses; Drug Evaluation; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged | 1987 |
[Itraconazole in the treatment of deep mycoses].
Topics: Antifungal Agents; Aspergillosis; Drug Evaluation; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Mycoses | 1987 |
[Results of an experimental study on skin tolerance and photo-biological activity of a product based on itraconazole].
Topics: Adolescent; Adult; Aged; Child; Dermatitis, Atopic; Dermatitis, Contact; Drug Eruptions; Drug Evaluation; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Ointments; Patch Tests; Photosensitivity Disorders | 1987 |
Treatment with itraconazole of experimental coccidioidomycosis in the Wistar rat.
Topics: Animals; Antifungal Agents; Coccidioidomycosis; Itraconazole; Ketoconazole; Rats; Rats, Inbred Strains | 1988 |
Itraconazole: increased activity by chlorhexidine.
Topics: Animals; Candida; Candida albicans; Chlorhexidine; Drug Combinations; Drug Synergism; Itraconazole; Ketoconazole; Trichomonas vaginalis | 1988 |
[New antiparasitic drugs].
Topics: Amebicides; Anthelmintics; Antifungal Agents; Antimalarials; Artemisinins; Fluconazole; Humans; Itraconazole; Ketoconazole; Mefloquine; Phenanthrenes; Quinolines; Sesquiterpenes; Triazoles | 1988 |
Oral itraconazole therapy for mycotic keratitis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Child; Female; Fusarium; Humans; Itraconazole; Keratitis; Ketoconazole; Male; Middle Aged; Mycoses | 1988 |
An evaluation of itraconazole in the management of onychomycosis.
Topics: Adult; Aged; Antifungal Agents; Drug Evaluation; Female; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Onychomycosis | 1988 |
Improved method for azole antifungal susceptibility testing.
Topics: Antifungal Agents; Azoles; Fluconazole; Fungi; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Triazoles | 1988 |
Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes.
Topics: Animals; Antifungal Agents; Chemical Phenomena; Chemistry; Cholesterol; Chromatography, Gas; Chromatography, Thin Layer; Dose-Response Relationship, Drug; Fluconazole; Gas Chromatography-Mass Spectrometry; Itraconazole; Ketoconazole; Leishmania; Leishmania braziliensis; Leishmania donovani; Leishmania mexicana; Leishmania tropica; Sterols; Triazoles | 1988 |
[The concentration of itraconazole in lung tissue in bronchoalveolar lavage (BAL) and in serum].
Topics: Administration, Oral; Aged; Bronchoalveolar Lavage Fluid; Female; Humans; Itraconazole; Ketoconazole; Lung; Male; Middle Aged | 1988 |
[Case of Acanthamoeba keratitis].
Topics: Acanthamoeba; Adult; Amebiasis; Animals; Antifungal Agents; Drug Therapy, Combination; Humans; Itraconazole; Keratitis; Ketoconazole; Male; Miconazole | 1988 |
Itraconazole pharmacokinetics in patients with renal dysfunction.
Topics: Administration, Oral; Aged; Antifungal Agents; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Uremia | 1988 |
Allogeneic bone marrow transplantation after partial lobectomy for aspergillosis of the lung.
Topics: Adult; Amphotericin B; Aspergillosis; Bone Marrow Transplantation; Female; Humans; Itraconazole; Ketoconazole; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Pneumonectomy | 1988 |
Treatment with itraconazole of widespread tinea corporis due to Trichophyton rubrum in a bone marrow transplant recipient.
Topics: Adult; Bone Marrow Transplantation; Drug Tolerance; Female; Humans; Itraconazole; Ketoconazole; Myelodysplastic Syndromes; Tinea | 1988 |
Pharmacokinetics of itraconazole following oral administration to normal volunteers.
Topics: Administration, Oral; Adult; Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Itraconazole; Ketoconazole; Male; Reference Values | 1988 |
[Treatment of paracoccidioidomycosis and histoplasmosis by oral itraconazole].
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Paracoccidioidomycosis | 1987 |
[Candida spondylodiscitis treated with itraconazole].
Topics: Adolescent; Antifungal Agents; Candidiasis; Discitis; Humans; Immunologic Deficiency Syndromes; Itraconazole; Ketoconazole; Male; Prognosis | 1988 |
Mode of action studies. Basis for the search of new antifungal drugs.
Topics: Acetates; Antifungal Agents; Candida; Candida albicans; Cytochrome P-450 Enzyme System; Drug Design; Ergosterol; Hydrogen-Ion Concentration; Itraconazole; Ketoconazole; Microsomes | 1988 |
Role of animal and human pharmacology in antifungal drug design.
Topics: Animals; Antifungal Agents; Drug Design; Drug Evaluation, Preclinical; Humans; Itraconazole; Ketoconazole | 1988 |
Activity of triazole derivatives against Pityrosporum orbiculare in vitro and in vivo.
Topics: Animals; Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Rabbits; Structure-Activity Relationship; Tinea Versicolor; Triazoles | 1988 |
Treatment of mycoses with itraconazole.
Topics: Adult; Aged; Antifungal Agents; Coccidioidomycosis; Female; Follow-Up Studies; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mycoses | 1988 |
Treatment of chromoblastomycosis with itraconazole.
Topics: Antifungal Agents; Chromoblastomycosis; Female; Follow-Up Studies; Humans; Itraconazole; Ketoconazole; Male; Middle Aged | 1988 |
The new generation of antifungal drugs.
Topics: Antifungal Agents; Echinocandins; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine; Triazoles | 1988 |
Itraconazole activity against fungal germination.
Topics: Antifungal Agents; Aspergillus; Candida albicans; Itraconazole; Ketoconazole; Mitosporic Fungi | 1988 |
Assay of itraconazole in leukemic patient plasma by reversed-phase small-bore liquid chromatography.
Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Itraconazole; Ketoconazole; Leukemia; Spectrophotometry, Ultraviolet | 1988 |
[Therapeutic effectiveness of fenticonazole and evaluation of its in vitro antifungal activity compared to other imidazole derivatives].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Arthrodermataceae; Child; Child, Preschool; Drug Evaluation; Female; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Miconazole; Middle Aged; Tinea | 1988 |
Itraconazole therapy for fungal keratitis.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Administration Routes; Female; Humans; Itraconazole; Keratitis; Ketoconazole; Male; Middle Aged; Mycoses | 1987 |
Efficacies of four antifungal agents in experimental murine sporotrichosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Evaluation, Preclinical; Itraconazole; Ketoconazole; Mice; Naphthalenes; Sporothrix; Sporotrichosis; Terbinafine; Triazoles | 1988 |
Treatment of experimental sub-acute cryptococcosis in the Wistar rat.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain Diseases; Cryptococcosis; Female; Granuloma, Giant Cell; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Polyethylene Glycols; Rats; Rats, Inbred Strains | 1988 |
Cytochrome-P-450-dependent metabolism of retinoic acid in rat skin microsomes: inhibition by ketoconazole.
Topics: Animals; Animals, Newborn; Antimetabolites; Biotransformation; Carbon Monoxide; Cricetinae; Cytochrome P-450 Enzyme System; In Vitro Techniques; Itraconazole; Ketoconazole; Mesocricetus; Miconazole; Microsomes; Microsomes, Liver; Oxygen; Rats; Rats, Inbred Strains; Skin; Tretinoin | 1988 |
Interaction of cyclosporin and itraconazole.
Topics: Antifungal Agents; Cyclosporins; Drug Interactions; Female; Humans; Itraconazole; Ketoconazole; Middle Aged; Stimulation, Chemical | 1987 |
Interaction of cyclosporin and itraconazole.
Topics: Animals; Cyclosporins; Drug Interactions; Humans; Itraconazole; Ketoconazole; Rats | 1987 |
Itraconazole and cyclosporin nephrotoxicity.
Topics: Antifungal Agents; Cyclosporins; Drug Interactions; Drug Therapy, Combination; Humans; Itraconazole; Ketoconazole; Kidney Diseases | 1987 |
Time course of cyclosporin/itraconazole interaction.
Topics: Cyclosporins; Drug Interactions; Heart Transplantation; Humans; Itraconazole; Ketoconazole; Male; Middle Aged | 1987 |
The action of itraconazole and ketoconazole on growth and sterol synthesis in Aspergillus fumigatus and Aspergillus niger.
Topics: Aspergillus fumigatus; Aspergillus niger; Itraconazole; Ketoconazole; Sterols; Structure-Activity Relationship | 1985 |
Treatment of chromomycosis with itraconazole.
Topics: Aged; Chromoblastomycosis; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged | 1985 |
[Experimental renal infection with Aspergillus fumigatus in mice: a chemotherapeutic model of an organic mycosis].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Flucytosine; Itraconazole; Ketoconazole; Kidney Diseases; Mice; Mice, Inbred Strains; Miconazole; Triazoles | 1985 |
In-vitro studies with SF 86-327, a new orally active allylamine derivative.
Topics: Allylamine; Antifungal Agents; Arthrodermataceae; Aspergillus; Blastomyces; Candida; Culture Media; Drug Resistance, Microbial; Fungi; Histoplasma; Itraconazole; Ketoconazole; Naphthalenes; Species Specificity; Sporothrix; Terbinafine | 1985 |
Itraconazole treatment of murine aspergillosis.
Topics: Amphotericin B; Animals; Aspergillosis; Aspergillus fumigatus; Itraconazole; Ketoconazole; Male; Mice; Mice, Inbred ICR | 1985 |
Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits.
Topics: Animals; Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Meningitis, Haemophilus; Rabbits; Triazoles | 1985 |
Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Flucytosine; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Triazoles | 1985 |
Treatment of sebopsoriasis with itraconazole.
Topics: Adult; Aged; Antifungal Agents; Dermatitis, Seborrheic; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Psoriasis | 1985 |
In vitro and in vivo effects of itraconazole against Trypanosoma cruzi.
Topics: Animals; Chagas Disease; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Itraconazole; Ketoconazole; Macrophages; Mice; Time Factors; Trypanocidal Agents; Trypanosoma cruzi | 1986 |
A new era in antimycotic agents.
Topics: Animals; Antifungal Agents; Azoles; Candida albicans; Chitin; Cholesterol; Cytochrome P-450 Enzyme Inhibitors; Dogs; Ergosterol; Fungi; Humans; Itraconazole; Ketoconazole; Lanosterol; Liver; Rats; Sterols | 1986 |
Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits.
Topics: Animals; Candidiasis; Cortisone; Cryptococcosis; Dose-Response Relationship, Drug; Fluconazole; Immunity; Itraconazole; Ketoconazole; Meningitis; Pyelonephritis; Rabbits; Triazoles | 1986 |
The activity of ketoconazole and itraconazole against Aspergillus fumigatus in mixed cultures with macrophages or leukocytes.
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Guinea Pigs; Itraconazole; Ketoconazole; Leukocytes; Macrophages | 1986 |
New and prospective developments in antifungal drugs.
Topics: Administration, Oral; Administration, Topical; Allylamine; Antifungal Agents; Clotrimazole; Dermatomycoses; Drug Compounding; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Terbinafine; Triazoles | 1986 |
Induction potential of antifungals containing an imidazole or triazole moiety. Miconazole and ketoconazole, but not itraconazole are able to induce hepatic drug metabolizing enzymes of male rats at high doses.
Topics: Aniline Hydroxylase; Animals; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochromes; Dose-Response Relationship, Drug; Enzyme Induction; Glucuronosyltransferase; Itraconazole; Ketoconazole; Kinetics; Male; Miconazole; Microsomes, Liver; Oxidoreductases, N-Demethylating; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1986 |
Itraconazole, a new orally active antifungal, in the treatment of pityriasis versicolor.
Topics: Administration, Oral; Drug Administration Schedule; Female; Humans; Itraconazole; Ketoconazole; Male; Tinea Versicolor | 1986 |
Azole resistance in Candida albicans.
Topics: Adult; Animals; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Chronic Mucocutaneous; Disease Models, Animal; Drug Resistance, Microbial; Econazole; Female; Fluconazole; Guinea Pigs; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Mice; Miconazole; Rats; Rats, Inbred Strains; Triazoles | 1986 |
Treatment of paracoccidioidomycosis with itraconazole in a murine model.
Topics: Animals; Antifungal Agents; Itraconazole; Ketoconazole; Kinetics; Male; Mice; Mice, Inbred BALB C; Paracoccidioidomycosis | 1985 |
Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Serotyping; Triazoles | 1986 |
A diffusion chamber technique for testing of antifungal drugs against Sporothrix schenckii in vivo.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Female; Itraconazole; Ketoconazole; Mice; Potassium Iodide; Sporothrix; Sporotrichosis; Triazoles | 1986 |
In-vitro effect of itraconazole, ketoconazole and amphotericin B on the phagocytic and candidacidal function of human neutrophils.
Topics: Amphotericin B; Candida albicans; Humans; Itraconazole; Ketoconazole; Neutrophils; Phagocytosis; Spores, Fungal | 1986 |
Itraconazole pharmacokinetics in the female genital tract: plasma and tissue levels in patients undergoing hysterectomy after a single dose of 200 mg itraconazole.
Topics: Adult; Antifungal Agents; Cervix Uteri; Female; Genitalia, Female; Humans; Hysterectomy; Itraconazole; Ketoconazole; Middle Aged; Mucous Membrane; Vagina | 1986 |
Itraconazole for cryptococcal infection in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Cryptococcosis; Humans; Itraconazole; Ketoconazole | 1987 |
Interaction of miconazole, ketoconazole and itraconazole with rat-liver microsomes.
Topics: Aniline Hydroxylase; Animals; Cytochrome P-450 Enzyme Inhibitors; Itraconazole; Ketoconazole; Kinetics; Male; Methylcholanthrene; Miconazole; Microsomes, Liver; Mixed Function Oxygenases; Oxidoreductases, N-Demethylating; Oxidoreductases, O-Demethylating; Phenobarbital; Rats | 1987 |
Therapeutic efficacy of itraconazole in systemic candidosis in guinea pigs.
Topics: Animals; Antifungal Agents; Basophils; Candidiasis; Drug Administration Schedule; Eosinophils; Guinea Pigs; Itraconazole; Ketoconazole; Leukocyte Count; Lymphocytes; Male; Monocytes; Neutrophils | 1987 |
Determination of itraconazole in plasma and animal tissues by high-performance liquid chromatography.
Topics: Animals; Antifungal Agents; Chromatography, High Pressure Liquid; Humans; Itraconazole; Ketoconazole; Kinetics | 1987 |
Treatment of pityriasis versicolor with itraconazole.
Topics: Adult; Antifungal Agents; Female; Humans; Itraconazole; Ketoconazole; Male; Random Allocation; Tinea Versicolor | 1987 |
Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Endophthalmitis; Eye; Fluconazole; Itraconazole; Ketoconazole; Kinetics; Male; Rabbits; Tissue Distribution; Triazoles | 1987 |
Effects of ketoconazole and itraconazole on growth and sterol synthesis in Pityrosporum ovale.
Topics: Antifungal Agents; Itraconazole; Ketoconazole; Malassezia; Sterols | 1986 |
Itraconazole treatment of experimental systemic candidiasis in male rats.
Topics: Animals; Antifungal Agents; Candidiasis; Dose-Response Relationship, Drug; Itraconazole; Ketoconazole; Male; Rats; Rats, Inbred Strains | 1987 |
Adrenal response to corticotropin during therapy with itraconazole.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Humans; Hydrocortisone; Itraconazole; Ketoconazole; Kinetics; Mycoses | 1987 |
Experience with itraconazole in deep mycoses in northern Italy.
Topics: Antifungal Agents; Aspergillosis; Cryptococcosis; Humans; Itraconazole; Ketoconazole; Sporotrichosis | 1987 |
Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells.
Topics: Animals; Antifungal Agents; Cell Survival; Centrifugation; Fluconazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Luminescent Measurements; Luminol; Mice; Mice, Inbred BALB C; Naphthalenes; Phagocytes; Rabbits; Rifampin; Spleen; Terbinafine; Triazoles | 1987 |
In vitro studies with R 51,211 (itraconazole).
Topics: Antifungal Agents; Fungi; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Morpholines; Triazoles | 1984 |
Comparison of itraconazole and ketoconazole in the treatment of experimental candidal vaginitis.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Itraconazole; Ketoconazole; Rats; Rats, Inbred Strains; Time Factors | 1984 |
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
Topics: Antifungal Agents; Aspergillus; Candida; Clotrimazole; Econazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Morpholines; Triazoles | 1984 |
Itraconazole, a new triazole that is orally active in aspergillosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Itraconazole; Ketoconazole; Mice | 1984 |
In vitro and in vivo activities of ketoconazole and itraconazole against Pityrosporum orbiculare.
Topics: Animals; Antifungal Agents; Itraconazole; Ketoconazole; Malassezia; Male; Microbial Sensitivity Tests; Rabbits; Tinea Versicolor | 1984 |
R 51211 (itraconazole) therapy of murine cryptococcosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Microbial; Itraconazole; Ketoconazole; Male; Meningitis; Mice; Mice, Inbred ICR | 1984 |
Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones.
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Candida; Candidiasis, Vulvovaginal; Cryptococcus neoformans; Dermatomycoses; Female; Guinea Pigs; Itraconazole; Ketoconazole; Microsporum; Phialophora; Rats; Rats, Inbred Strains; Sporothrix; Triazoles; Trichophyton | 1984 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
Effect of azoles on the glucuronidation of zidovudine by human liver UDP-glucuronosyltransferase.
Topics: Antifungal Agents; Antiviral Agents; Drug Interactions; Fluconazole; Glucuronosyltransferase; Humans; Itraconazole; Ketoconazole; Liver; Zidovudine | 1995 |
Disseminated opportunistic fungal disease in dogs: 10 cases (1982-1990).
Topics: Animals; Discitis; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Fungi; Itraconazole; Ketoconazole; Male; Mycoses; Opportunistic Infections; Prognosis; Radiography; Retrospective Studies; Spine; Spondylitis; Urine | 1995 |
Effect of different inhibitors of sterol biosynthesis on both fungal growth and aflatoxin production.
Topics: Aflatoxins; Antifungal Agents; Aspergillus; Culture Media; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Econazole; Ergosterol; Fatty Acids; Itraconazole; Ketoconazole; Miconazole | 1995 |
Resistant P45051A1 activity in azole antifungal tolerant Cryptococcus neoformans from AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Cryptococcosis; Cryptococcus neoformans; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Resistance, Microbial; Drug Tolerance; Ergosterol; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Microsomes; Oxidoreductases; Sterol 14-Demethylase; Sterols; Treatment Failure | 1995 |
[Post-antibiotic effect and post-exposure polyene antagonism of azole antimycotics in Candida albicans: dependency on lipophilia].
Topics: Amphotericin B; Candida albicans; Drug Interactions; Fluconazole; Itraconazole; Ketoconazole; Lipids; Miconazole; Microbial Sensitivity Tests; Structure-Activity Relationship | 1995 |
[Aspergillosis of the larynx].
Topics: Adult; Aspergillosis; Aspergillus fumigatus; Female; Follow-Up Studies; Humans; Itraconazole; Ketoconazole; Laryngeal Diseases; Male | 1995 |
Increased resistance to antifungal antibiotics of Candida spp. adhered to silicone.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Candidiasis; Cell Adhesion; Drug Resistance, Microbial; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Silicones; Urinary Catheterization | 1995 |
Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing.
Topics: Antifungal Agents; Candida; Cryptococcus neoformans; Double-Blind Method; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Prospective Studies; Sensitivity and Specificity | 1995 |
Functional expression of Saccharomyces cerevisiae CYP51A1 encoding lanosterol-14-demethylase in tobacco results in bypass of endogenous sterol biosynthetic pathway and resistance to an obtusifoliol-14-demethylase herbicide inhibitor.
Topics: Cholestadienols; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Resistance; Fungal Proteins; Herbicides; Itraconazole; Ketoconazole; Nicotiana; Oxidoreductases; Plants, Genetically Modified; Plants, Toxic; Recombinant Fusion Proteins; Saccharomyces cerevisiae; Silanes; Sterol 14-Demethylase; Sterols; Triazoles | 1995 |
In vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp.
Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Triazoles | 1995 |
Fluconazole, itraconazole and ketoconazole in vitro activity against Candida spp.
Topics: Candida; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1994 |
Antidermatophytic activity of allylamine derivatives.
Topics: Allylamine; Antifungal Agents; Arthrodermataceae; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 1994 |
[Oral treatment of onychomycosis of the toe nails; comparison of cost-effectiveness of griseofulvin, itraconazole, ketoconazole and terbinafine].
Topics: Administration, Oral; Antifungal Agents; Cost-Benefit Analysis; Drug Costs; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Oxygenases; Terbinafine; Toes | 1994 |
Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Blood; Cerebrospinal Fluid; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Skin | 1994 |
Pneumocystis carinii is resistant to imidazole antifungal agents.
Topics: Animals; Antifungal Agents; Ergosterol; Female; Fluconazole; Gas Chromatography-Mass Spectrometry; Itraconazole; Ketoconazole; Miconazole; Pneumocystis; Rats; Rats, Sprague-Dawley; Triazoles | 1994 |
In vitro evaluation of griseofulvin, ketoconazole, and itraconazole against various dermatophytes in Singapore.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Resistance, Microbial; Epidermophyton; Female; Griseofulvin; Humans; Infant; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Singapore; Tinea; Tinea Pedis; Trichophyton | 1994 |
Blastomycosis and human immunodeficiency virus: three new cases and review.
Topics: Adult; Blastomycosis; CD4 Antigens; CD4-CD8 Ratio; HIV Infections; HIV Seropositivity; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Survival Rate | 1994 |
Itraconazole and allergic bronchopulmonary aspergillosis in twin brothers with cystic fibrosis.
Topics: Adolescent; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Cystic Fibrosis; Diseases in Twins; Humans; Itraconazole; Ketoconazole; Male | 1993 |
Candida nail bed infection and cosmetic acrylic nail extensions--a potential source of hospital infection?
Topics: Adult; Antifungal Agents; Candidiasis; Cosmetics; Cross Infection; Female; Humans; Itraconazole; Ketoconazole; Morpholines; Nail Diseases; United Kingdom | 1993 |
Short report: the absorption of fluconazole and itraconazole under conditions of low intragastric acidity.
Topics: Adult; Antifungal Agents; Biological Availability; Famotidine; Gastric Acid; Humans; Intestinal Absorption; Itraconazole; Ketoconazole; Male | 1993 |
Severe candidal infections in neutropenic patients.
Topics: Amphotericin B; Candidiasis; Fluconazole; Humans; Itraconazole; Ketoconazole; Neutropenia | 1993 |
Systemic antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses | 1994 |
Pulmonary sporotrichosis treated with itraconazole.
Topics: Amphotericin B; Antifungal Agents; Female; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Middle Aged; Potassium Iodide; Sporotrichosis | 1993 |
Itraconazole.
Topics: Antifungal Agents; Blastomycosis; Drug Interactions; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses | 1993 |
[Liver damage during administration of itraconazole (Trisporal)].
Topics: Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Chemical and Drug Induced Liver Injury; Female; Humans; Itraconazole; Ketoconazole; Liver Function Tests; Male; Middle Aged; Onychomycosis | 1993 |
[Liver damage during administration of itraconazole (Trisporal)].
Topics: Antifungal Agents; Chemical and Drug Induced Liver Injury; Humans; Itraconazole; Ketoconazole; Liver Function Tests | 1993 |
Itraconazole released for blastomycosis and histoplasmosis therapy.
Topics: Antifungal Agents; Blastomycosis; Drug Approval; Drug Therapy, Combination; Histoplasmosis; Humans; Itraconazole; Ketoconazole | 1993 |
Successful treatment of Trypanosoma cruzi encephalitis in a patient with hemophilia and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Chagas Disease; Drug Therapy, Combination; Encephalitis; Fluconazole; Hemophilia A; Humans; Itraconazole; Ketoconazole; Male; Nitroimidazoles; Transfusion Reaction; Trypanocidal Agents | 1993 |
Torsades de pointes after terfenadine-itraconazole interaction.
Topics: Adult; Drug Interactions; Female; Humans; Itraconazole; Ketoconazole; Terfenadine; Torsades de Pointes | 1993 |
Serologic response to itraconazole in allergic bronchopulmonary aspergillosis.
Topics: Administration, Oral; Adult; Antibodies, Fungal; Antibody Specificity; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Female; Humans; Immunoglobulin G; Itraconazole; Ketoconazole | 1993 |
Interaction of itraconazole and digoxin.
Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Digoxin; Drug Interactions; Half-Life; Humans; Itraconazole; Ketoconazole; Least-Squares Analysis; Male; Osteomyelitis | 1993 |
Cryptococcosis in an AIDS patient: itraconazole efficacy after other therapeutic failures.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Humans; Itraconazole; Ketoconazole; Male; Meningitis, Cryptococcal | 1993 |
A banner year for AIDS therapy.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antitubercular Agents; Atovaquone; HIV Infections; Humans; Itraconazole; Ketoconazole; Naphthoquinones; Rifabutin; Rifamycins; United States; United States Food and Drug Administration; Zalcitabine | 1993 |
Complete eradication of Aspergillus fumigatus from the lung in an immunocompromised patient by oral itraconazole.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus fumigatus; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Neutropenia; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1993 |
Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers.
Topics: Adult; Antifungal Agents; Biological Availability; Capsules; Chromatography, High Pressure Liquid; Food; Humans; Hydroxylation; Itraconazole; Ketoconazole; Male | 1993 |
Uptake of itraconazole by alveolar macrophages.
Topics: Animals; Antifungal Agents; Clindamycin; Colony Count, Microbial; Erythrocytes; In Vitro Techniques; Itraconazole; Ketoconazole; Macrophages, Alveolar; Mycobacterium bovis; Rabbits | 1993 |
A case of chromoblastomycosis responding to treatment with itraconazole.
Topics: Antifungal Agents; Chromoblastomycosis; Humans; Itraconazole; Ketoconazole; Male; Middle Aged | 1993 |
Renal aspergilloma in AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Humans; Itraconazole; Ketoconazole; Kidney Diseases | 1993 |
Successful treatment of concomitant pulmonary nocardiosis and aspergillosis in an immunocompromised renal patient.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cyclophosphamide; Drug Therapy, Combination; Humans; IgA Vasculitis; Imipenem; Immunocompromised Host; Itraconazole; Ketoconazole; Kidney Failure, Chronic; Lung; Lung Diseases, Fungal; Male; Nocardia Infections; Pneumonia; Prednisolone; Radiography; Renal Dialysis; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
Successful treatment of pulmonary pseudallescheriasis with itraconazole.
Topics: Adult; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Pseudallescheria | 1993 |
Ventricular fibrillation secondary to itraconazole induced hypokalaemia.
Topics: Adult; Antifungal Agents; Humans; Hypokalemia; Itraconazole; Ketoconazole; Male; Ventricular Fibrillation | 1993 |
Successful treatment of pneumonia due to Scedosporium apiospermum with itraconazole: case report.
Topics: Adult; Antifungal Agents; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Male; Mycetoma; Pneumonia, Pneumococcal; Pseudallescheria | 1993 |
Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata.
Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Resistance, Microbial; Econazole; Female; Fluconazole; Gentian Violet; Humans; Itraconazole; Ketoconazole; Medroxyprogesterone Acetate; Microbial Sensitivity Tests; Nystatin | 1993 |
Antimycotic susceptibility testing of agents of black grain eumycetoma.
Topics: Antifungal Agents; Econazole; Fungi; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Mycoses; Species Specificity | 1993 |
A preliminary study of in vitro antibiotic activity of saperconazole and other azoles on Paracoccidioides brasiliensis.
Topics: Antifungal Agents; Azoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Microscopy, Electron; Paracoccidioides | 1993 |
Histoplasmosis in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Antifungal Agents; Fluconazole; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Middle Aged; Retrospective Studies; Treatment Outcome | 1993 |
[Strategy for examination and therapy of mycotic keratitis].
Topics: Acremonium; Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Contact Lenses; Drug Therapy, Combination; Female; Fluconazole; Humans; Itraconazole; Keratitis; Ketoconazole; Mycoses; Ophthalmic Solutions; Therapeutic Irrigation | 1993 |
Cutaneous cryptococcosis successfully treated with itraconazole.
Topics: Administration, Oral; Aged; Antifungal Agents; Cryptococcosis; Dermatomycoses; Humans; Itraconazole; Ketoconazole; Male; Treatment Outcome | 1993 |
Successful treatment of simultaneous pulmonary Pseudallescheria boydii and Aspergillus terreus infection with oral itraconazole.
Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Bone Marrow Transplantation; Debridement; Graft vs Host Disease; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Lung; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycetoma; Opportunistic Infections; Pseudallescheria; Tomography, X-Ray Computed; Transplantation, Autologous | 1993 |
Combined anti-fungal therapy and surgical resection as treatment of disseminated aspergillosis of the lung and brain following BMT.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Child; Female; Humans; Itraconazole; Ketoconazole; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tomography, X-Ray Computed | 1993 |
Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Combined Modality Therapy; Female; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Medical History Taking; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Treatment Failure | 1993 |
Treatment of cryptococcal meningitis with short-course amphotericin B and flucytosine, followed by itraconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis, Cryptococcal; Middle Aged | 1993 |
[Mycetoma of the foot; a disease from the tropics].
Topics: Antifungal Agents; Cladosporium; Combined Modality Therapy; Debridement; Female; Foot Diseases; Fusarium; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mycetoma | 1993 |
Treatment of sporotrichosis with itraconazole. NIAID Mycoses Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Sporotrichosis; Treatment Outcome | 1993 |
Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes.
Topics: Amphotericin B; Antifungal Agents; Antiviral Agents; Chromatography, High Pressure Liquid; Fluconazole; Flucytosine; Glucuronates; Humans; Itraconazole; Ketoconazole; Miconazole; Microsomes, Liver; Zidovudine | 1995 |
[Mycetoma of the neck and the nape of the neck due to Madurella mycetomatis. Apropos of a case in Mauritania].
Topics: Adult; Antifungal Agents; Dermatomycoses; Humans; Itraconazole; Ketoconazole; Male; Mauritania; Mitosporic Fungi; Mycetoma; Neck; Recurrence | 1995 |
Systemic antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses | 1996 |
Use of terfenadine and contraindicated drugs.
Topics: Anti-Bacterial Agents; Antifungal Agents; Clarithromycin; Contraindications; Drug Interactions; Drug Utilization; Erythromycin; Histamine H1 Antagonists; Humans; Itraconazole; Ketoconazole; Pharmaceutical Services; Product Labeling; Retrospective Studies; Terfenadine; Troleandomycin | 1996 |
Azole drug resistance in yeasts.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Candidiasis; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses | 1995 |
[African histoplasmosis in a patient with HIV-2 infection].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Dermatomycoses; Drug Therapy, Combination; Facial Dermatoses; Histoplasma; Histoplasmosis; HIV-2; Humans; Itraconazole; Ketoconazole; Male | 1996 |
Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique.
Topics: Antifungal Agents; Candida; Cryptococcus neoformans; Culture Media; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results | 1996 |
Two cases of protothecosis in Nagoya, Japan.
Topics: Adult; Antifungal Agents; Chlorophyta; Facial Dermatoses; Female; Humans; Itraconazole; Japan; Ketoconazole; Middle Aged; Skin Diseases, Infectious | 1996 |
Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Evaluation Studies as Topic; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Quality Control; Reproducibility of Results | 1996 |
Different effects of azole-antifungal agents on the regulation of intracellular calcium concentration of Trichophyton rubrum.
Topics: Antifungal Agents; Azoles; Calcium; Chelating Agents; Edetic Acid; Humans; Imidazoles; Intracellular Membranes; Itraconazole; Ketoconazole; Osmolar Concentration; Trichophyton | 1996 |
Quality control guidelines for National Committee for Clinical Laboratory Standards--recommended broth macrodilution testing of ketoconazole and itraconazole.
Topics: Antifungal Agents; Candida; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Quality Control; Reproducibility of Results | 1996 |
Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azoles; Candida; Drug Resistance, Microbial; Fluconazole; Fluorescent Dyes; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Rhodamine 123; Rhodamines | 1996 |
[White piedra. Report of a case].
Topics: Adolescent; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Piedra; Scalp Dermatoses; Trichosporon | 1996 |
Biotransformation of mestranol to ethinyl estradiol in vitro: the role of cytochrome P-450 2C9 and metabolic inhibitors.
Topics: Adult; Antifungal Agents; Biotransformation; Cells, Cultured; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Estradiol Congeners; Ethinyl Estradiol; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Mestranol; Microsomes, Liver | 1997 |
Effect of pH and buffer system on the in-vitro activity of five antifungals against yeasts.
Topics: Amphotericin B; Antifungal Agents; Buffers; Candida; Culture Media; Fluconazole; Flucytosine; Fungi; Hydrogen-Ion Concentration; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results; Species Specificity; Spectrophotometry | 1997 |
Rapid high performance liquid chromatographic assay for antifungal agents in human sera.
Topics: Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Spectrophotometry, Ultraviolet | 1996 |
Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Biological Transport; Candida albicans; Drug Resistance, Microbial; Fluconazole; Genes, Fungal; Genes, MDR; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; RNA, Messenger | 1997 |
Outpatient therapy of HIV-associated oral and oesophageal candidosis.
Topics: AIDS-Related Opportunistic Infections; Ambulatory Care; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Esophagitis; Fluconazole; Guidelines as Topic; Humans; Itraconazole; Ketoconazole; Medical Audit; Nystatin; Retrospective Studies | 1997 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidomycosis; Cryptococcosis; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Fluconazole; Flucytosine; Gynecomastia; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Kidney Diseases; Liposomes; Male; Mixed Function Oxygenases; Mucormycosis; Nausea; Paracoccidioidomycosis; Sporotrichosis; Teratogens | 1997 |
A yeast sterol auxotroph (erg25) is rescued by addition of azole antifungals and reduced levels of heme.
Topics: Antifungal Agents; Azoles; Clotrimazole; Genes, Fungal; Genotype; Heme; Itraconazole; Ketoconazole; Lanosterol; Mixed Function Oxygenases; Mutation; Saccharomyces cerevisiae; Sterols; Suppression, Genetic | 1997 |
Unresponsive HIV-related oro-oesophageal candidosis--an evaluation of two new in-vitro azole susceptibility tests.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Microbial; Esophageal Diseases; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1997 |
Azole antifungals: weak inhibitors of inducible nitric oxide synthase in mouse and human cells.
Topics: Adenocarcinoma; Adult; Animals; Antifungal Agents; Azoles; Candida albicans; Colorectal Neoplasms; Enzyme Induction; Enzyme Inhibitors; Female; Humans; Itraconazole; Ketoconazole; Macrophages, Peritoneal; Male; Mice; Miconazole; Middle Aged; Monocytes; Nitric Oxide Synthase; Tumor Cells, Cultured | 1997 |
Clinically significant azole cross-resistance in Candida isolates from HIV-positive patients with oral candidosis.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluconazole; Humans; Itraconazole; Ketoconazole | 1997 |
[Effect of keratin on the efficacy of fluconazole].
Topics: Animals; Antifungal Agents; Blood Proteins; Fluconazole; Itraconazole; Keratins; Ketoconazole; Kinetics; Sheep; Skin; Wool | 1997 |
[Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Recurrence | 1997 |
Effects of three azole derivatives on the lipids of different strains of Sporothrix schenckii.
Topics: Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Lanosterol; Lipids; Sporothrix | 1997 |
[Evaluation of the E-test: comparison of E-test and microbroth dilution method in azole antifungal susceptibility test].
Topics: Antifungal Agents; Candida albicans; Fluconazole; Indicator Dilution Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results | 1998 |
Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis.
Topics: Analysis of Variance; Animals; Antifungal Agents; Aspergillus; Cornea; Corneal Ulcer; Drug Resistance, Microbial; Eye Infections, Fungal; Fluconazole; Fungi; Fusarium; Horse Diseases; Horses; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Natamycin; Penicillium | 1998 |
African histoplasmosis: therapeutic efficacy of itraconazole.
Topics: Antifungal Agents; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Male; Middle Aged | 1998 |
Susceptibilities of clinical and laboratory isolates of Blastomyces dermatitidis to ketoconazole, itraconazole, and fluconazole.
Topics: Antifungal Agents; Blastomyces; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1998 |
Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus; Evaluation Studies as Topic; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1998 |
Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Fluconazole; Fungemia; Humans; Incidence; Itraconazole; Ketoconazole; Male; Mitosporic Fungi; Neoplasms; Pichia; Retrospective Studies; Risk Factors; Slovakia; Treatment Outcome | 1998 |
Cytochrome P450 specificity of metabolism and interactions of oxybutynin in human liver microsomes.
Topics: Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Hydroxylation; Isoenzymes; Itraconazole; Ketoconazole; Mandelic Acids; Microsomes, Liver; Oxidoreductases, N-Demethylating; Substrate Specificity; Testosterone | 1998 |
Disseminated histoplasmosis in an 'immunocompetent' child.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Child; Histoplasma; Histoplasmosis; Humans; Immunocompetence; Itraconazole; Ketoconazole; Male; Vancomycin | 1998 |
Prediction of drug-drug interactions of zonisamide metabolism in humans from in vitro data.
Topics: Anticonvulsants; Cyclosporine; Cytochrome P-450 Enzyme System; Dihydroergotamine; Drug Interactions; Humans; In Vitro Techniques; Isoxazoles; Itraconazole; Ketoconazole; Metabolic Clearance Rate; Miconazole; Triazolam; Zonisamide | 1998 |
P-glycoprotein-mediated transport of itraconazole across the blood-brain barrier.
Topics: Animals; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Behavior, Animal; Biological Transport; Blood-Brain Barrier; Brain; Drug Interactions; Injections, Intravenous; Itraconazole; Ketoconazole; Male; Mice; Mice, Knockout; Rats; Rats, Sprague-Dawley; Tissue Distribution; Verapamil; Vinblastine; Vincristine | 1998 |
The Madura foot: an "innocent foot mycosis"?
Topics: Adult; Aged; Amputation, Surgical; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Biopsy; Cutaneous Fistula; Endemic Diseases; Foot Deformities, Acquired; Foot Diseases; Global Health; Humans; Itraconazole; Ketoconazole; Male; Mycetoma; Netherlands; Suppuration; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
Effect of metabolic inhibitors on cyclosporine pharmacokinetics using a population approach.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Calcium Channel Blockers; Child; Cyclosporine; Diltiazem; Drug Administration Schedule; Drug Interactions; Fluconazole; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Individuality; Itraconazole; Ketoconazole; Linear Models; Middle Aged | 1998 |
In vitro susceptibility of filamentous fungi to itraconazole.
Topics: Antifungal Agents; Aspergillus; Cladosporium; Drug Resistance, Microbial; Fungi; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Mycoses; Penicillium | 1995 |
Blastomycosis in dogs: 115 cases (1980-1995).
Topics: Age Distribution; Amphotericin B; Animals; Antibodies, Fungal; Antifungal Agents; Blastomyces; Blastomycosis; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Fluconazole; Housing, Animal; Immunodiffusion; Itraconazole; Ketoconazole; Louisiana; Male; Radiography, Thoracic; Retrospective Studies; Seasons; Treatment Outcome | 1998 |
Aspergillus versicolor as cause of onychomycosis: report of 12 cases and susceptibility testing to antifungal drugs.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Female; Foot Dermatoses; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Onychomycosis; Spain; Terbinafine | 1998 |
Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.
Topics: Antifungal Agents; Candida; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Prototheca | 1998 |
Infectious crystalline keratopathy: a case report.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Conjunctiva; Cornea; Corneal Diseases; Diagnosis, Differential; Eye Infections, Fungal; Humans; Itraconazole; Ketoconazole; Malassezia; Male | 1998 |
The effect of vehicle on corneal penetration of triturated ketoconazole and itraconazole.
Topics: Animals; Antifungal Agents; Corneal Stroma; Follow-Up Studies; Itraconazole; Ketoconazole; Ophthalmic Solutions; Pharmaceutical Vehicles; Rabbits | 1998 |
Recurrent histoplasmosis of the wrist: a case report.
Topics: Adult; Antifungal Agents; Carpal Tunnel Syndrome; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Male; Radiography; Recurrence; Wrist Joint | 1998 |
The effect of keratolytic agents on the permeability of three imidazole antimycotic drugs through the human nail.
Topics: Antifungal Agents; Humans; In Vitro Techniques; Itraconazole; Keratolytic Agents; Ketoconazole; Linear Models; Miconazole; Nails; Papain; Permeability; Reference Values; Salicylic Acid; Urea | 1998 |
Azole resistance among oral Candida species isolates from AIDS patients under ketoconazole exposure.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antifungal Agents; Azoles; Brazil; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mouth Mucosa; Mycology; Prevalence; Prospective Studies; Statistics, Nonparametric | 1998 |
Antifungal susceptibility of Candida isolates at the American University of Beirut Medical Center.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Fluconazole; Flucytosine; Hospitals, University; Humans; Itraconazole; Ketoconazole; Lebanon; Microbial Sensitivity Tests | 1998 |
Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus; Fluconazole; Flucytosine; Guidelines as Topic; Itraconazole; Ketoconazole; Laboratories; Microbial Sensitivity Tests; Quality Assurance, Health Care; Reference Standards; Yeasts | 1999 |
Quantitative prediction of metabolic inhibition of midazolam by itraconazole and ketoconazole in rats: implication of concentrative uptake of inhibitors into liver.
Topics: Animals; Antifungal Agents; Blood Proteins; Hypnotics and Sedatives; Itraconazole; Ketoconazole; Male; Microsomes, Liver; Midazolam; Predictive Value of Tests; Protein Binding; Rats; Rats, Sprague-Dawley | 1999 |
A case of subcutaneous infection in a patient with discoid lupus erythematosus caused by a Scytalidium synanamorph of Nattrassia mangiferae, and its treatment.
Topics: Adult; Antifungal Agents; Dermatomycoses; Female; Hand; Humans; Itraconazole; Ketoconazole; Lupus Erythematosus, Discoid; Mitosporic Fungi; Skin; Treatment Outcome | 1998 |
Characteristics of the heterologously expressed human lanosterol 14alpha-demethylase (other names: P45014DM, CYP51, P45051) and inhibition of the purified human and Candida albicans CYP51 with azole antifungal agents.
Topics: Antifungal Agents; Binding Sites; Candida albicans; Carbon Monoxide; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Formates; Humans; Inhibitory Concentration 50; Itraconazole; Ketoconazole; Kinetics; Ligands; Oxidoreductases; Recombinant Proteins; Spectrum Analysis; Sterol 14-Demethylase; Titrimetry | 1999 |
[Epidemiology of fungemia in a university hospital; therapeutic incidence].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child, Preschool; Female; Fluconazole; France; Fungemia; Hospitals, University; Humans; Infant; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Postoperative Complications; Saccharomyces cerevisiae | 1999 |
Comparative evaluation of Fungitest-, Neo-Sensitabs- and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Reagent Kits, Diagnostic | 1999 |
Drug interactions.
Topics: Anti-Bacterial Agents; Antifungal Agents; Binding, Competitive; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Erythromycin; Humans; Isoenzymes; Itraconazole; Ketoconazole; Microsomes, Liver; Mixed Function Oxygenases; Pharmacokinetics | 1999 |
Lactate dehydrogenase isoenzyme patterns in cetaceans.
Topics: Alanine Transaminase; Amikacin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antineoplastic Agents; Aspartate Aminotransferases; Dolphins; Enrofloxacin; Female; Fluoroquinolones; Injections, Intramuscular; Isoenzymes; Itraconazole; Ketoconazole; L-Lactate Dehydrogenase; Liver; Male; Quinolones; Reference Values; Whales | 1999 |
[Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Yeasts | 1999 |
Midazolam alpha-hydroxylation by human liver microsomes in vitro: inhibition by calcium channel blockers, itraconazole and ketoconazole.
Topics: Antifungal Agents; Biotransformation; Calcium Channel Blockers; GABA Modulators; Humans; Hydroxylation; Itraconazole; Ketoconazole; Male; Microsomes, Liver; Midazolam | 1999 |
Tinea capitis in Siena, Italy. An 18-year survey.
Topics: Adolescent; Animals; Antifungal Agents; Cats; Child; Child, Preschool; Dogs; Female; Griseofulvin; Humans; Infant; Infant, Newborn; Italy; Itraconazole; Ketoconazole; Longitudinal Studies; Male; Middle Aged; Rabbits; Retrospective Studies; Tinea Capitis | 1999 |
Chronic pulmonary histoplasmosis in the State of Rio de Janeiro, Brazil.
Topics: Aged; Amphotericin B; Antifungal Agents; Brazil; Fatal Outcome; Female; Histoplasma; Histoplasmosis; Humans; Immunodiffusion; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Lung Diseases, Obstructive; Male; Middle Aged; Radiography, Thoracic; Recurrence; Sputum | 1999 |
The use of systemic antimycotics in dermatotherapy.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Cost-Benefit Analysis; Dermatomycoses; Fluconazole; Griseofulvin; Hair Diseases; Humans; Itraconazole; Ketoconazole; Naphthalenes; Odds Ratio; Onychomycosis; Terbinafine; Tinea | 2000 |
In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine.
Topics: Allylamine; Antifungal Agents; Colony Count, Microbial; Humans; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests | 2000 |
Effects of amphotericin B and three azole derivatives on the lipids of yeast cells of Paracoccidioides brasiliensis.
Topics: Amphotericin B; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Paracoccidioides; Sterols | 2000 |
Susceptibility testing of Candida species: comparison of NCCLS microdilution method with Fungitest.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 2000 |
The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Azoles; Bone Marrow Transplantation; Candida; Candidiasis; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Hematologic Neoplasms; Humans; Itraconazole; Ketoconazole; Neutropenia; Prospective Studies; Retrospective Studies | 2001 |
Effect of ketoconazole, itraconazole and fluconazole on the gastrointestinal colonization of mice by Candida albicans.
Topics: Animals; Antifungal Agents; Azoles; Candida albicans; Candidiasis; Digestive System; Fluconazole; Itraconazole; Ketoconazole; Mice | 2001 |
In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1999 |
Effect of inoculum form on in vitro antifungal susceptibilities of Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Spores, Fungal | 2001 |
Oropharyngeal candidiasis in patients with human immunodeficiency virus: correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppression.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Child; Drug Resistance, Microbial; Female; Fluconazole; HIV-1; Humans; Immune Tolerance; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Oropharynx; Pharyngeal Diseases | 2001 |
Candidiasis at ICAAC.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antifungal Agents; Biological Availability; Candida albicans; Candidiasis, Oral; Clinical Trials as Topic; Drug Resistance, Microbial; Fluconazole; HIV; Humans; Itraconazole; Ketoconazole; Mutation | 1995 |
Histoplasmosis: update 1998.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Central Nervous System Diseases; Clinical Trials as Topic; Dosage Forms; Fluconazole; Histoplasmosis; Itraconazole; Ketoconazole; Remission Induction | 1998 |
[Endemic mycotic infections].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Diagnosis, Differential; Fluconazole; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Travel | 2001 |
In vitro activities of 10 antifungal drugs against 508 dermatophyte strains.
Topics: Antifungal Agents; Arthrodermataceae; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 2001 |
Application of capillary zone electrophoresis with off-line solid-phase extraction to in vitro metabolism studies of antifungals.
Topics: Acetic Acid; Acetonitriles; Antifungal Agents; Clotrimazole; Drug Stability; Electrophoresis, Capillary; Fluconazole; Humans; Itraconazole; Ketoconazole; Methanol; Microsomes, Liver; Molecular Structure; Molecular Weight; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Solvents; Triazoles; Verapamil; Voriconazole | 2001 |
[In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
Topics: Agar; Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Diffusion; Drug Resistance, Fungal; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mitosporic Fungi | 2001 |
Effects of azoles on human acute myelogenous leukemia blasts and T lymphocytes derived from acute leukemia patients with chemotherapy-induced cytopenia.
Topics: Acute Disease; Aged; Aged, 80 and over; Antifungal Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Division; Clone Cells; Female; Fluconazole; Humans; Interferon-gamma; Interleukin-4; Itraconazole; Ketoconazole; Leukemia, Myeloid; Leukopenia; Lymphocyte Activation; Male; Miconazole; Middle Aged; Neoplastic Stem Cells; T-Lymphocytes | 2001 |
Comparison of two methods for antifungal susceptibility testing of Trichophyton rubrum.
Topics: Antifungal Agents; Clotrimazole; Culture Media; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Sensitivity and Specificity; Terbinafine; Trichophyton | 2002 |
Drug susceptibility testing of Malassezia furfur strains to antifungal agents.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests | 2001 |
Multicenter Brazilian study of oral Candida species isolated from AIDS patients.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Serotyping | 2002 |
[Candida infection of the skin and mucous membranes still a topic. Administering azoles with clinical understanding].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Drug Interactions; Humans; Itraconazole; Ketoconazole | 2002 |
Use of the sensititre colorimetric microdilution panel for antifungal susceptibility testing of dermatophytes.
Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Colorimetry; Coloring Agents; Dermatomycoses; Drug Resistance, Fungal; Epidermophyton; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Microsporum; Oxazines; Sensitivity and Specificity; Trichophyton; Xanthenes | 2002 |
[Identification and antifungal susceptibility of Candida spp isolated from invasive mycoses. Influence of growth inhibition percentage to determine minimal inhibitory concentration].
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child; Fluconazole; Growth Inhibitors; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 2002 |
Synthesis of novel water soluble benzylazolium prodrugs of lipophilic azole antifungals.
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Azoles; Candida albicans; Candidiasis; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Prodrugs; Rats; Solubility; Thiazoles; Triazoles | 2002 |
Paracoccidioidomycosis: report of 2 cases mimicking squamous cell carcinoma.
Topics: Antifungal Agents; Carcinoma, Squamous Cell; Chronic Disease; Diagnosis, Differential; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Mexico; Middle Aged; Mouth Diseases; Paracoccidioidomycosis | 2002 |
[How to manage seborrheic dermatitis].
Topics: Antifungal Agents; Dermatitis, Seborrheic; Humans; Itraconazole; Ketoconazole; Malassezia | 2003 |
Evaluation of different calorimetric methods to determine the glass transition temperature and molecular mobility below T(g) for amorphous drugs.
Topics: Azoles; Calorimetry, Differential Scanning; Chemical Phenomena; Chemistry, Physical; Drug Stability; Fluorouracil; Itraconazole; Ketoconazole; Loperamide; Miconazole; Polyesters; Temperature | 2003 |
Variations in color.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Antifungal Agents; Black People; Diagnosis, Differential; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Selenium Compounds; Skin Pigmentation; Tinea Versicolor | 2003 |
In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Flucytosine; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Triazoles; Voriconazole | 2003 |
[Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].
Topics: Amphotericin B; Antifungal Agents; Chile; Communicable Diseases, Emerging; Cross Infection; Drug Resistance, Fungal; Fatal Outcome; Fluconazole; Humans; Immunocompromised Host; Intensive Care Units; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Multiple Myeloma; Mycoses; Opportunistic Infections; Parkinson Disease; Postoperative Complications; Trichosporon; Urinary Catheterization; Urinary Tract Infections; Ventriculoperitoneal Shunt | 2003 |
In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
Topics: Antifungal Agents; Arthrodermataceae; Ciclopirox; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Fungi; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Terbinafine | 2003 |
Oral manifestations of paracoccidioidomycosis. Report of 21 cases from Argentina.
Topics: Adult; Aged; Antifungal Agents; Argentina; Female; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Lymph Nodes; Male; Middle Aged; Mouth Diseases; Nose Diseases; Paracoccidioidomycosis | 2003 |
Fungal peritonitis in 15 patients on continuous ambulatory peritoneal dialysis (CAPD).
Topics: Acremonium; Aged; Antifungal Agents; Aspergillus; Candida; Child; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Kidney Failure, Chronic; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 2003 |
Experimental evaluation of antifungal and antiseptic agents against Rhodotorula spp.
Topics: Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Rhodotorula | 2003 |
In vitro and in vivo activities of the novel azole antifungal agent r126638.
Topics: Animals; Antifungal Agents; Candida; Dermatomycoses; Dose-Response Relationship, Drug; Guinea Pigs; Imidazoles; Itraconazole; Ketoconazole; Mice; Microbial Sensitivity Tests; Microsporidia; Skin; Tinea; Triazoles; Trichophyton | 2004 |
[Modern antimycotics. What the treating physician needs to know].
Topics: Antifungal Agents; Arthrodermataceae; Child; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine; Time Factors | 2004 |
Prevalence of Candida dubliniensis among germ tube-positive yeasts recovered from the respiratory specimens in HIV-negative patients.
Topics: Adult; Aged; Amphotericin B; Candida; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Respiratory System; Saudi Arabia; Serotyping | 2004 |
Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Chromoblastomycosis; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Terbinafine | 2004 |
Solubilizing poorly soluble antimycotic agents by emulsification via a solvent-free process.
Topics: Antifungal Agents; Chemistry, Pharmaceutical; Drug Stability; Emulsions; Itraconazole; Ketoconazole; Oils; Solubility; Solvents; Water | 2004 |
Concurrent Fusarium chlamydosporum and Microsphaeropsis arundinis infections in a cat.
Topics: Animals; Antifungal Agents; Cat Diseases; Cats; Dermatomycoses; Diagnosis, Differential; Fusarium; Hindlimb; Itraconazole; Ketoconazole; Lactams; Male; Mitosporic Fungi | 2004 |
Antifungal susceptibility of 50 Candida isolates from invasive mycoses in Chile.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Chile; Critical Care; Drug Resistance, Fungal; Fluconazole; Humans; Inpatients; Intensive Care Units; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 2004 |
Paranasal sinus aspergillosis: its categorization to develop a treatment protocol.
Topics: Adolescent; Adult; Aged; Algorithms; Antifungal Agents; Aspergillosis; Child; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Paranasal Sinus Diseases; Paranasal Sinuses; Radiography | 2004 |
Comparative evaluation of Sensititre YeastOne vs. the NCCLS M27A protocol and E-test for antifungal susceptibility testing of yeasts.
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Itraconazole; Ketoconazole; Laboratories; Microbial Sensitivity Tests; Quality Assurance, Health Care; Reference Standards | 2004 |
Evaluation of a colorimetric antifungal susceptibility test by using 2,3-diphenyl-5-thienyl-(2)-tetrazolium chloride.
Topics: Candida; Colorimetry; Indicators and Reagents; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Tetrazolium Salts | 2004 |
Etest for assessing the susceptibility of filamentous fungi.
Topics: Antifungal Agents; Culture Media; Fluconazole; Fungi; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Quality Control; Reproducibility of Results | 2004 |
In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis.
Topics: Antifungal Agents; Arthrodermataceae; Ascomycota; Clotrimazole; Econazole; Fluconazole; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Terbinafine; Thiophenes | 2004 |
[Prophylaxis of fungal infection in patients with hematologic neoplasms and severe neutropenia after high-dose chemotherapy].
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Antineoplastic Agents; Fluconazole; Hematologic Neoplasms; Humans; Itraconazole; Ketoconazole; Middle Aged; Mycoses; Neutropenia; Randomized Controlled Trials as Topic; Retrospective Studies | 2004 |
Determination of the absolute configuration and solution conformation of the antifungal agents ketoconazole, itraconazole, and miconazole with vibrational circular dichroism.
Topics: Antifungal Agents; Circular Dichroism; Itraconazole; Ketoconazole; Miconazole; Models, Molecular; Molecular Conformation; Solutions; Spectroscopy, Fourier Transform Infrared; Stereoisomerism | 2005 |
Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay.
Topics: Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Propolis; Terbinafine; Trichophyton; Turkey | 2005 |
DNA fingerprinting pattern and susceptibility to antifungal drugs in Cryptococcus neoformans variety grubii isolates from Barcelona city and rural environmental samples.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; DNA Fingerprinting; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Soil Microbiology; Spain; Triazoles; Voriconazole | 2005 |
[Allergic fungal sinusitis and allergic broncho-pulmonary aspergillosis: a fortuitous association or a nosological rhino-bronchial entity?].
Topics: Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Combined Modality Therapy; Endoscopy; Female; Flucytosine; Follow-Up Studies; Humans; Immunoglobulin E; Itraconazole; Ketoconazole; Male; Middle Aged; Mycoses; Prednisolone; Respiratory Hypersensitivity; Retrospective Studies; Sinusitis; Time Factors; Treatment Outcome | 2005 |
In vitro susceptibility of oral Candida to seven antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mouth Diseases; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2005 |
[In vitro activity of ketoconazole, itraconazole and terbinafine against Malassezia strains isolated from neonates].
Topics: Antifungal Agents; Cheek; Dermatomycoses; Humans; Infant, Newborn; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Naphthalenes; Scalp; Terbinafine | 2005 |
In vitro efficacy of a buffered chelating solution as an antimicrobial potentiator for antifungal drugs against fungal pathogens obtained from horses with mycotic keratitis.
Topics: Animals; Antifungal Agents; Chelating Agents; Drug Synergism; Horse Diseases; Horses; Itraconazole; Keratitis; Ketoconazole; Miconazole; Mycoses; Natamycin; Solutions | 2006 |
Aureobasidium pullulans keratitis.
Topics: Ascomycota; Corneal Ulcer; Eye Infections, Fungal; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mycoses; Retrospective Studies | 2006 |
Surface plasmon resonance analysis of antifungal azoles binding to CYP3A4 with kinetic resolution of multiple binding orientations.
Topics: Antifungal Agents; Binding Sites; Cytochrome P-450 CYP3A; Enzyme Inhibitors; Humans; Imidazoles; Itraconazole; Ketoconazole; Kinetics; Light; Protein Conformation; Spectrophotometry, Ultraviolet; Stereoisomerism; Surface Plasmon Resonance | 2006 |
In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 2006 |
[Skin infection with Fusarium in an immunocompetent patient].
Topics: Aged; Antifungal Agents; Dermatomycoses; Drug Therapy, Combination; Female; Fusarium; Humans; Immunocompetence; Itraconazole; Ketoconazole; Leg Ulcer; Mud Therapy; Potassium Permanganate; Soil Microbiology; Venous Insufficiency | 2006 |
A modified Christensen's urea and CLSI broth microdilution method for testing susceptibilities of six Malassezia species to voriconazole, itraconazole, and ketoconazole.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Culture Media; Dermatomycoses; HIV Infections; Humans; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Polysorbates; Pyrimidines; Triazoles; Urea; Voriconazole | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
In vitro methods for antifungal susceptibility testing of Trichophyton spp.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine; Trichophyton | 2006 |
Antifungal activities of azole agents against the Malassezia species.
Topics: Antifungal Agents; Azoles; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Tinea Versicolor; Triazoles; Voriconazole | 2007 |
Induction of cytochrome P450 1A1 by ketoconazole and itraconazole but not fluconazole in murine and human hepatoma cell lines.
Topics: Animals; Antifungal Agents; Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cytochrome P-450 CYP1A1; Dose-Response Relationship, Drug; Enzyme Induction; Enzyme Inhibitors; Fluconazole; Genes, Reporter; Humans; Itraconazole; Ketoconazole; Liver Neoplasms; Luciferases; Mice; Promoter Regions, Genetic; Receptors, Aryl Hydrocarbon; RNA, Messenger; Time Factors; Transcription, Genetic | 2007 |
Antifungal susceptibility testing of Trichophyton rubrum by E-test.
Topics: Antifungal Agents; Cells, Cultured; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Tinea; Triazoles; Trichophyton; Voriconazole | 2007 |
Lecythophora hoffmannii isolated from a case of canine osteomyelitis in Japan.
Topics: Animals; Antifungal Agents; Ascomycota; Biopsy; DNA, Fungal; DNA, Ribosomal; Dog Diseases; Dogs; Drug Resistance, Fungal; Extremities; Female; Histocytochemistry; Itraconazole; Japan; Ketoconazole; Lymph Nodes; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Ossification, Heterotopic; Osteomyelitis; Radiography; RNA, Ribosomal, 28S; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
[Cutaneous sporotricosis in a Malagasy patient].
Topics: Adult; Antifungal Agents; Drug Therapy, Combination; Female; Humans; Itraconazole; Ketoconazole; Madagascar; Sporotrichosis | 2007 |
Interactions of azole antifungal agents with the human breast cancer resistance protein (BCRP).
Topics: Antifungal Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line; Cell Survival; Chlorophyll; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Neoplasm; Flow Cytometry; Fluconazole; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Itraconazole; Ketoconazole; Neoplasm Proteins; Pyrimidines; Topotecan; Transfection; Triazoles; Voriconazole | 2007 |
Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Ciclopirox; Fluconazole; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyridones; Terbinafine | 2007 |
Report of an imported cutaneous disseminated case of paracoccidioidomycosis.
Topics: Adult; Antifungal Agents; Blastomycosis; Chemical and Drug Induced Liver Injury; Cholecystitis; Dermatomycoses; Diagnosis, Differential; Diagnostic Errors; Drug Resistance, Fungal; Ecuador; Emigration and Immigration; Humans; Itraconazole; Jaundice, Obstructive; Ketoconazole; Male; Paracoccidioides; Paracoccidioidomycosis; Spain | 2007 |
Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole.
Topics: Antifungal Agents; Drug Resistance, Multiple, Fungal; Humans; Itraconazole; Ketoconazole; Madurella; Melanins; Mycetoma; Oxidants | 2007 |
Induction of the NAD(P)H:quinone oxidoreductase 1 by ketoconazole and itraconazole: a mechanism of cancer chemoprotection.
Topics: Animals; Antifungal Agents; Carcinoma, Hepatocellular; Enzyme Activation; Enzyme Induction; Fluconazole; Itraconazole; Ketoconazole; Liver Neoplasms, Experimental; Mice; NAD; NAD(P)H Dehydrogenase (Quinone); Receptors, Aryl Hydrocarbon; RNA, Messenger; Time Factors; Transcription, Genetic; Tumor Cells, Cultured | 2007 |
Pharmacokinetic interaction of ketoconazole and itraconazole with ciprofloxacin.
Topics: Animals; Anti-Infective Agents; Antifungal Agents; Area Under Curve; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Interactions; Half-Life; Itraconazole; Ketoconazole; Metabolic Clearance Rate; Mice; Mice, Inbred Strains; Time Factors | 2008 |
Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tablets.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Pyrimidines; Rhodotorula; Triazoles; Trichosporon; Voriconazole | 2008 |
[Resistance to azolic compounds in clinical Trichophyton spp. strains].
Topics: Adult; Antifungal Agents; Cross Infection; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Epidermophyton; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Mexico; Microsporum; Onychomycosis; Tinea; Tinea Capitis; Tinea Pedis; Trichophyton | 2007 |
[Itraconazole treatment in the suspension of pathological fungal colonization of the airway in patients with pulmonary tuberculosis].
Topics: Antifungal Agents; Antitubercular Agents; Candida albicans; Candidiasis; Fungi; Humans; Itraconazole; Ketoconazole; Tuberculosis, Pulmonary | 2008 |
A statistical methodology for drug-drug interaction surveillance.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents, Non-Steroidal; Contraceptives, Oral; Diuretics; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Humans; Itraconazole; Ketoconazole; Models, Statistical; Product Surveillance, Postmarketing; Terfenadine | 2008 |
Phaeohyphomycosis caused by Ulocladium species in a cat.
Topics: Animals; Antifungal Agents; Ascomycota; Cat Diseases; Cats; Dermatomycoses; Female; Itraconazole; Ketoconazole; Mycoses; Treatment Outcome | 2008 |
Malassezia folliculitis in China.
Topics: Adult; China; Dermatomycoses; Folliculitis; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Malassezia; Male; Middle Aged | 2008 |
Widespread, chronic, and fluconazole-resistant Trichophyton rubrum infection in an immunocompetent patient.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Female; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Middle Aged; Thiophenes; Tinea; Trichophyton | 2008 |
Combinatorial anti-Trichophyton effects of Ligusticum chuanxiong essential oil components with antibiotics.
Topics: 4-Butyrolactone; Anti-Bacterial Agents; Antifungal Agents; Drug Synergism; Drugs, Chinese Herbal; Gas Chromatography-Mass Spectrometry; Itraconazole; Ketoconazole; Ligusticum; Microbial Sensitivity Tests; Oils, Volatile; Phthalic Anhydrides; Plant Oils; Plant Roots; Trichophyton | 2008 |
In vitro antifungal activity of 2-(4-substituted phenyl)-3(2H)-isothiazolones.
Topics: Antifungal Agents; Ascomycota; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Thiazoles | 2007 |
Comparison of the anti-inflammatory activities of imidazole antimycotics in relation to molecular structure.
Topics: Anti-Inflammatory Agents; Antifungal Agents; Cells, Cultured; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Leukotriene B4; Molecular Structure; Neutrophils; Platelet Activating Factor; Pyrimidines; Triazoles; Voriconazole | 2008 |
Aqueous solvent system for the solubilization of azole compounds.
Topics: Acetates; Azoles; Calcium Gluconate; Ethanol; Glycerol; Hydrogen-Ion Concentration; Itraconazole; Ketoconazole; Miconazole; Phosphoric Acids; Polyethylene Glycols; Polysorbates; Propylene Glycol; Solubility; Solvents; Surface-Active Agents; Water | 2009 |
Identification and chromosomal localization of one locus of Leishmania (L.) major related with resistance to itraconazole.
Topics: Animals; Antiprotozoal Agents; Blotting, Southern; Drug Resistance; Genes, Protozoan; Itraconazole; Ketoconazole; Leishmania major; Microbial Viability; Mutagenesis, Insertional; Sequence Analysis, DNA | 2009 |
The amino acid residues of transmembrane helix 5 of multidrug resistance protein CaCdr1p of Candida albicans are involved in substrate specificity and drug transport.
Topics: Adenosine Triphosphatases; Amino Acid Sequence; Azides; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Membrane Transport Proteins; Miconazole; Mutagenesis, Site-Directed; Prazosin; Protein Transport; Rhodamines; Saccharomyces cerevisiae; Substrate Specificity | 2009 |
Growth inhibitory action of ebselen on fluconazole-resistant Candida albicans: role of the plasma membrane H+-ATPase.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Cyclooxygenase Inhibitors; Cysteine; Drug Resistance, Fungal; Fluconazole; Isoindoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Organoselenium Compounds; Proton-Translocating ATPases; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins | 2009 |
In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
Topics: Amphotericin B; Antifungal Agents; Antitubercular Agents; Caspofungin; Coccidioides; Coccidioidomycosis; Drug Synergism; Echinocandins; Ethambutol; Fluconazole; Humans; Isoniazid; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole | 2009 |
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors; Triazoles; Voriconazole | 2009 |
Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection.
Topics: Calibration; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Stability; Fluconazole; Humans; Itraconazole; Ketoconazole; Pyrimidines; Quality Control; Reproducibility of Results; Spectrophotometry, Ultraviolet; Time Factors; Triazoles; Ultraviolet Rays; Voriconazole | 2009 |
Aetiological treatment with itraconazole or ketoconazole in individuals with Trypanosoma cruzi/HIV co-infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Brazil; Chagas Disease; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Parasitemia; Trypanocidal Agents; Trypanosoma cruzi | 2009 |
Subcutaneous zygomycosis: report of 10 cases from two institutions in North India.
Topics: Adult; Aged; Child; Child, Preschool; Dermatomycoses; Drug Therapy, Combination; Entomophthorales; Eosinophils; Female; Humans; India; Itraconazole; Ketoconazole; Male; Middle Aged; Mucorales; Potassium Iodide; Retrospective Studies; Skin; Young Adult; Zygomycosis | 2010 |
Current concepts in systemic and topical therapy for superficial mycoses.
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Antifungal Agents; Azoles; Dermatomycoses; Drug Administration Schedule; Drug Resistance, Fungal; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Morpholines; Tolnaftate; United States | 2010 |
Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51).
Topics: Antifungal Agents; Azoles; Candida albicans; Econazole; Fluconazole; Itraconazole; Ketoconazole; Miconazole; Protein Binding; Pyrimidines; Sterol 14-Demethylase; Triazoles; Voriconazole | 2010 |
Primary cutaneous aspergillosis.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Antifungal Agents; Aspergillosis; Aspergillus flavus; Dose-Response Relationship, Drug; Female; Humans; Itraconazole; Ketoconazole; Skin; Skin Diseases, Infectious; Treatment Outcome | 2010 |
Ketoconazole and miconazole alter potassium homeostasis in Saccharomyces cerevisiae.
Topics: Antifungal Agents; Cations; Fluconazole; Glucose; Glucosephosphate Dehydrogenase; Homeostasis; Hydrogen-Ion Concentration; Itraconazole; Ketoconazole; Miconazole; Nucleotides; Oxygen Consumption; Potassium; Protons; Saccharomyces cerevisiae | 2011 |
An azole-resistant isolate of Malassezia pachydermatis.
Topics: Animals; Antifungal Agents; Cats; Dogs; Drug Resistance, Fungal; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests | 2011 |
In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafine.
Topics: Antifungal Agents; Itraconazole; Ketoconazole; Madurella; Microbial Sensitivity Tests; Naphthalenes; Terbinafine; Triazoles | 2011 |
[Determination of hemolytic activity and in vitro antifungal susceptibility of Trichophyton rubrum clinical strains].
Topics: Antifungal Agents; Econazole; Hair; Hemolysis; Humans; Imidazoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Nails; Naphthalenes; Skin; Terbinafine; Tinea; Trichophyton | 2011 |
In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole | 2011 |
In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
Topics: Animals; Antifungal Agents; Dermatomycoses; Dog Diseases; Dogs; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Miconazole; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
Tocol modified glycol chitosan for the oral delivery of poorly soluble drugs.
Topics: Administration, Oral; Caco-2 Cells; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Humans; Intestinal Mucosa; Itraconazole; Ketoconazole; Kinetics; Micelles; Microscopy, Atomic Force; Microscopy, Electron, Transmission; Particle Size; Permeability; Solubility; Surface Properties; Technology, Pharmaceutical; Tocopherols | 2012 |
In vitro activities of antifungal agents against clinical isolates of dermatophytes from animals.
Topics: Animals; Antifungal Agents; Arthrodermataceae; Drug Resistance, Fungal; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 2012 |
Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
CDR4 is the major contributor to azole resistance among four Pdr5p-like ABC transporters in Neurospora crassa.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Gene Knockout Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Neurospora crassa; Phylogeny; Sequence Homology, Amino Acid | 2012 |
Predictors of cure, amputation and follow-up dropout among patients with mycetoma seen at the Mycetoma Research Centre, University of Khartoum, Sudan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amputation, Surgical; Antifungal Agents; Child; Child, Preschool; Delivery of Health Care; Female; Ferrous Compounds; Folic Acid; Follow-Up Studies; Health Services Needs and Demand; Humans; Itraconazole; Ketoconazole; Logistic Models; Male; Middle Aged; Mycetoma; Patient Dropouts; Patient Education as Topic; Prospective Studies; Recurrence; Sudan; Young Adult | 2012 |
Retigeric acid B enhances the efficacy of azoles combating the virulence and biofilm formation of Candida albicans.
Topics: Animals; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biofilms; Caco-2 Cells; Candida albicans; Candidiasis; Drug Synergism; Fluconazole; Fungal Proteins; Humans; Itraconazole; Ketoconazole; Male; Membrane Transport Proteins; Mice; Mice, Inbred BALB C; Triterpenes; Virulence | 2012 |
In vitro antifungal activity of isavuconazole against Madurella mycetomatis.
Topics: Antifungal Agents; Humans; Itraconazole; Ketoconazole; Madurella; Microbial Sensitivity Tests; Mycetoma; Nitriles; Pyridines; Triazoles | 2012 |
Surfactant choice and the physical stability of nanosuspensions as a function of pH.
Topics: Dioctyl Sulfosuccinic Acid; Drug Compounding; Drug Stability; Furosemide; Hydrogen-Ion Concentration; Itraconazole; Ketoconazole; Nanoparticles; Piroxicam; Povidone; Surface-Active Agents; Suspensions | 2012 |
Azole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens.
Topics: Antifungal Agents; Candida albicans; Clotrimazole; Escherichia coli; Fluconazole; Fungal Proteins; Humans; Itraconazole; Ketoconazole; Kinetics; Lanosterol; NADP; Protein Binding; Pyrimidines; Recombinant Proteins; Species Specificity; Sterol 14-Demethylase; Triazoles; Voriconazole | 2013 |
Differential pulse polarographic investigation of the antifungal drugs itraconazole, ketoconazole, fluconazole and voriconazole using a dropping mercury electrode.
Topics: Antifungal Agents; Electrochemistry; Electrodes; Fluconazole; Hydrogen-Ion Concentration; Indicators and Reagents; Itraconazole; Ketoconazole; Mercury; Polarography; Pyrimidines; Reference Standards; Reproducibility of Results; Triazoles; Voriconazole | 2012 |
Pityriasis versicolor: a case of resistance to treatment.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Middle Aged; Naphthalenes; Recurrence; Terbinafine; Tinea Versicolor; Treatment Failure | 2014 |
Effect of CYP3A5 expression on the inhibition of CYP3A-catalyzed drug metabolism: impact on modeling CYP3A-mediated drug-drug interactions.
Topics: Biocatalysis; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Genotype; Humans; Itraconazole; Ketoconazole; Male; Microsomes, Liver; Midazolam; Terfenadine; Testosterone; Vincristine | 2013 |
Differential effects of ketoconazole, itraconazole and voriconazole on the pharmacokinetics of imatinib and its main metabolite GCP74588 in rat.
Topics: Animals; Antifungal Agents; Benzamides; Drug Interactions; Imatinib Mesylate; Itraconazole; Ketoconazole; Male; Piperazines; Pyrimidines; Random Allocation; Rats; Rats, Sprague-Dawley; Voriconazole | 2014 |
In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.
Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Drug Resistance, Fungal; Epidermophyton; Griseofulvin; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine; Trichophyton; Turkey | 2013 |
Endemic oral paracoccidioidomycosis: clinical presentation, management, and outcomes.
Topics: Adult; Aged; Antifungal Agents; Biopsy; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mouth; Mouth Diseases; Paracoccidioides; Paracoccidioidomycosis; Treatment Outcome | 2014 |
Effect of antimicrobial agents incorporated into resilient denture relines on the Candida albicans biofilm.
Topics: Antifungal Agents; Biofilms; Candida albicans; Chlorhexidine; Denture Liners; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin | 2015 |
In vitro susceptibility of Malassezia pachydermatis isolates from canine skin with atopic dermatitis to ketoconazole and itraconazole in East Asia.
Topics: Animals; Antifungal Agents; Asia, Eastern; Dermatomycoses; Dog Diseases; Dogs; Drug Resistance, Fungal; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests | 2014 |
Transcription factor CCG-8 as a new regulator in the adaptation to antifungal azole stress.
Topics: Antifungal Agents; Down-Regulation; Drug Resistance, Fungal; Fluconazole; Fusarium; Gene Expression Regulation, Fungal; Genes, Fungal; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Neurospora crassa; Transcription Factors | 2014 |
Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Echinocandins; Fungemia; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Spain; Triazoles; Voriconazole | 2014 |
Itraconazole and clarithromycin as ketoconazole alternatives for clinical CYP3A inhibition studies.
Topics: Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Databases, Factual; Drug Design; Drug Interactions; Enzyme Inhibitors; Europe; Humans; Itraconazole; Ketoconazole; United States; United States Food and Drug Administration | 2014 |
Madurella mycetomatis is highly susceptible to ravuconazole.
Topics: Antifungal Agents; Itraconazole; Ketoconazole; Madurella; Microbial Sensitivity Tests; Thiazoles; Triazoles | 2014 |
Effect of the addition of antimicrobial agents on Shore A hardness and roughness of soft lining materials.
Topics: Anti-Infective Agents; Chlorhexidine; Denture Liners; Hardness; Itraconazole; Ketoconazole; Materials Testing; Miconazole; Nystatin; Polymethacrylic Acids; Surface Properties | 2015 |
Clinical CYP3A inhibitor alternatives to ketoconazole, clarithromycin and itraconazole, are not transported into the liver by hepatic organic anion transporting polypeptides and organic cation transporter 1.
Topics: Animals; Clarithromycin; Cytochrome P-450 CYP3A Inhibitors; Itraconazole; Ketoconazole; Liver; Male; Mice; Mice, Knockout; Organic Anion Transporters; Organic Cation Transporter 1 | 2014 |
A case of cutaneous protothecosis mimics eczema.
Topics: Aged, 80 and over; Antifungal Agents; Base Sequence; DNA, Plant; Drug Therapy, Combination; Eczema; Humans; Infections; Itraconazole; Ketoconazole; Male; Molecular Typing; Prototheca; Sequence Analysis, DNA | 2015 |
Genotypic, phenotypic, and proteomic characterization of Candida glabrata during sequential fluconazole exposure.
Topics: Antifungal Agents; Candida glabrata; Chromosomes, Fungal; Copper Sulfate; Culture Media; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Genotype; Hemolysin Proteins; Humans; Itraconazole; Ketoconazole; Metallothionein; Phenotype; Proteome; Virulence; Voriconazole | 2011 |
In vitro interaction of currently used azoles with terbinafine against Madurella mycetomatis.
Topics: Azoles; Itraconazole; Ketoconazole; Madurella; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 2015 |
In vitro susceptibility of filamentous fungi from mycotic keratitis to azole drugs.
Topics: Antifungal Agents; Azoles; Corneal Ulcer; Drug Resistance, Fungal; Eye Infections, Fungal; Fungi; Humans; Itraconazole; Keratitis; Ketoconazole; Microbial Sensitivity Tests | 2015 |
Antifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapy.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Carcinoma; Caspofungin; Chemoradiotherapy; Chemotherapy, Adjuvant; Drug Resistance, Fungal; Echinocandins; Exophiala; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Lipopeptides; Male; Middle Aged; Mouth Diseases; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Opportunistic Infections; Phaeohyphomycosis; Radiotherapy, Intensity-Modulated; Voriconazole | 2015 |
Thermodynamic scaling of molecular dynamics in supercooled liquid state of pharmaceuticals: Itraconazole and ketoconazole.
Topics: Humans; Itraconazole; Ketoconazole; Liquid Crystals; Molecular Dynamics Simulation; Phase Transition; Thermodynamics; Transition Temperature | 2015 |
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole | 2015 |
Transcription factor ADS-4 regulates adaptive responses and resistance to antifungal azole stress.
Topics: Antifungal Agents; Azoles; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Neurospora crassa | 2015 |
Electrochemical behavior of the antifungal agents itraconazole, posaconazole and ketoconazole at a glassy carbon electrode.
Topics: Antifungal Agents; Carbon; Electrochemical Techniques; Electrochemistry; Electrodes; Indicators and Reagents; Itraconazole; Ketoconazole; Solutions; Triazoles | 2015 |
Cosolvency approach for assessing the solubility of drugs in poly(vinylpyrrolidone).
Topics: Griseofulvin; Itraconazole; Ketoconazole; Models, Chemical; Polymers; Povidone; Ritonavir; Solubility; Solvents; X-Ray Diffraction | 2015 |
Seventeen years of subcutaneous infection by Aspergillus flavus; eumycetoma confirmed by immunohistochemistry.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Chronic Disease; Delayed Diagnosis; Diagnostic Errors; Foot Dermatoses; Humans; Immunohistochemistry; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycetoma; Radiography; Scedosporium; Subcutaneous Tissue; Sudan; Voriconazole | 2015 |
Evaluation of Ketoconazole and Its Alternative Clinical CYP3A4/5 Inhibitors as Inhibitors of Drug Transporters: The In Vitro Effects of Ketoconazole, Ritonavir, Clarithromycin, and Itraconazole on 13 Clinically-Relevant Drug Transporters.
Topics: Biological Transport; Cell Line; Clarithromycin; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; HEK293 Cells; Humans; Itraconazole; Ketoconazole; Membrane Transport Proteins; Ritonavir | 2016 |
Biofilm production and antifungal susceptibility of co-cultured Malassezia pachydermatis and Candida parapsilosis isolated from canine seborrheic dermatitis.
Topics: Animals; Antifungal Agents; Biofilms; Candida; Dermatitis, Seborrheic; Dog Diseases; Dogs; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Microscopy, Electron, Scanning | 2016 |
Molecular typing of environmental Cryptococcus neoformans/C. gattii species complex isolates from Manaus, Amazonas, Brazil.
Topics: Amphotericin B; Animals; Antifungal Agents; Birds; Brazil; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Disease Reservoirs; Environmental Microbiology; Feces; Fluconazole; Humans; Itraconazole; Ketoconazole; Molecular Typing; Mycological Typing Techniques; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Trees | 2016 |
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme.
Topics: Antifungal Agents; Clotrimazole; Cryptococcus; Enzyme Activation; Ergosterol; Fluconazole; Humans; Itraconazole; Ketoconazole; Lanosterol; Pyridines; Sterol 14-Demethylase; Tetrazoles; Voriconazole | 2016 |
Azole Antifungal Sensitivity of Sterol 14α-Demethylase (CYP51) and CYP5218 from Malassezia globosa.
Topics: Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Cytochrome P450 Family 51; Drug Evaluation, Preclinical; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Kinetics; Lipids; Malassezia; Spectrophotometry; Sterol 14-Demethylase; Sterols; Voriconazole | 2016 |
Treatment Outcomes for Malassezia Folliculitis in theDermatology Department of a University Hospital in Japan.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Antifungal Agents; Dermatology; Female; Folliculitis; Hospital Departments; Hospitals, University; Humans; Itraconazole; Japan; Ketoconazole; Malassezia; Male; Middle Aged; Time Factors; Tinea Versicolor; Treatment Outcome; Young Adult | 2016 |
Triazoles inhibit cholesterol export from lysosomes by binding to NPC1.
Topics: Androstenes; Animals; Antifungal Agents; Binding Sites; Biological Transport; Carrier Proteins; Cell Line; CHO Cells; Cholesterol; Cricetulus; Endocytosis; Itraconazole; Ketoconazole; Lysosomes; Membrane Glycoproteins; Protein Binding; Protein Domains; Triazoles | 2017 |
Comparison of two in vitro antifungal sensitivity tests and monitoring during therapy of Sporothrix schenckii sensu stricto in Malaysian cats.
Topics: Amphotericin B; Animals; Antifungal Agents; Cat Diseases; Cats; In Vitro Techniques; Itraconazole; Ketoconazole; Malaysia; Microbial Sensitivity Tests; Naphthalenes; Sporothrix; Sporotrichosis; Terbinafine; Triazoles | 2017 |
Cutaneous basidiobolomycosis: Seven cases in southern Benin.
Topics: Adolescent; Adult; Antifungal Agents; Benin; Child; Child, Preschool; Cross-Sectional Studies; Dermatomycoses; Diagnosis, Differential; Entomophthorales; Eosinophilia; Female; Granuloma; Humans; Hyperpigmentation; Infant; Itraconazole; Ketoconazole; Male; Retrospective Studies; Young Adult; Zygomycosis | 2017 |
Mycetoma: A global medical and socio-economic dilemma.
Topics: Antifungal Agents; Biomedical Research; Cost-Benefit Analysis; Global Health; Health Services Accessibility; Humans; Itraconazole; Ketoconazole; Medication Adherence; Mycetoma; Neglected Diseases; Socioeconomic Factors; Treatment Outcome; Tropical Medicine | 2017 |
Development of a Biorelevant, Material-Sparing Membrane Flux Test for Rapid Screening of Bioavailability-Enhancing Drug Product Formulations.
Topics: Administration, Oral; Biological Availability; Colloids; Drug Compounding; Itraconazole; Ketoconazole; Micelles; Solubility | 2017 |
Minimal inhibitory concentration distributions and epidemiological cutoff values of five antifungal agents against Sporothrix brasiliensis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cats; Drug Resistance, Fungal; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Sporothrix; Terbinafine; Triazoles | 2017 |
The Tetrazole VT-1161 Is a Potent Inhibitor of Trichophyton rubrum through Its Inhibition of T. rubrum CYP51.
Topics: Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyridines; Sterol 14-Demethylase; Substrate Specificity; Tetrazoles; Trichophyton; Voriconazole | 2017 |
Prediction of drug-drug interactions using physiologically-based pharmacokinetic models of CYP450 modulators included in Simcyp software.
Topics: Ciprofloxacin; Clarithromycin; Computer Simulation; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme Inducers; Drug Interactions; Fluconazole; Humans; Itraconazole; Ketoconazole; Models, Biological; Paroxetine; Quinidine; Rifampin; Software | 2018 |
In silico analysis of cytochrome P450 monooxygenases in chronic granulomatous infectious fungus Sporothrix schenckii: Special focus on CYP51.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Catalytic Domain; Crystallography, X-Ray; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Genome, Fungal; Humans; Itraconazole; Ketoconazole; Molecular Docking Simulation; Multigene Family; Phylogeny; Plants; Protein Binding; Protein Interaction Domains and Motifs; Protein Structure, Secondary; Sequence Alignment; Sporothrix; Sporotrichosis; Structural Homology, Protein | 2018 |
Effect of Incorporation of Antifungal Agents on the Ultimate Tensile Strength of Temporary Soft Denture Liners.
Topics: Antifungal Agents; Biofilms; Candida albicans; Chlorhexidine; Denture Liners; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Tensile Strength | 2018 |
Fusariosis in a Captive South American Sea Lion (Otaria flavescens): A Case Report.
Topics: Animals; Antifungal Agents; Dogs; Fusariosis; Fusarium; Histocytochemistry; Itraconazole; Ketoconazole; Male; Miconazole; Microbiological Techniques; Molecular Diagnostic Techniques; Sea Lions; Skin; South America; Treatment Outcome | 2019 |
Malassezia pachydermatis from animals: Planktonic and biofilm antifungal susceptibility and its virulence arsenal.
Topics: Animals; Antifungal Agents; Bacterial Adhesion; Biofilms; Caenorhabditis elegans; Cat Diseases; Cats; Dermatomycoses; Dog Diseases; Dogs; Epithelial Cells; Fluconazole; Foxes; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Peptide Hydrolases; Phospholipases; Virulence | 2018 |
Comparison of particle size methodology and assessment of nanoparticle tracking analysis (NTA) as a tool for live monitoring of crystallisation pathways.
Topics: Antifungal Agents; Chemistry, Pharmaceutical; Crystallization; Dynamic Light Scattering; Excipients; Itraconazole; Ketoconazole; Nanoparticles; Particle Size; Polyethylene Glycols; Solvents; Technology, Pharmaceutical; Triazoles | 2018 |
Pityriasis versicolor with uncommon localizations.
Topics: Adult; Antifungal Agents; Back; Extremities; Humans; Itraconazole; Ketoconazole; Knee; Male; Organ Specificity; Tinea Versicolor; Torso | 2020 |
Antifungal susceptibility of yeasts isolated from anthropogenic watershed.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fresh Water; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Reference Values; Sequence Analysis, DNA; Voriconazole; Yeasts | 2019 |
Effects of ketoconazole, voriconazole, and itraconazole on the pharmacokinetics of apatinib in rats.
Topics: Animals; Antifungal Agents; Antineoplastic Agents; Drug Evaluation, Preclinical; Drug Interactions; Drug Monitoring; Itraconazole; Ketoconazole; Male; Mycoses; Pyridines; Rats; Rats, Sprague-Dawley; Stomach Neoplasms; Voriconazole | 2019 |
Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.
Topics: Antifungal Agents; Azoles; Candida; Candida glabrata; Candidiasis, Oral; DNA-Binding Proteins; Drug Resistance, Fungal; Fungal Proteins; Gene Expression Regulation, Fungal; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mutation, Missense; Thailand; Transcription Factors | 2019 |
Comparative omics analyses of hepatotoxicity induced by oral azole drugs in mice liver and primary hepatocytes.
Topics: Animals; Antifungal Agents; Azoles; Cell Survival; Gene Expression Profiling; Hepatocytes; Itraconazole; Ketoconazole; Liver; Male; Metabolomics; Mice, Inbred C57BL; Primary Cell Culture; Transcriptome | 2019 |
Comparison of the inhibitory effect of ketoconazole, voriconazole, fluconazole, and itraconazole on the pharmacokinetics of bosentan and its corresponding active metabolite hydroxy bosentan in rats.
Topics: Animals; Antifungal Agents; Antihypertensive Agents; Bosentan; Drug Interactions; Fluconazole; Itraconazole; Ketoconazole; Male; Rats; Rats, Sprague-Dawley; Triazoles; Voriconazole | 2020 |
Linalool modulates dermatophyte susceptibility to azole drugs.
Topics: Acyclic Monoterpenes; Antifungal Agents; Azoles; Drug Synergism; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Microsporum; Trichophyton | 2020 |
Evaluation of the Antifungal Activity of
Topics: Animals; Antifungal Agents; Arthrodermataceae; Azoles; Candida; Cryptococcus; Drug Combinations; Drug Synergism; Fluconazole; Guidelines as Topic; Humans; Itraconazole; Ketoconazole; Mentha piperita; Microbial Sensitivity Tests; Monoterpenes; Oils, Volatile | 2019 |
Identification and Antifungal Activity Profile of Candida Species Isolated from Patients with Pemphigus Vulgaris with Oral Lesions.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Disk Diffusion Antimicrobial Tests; Econazole; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Pemphigus; Triazoles | 2019 |
Topics: Antifungal Agents; Base Sequence; Epidermophyton; Humans; Iran; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Terbinafine; Tinea; Trichophyton; Voriconazole | 2019 |
In vitro antifungal activity of luliconazole against nondermatophytic moulds.
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole | 2020 |
The Influence of Different Triazole Antifungal Agents on the Pharmacokinetics of Cyclophosphamide.
Topics: Antifungal Agents; Cyclophosphamide; Drug Interactions; Fluconazole; Humans; Itraconazole; Ketoconazole; Models, Biological | 2020 |
Predicting Clinical Effects of CYP3A4 Modulators on Abemaciclib and Active Metabolites Exposure Using Physiologically Based Pharmacokinetic Modeling.
Topics: Administration, Oral; Adult; Aged; Alkynes; Aminopyridines; Area Under Curve; Benzimidazoles; Benzoxazines; Bosentan; Clarithromycin; Computer Simulation; Cyclin-Dependent Kinases; Cyclopropanes; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Diltiazem; Drug Interactions; Female; Healthy Volunteers; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Modafinil; Models, Biological; Rifampin; Verapamil | 2020 |
Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Terbinafine; Tinea; Tinea Pedis; Triazoles; Trichophyton; Voriconazole | 2020 |
Comparative evaluation of E-test and CLSI methods for Itraconazole, Fluconazole and Ketoconazole susceptibilities of Microsporum canis strains.
Topics: Animals; Antifungal Agents; Cats; Dogs; Fluconazole; Indicator Dilution Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Microsporum | 2020 |
Canine sporotrichosis: polyphasic taxonomy and antifungal susceptibility profiles of Sporothrix species in an endemic area in Brazil.
Topics: Amphotericin B; Animals; Antifungal Agents; Brazil; Dog Diseases; Dogs; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Phylogeny; Sporothrix; Sporotrichosis; Terbinafine | 2021 |
Physiologically based pharmacokinetic modeling and simulation to predict drug-drug interactions of ivosidenib with CYP3A perpetrators in patients with acute myeloid leukemia.
Topics: Administration, Oral; Antineoplastic Agents; Area Under Curve; Computer Simulation; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Fluconazole; Glycine; Healthy Volunteers; Humans; Itraconazole; Ketoconazole; Leukemia, Myeloid, Acute; Male; Microsomes, Liver; Models, Biological; Pyridines; Rifampin | 2020 |
Differential Impacts of Azole Antifungal Drugs on the Pharmacokinetic Profiles of Dasatinib in Rats by LC-MS-MS.
Topics: Administration, Oral; Animals; Antifungal Agents; Area Under Curve; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dasatinib; Drug Interactions; Drug Monitoring; Humans; Itraconazole; Ketoconazole; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Models, Animal; Protein Kinase Inhibitors; Rats; Tandem Mass Spectrometry; Triazoles; Voriconazole | 2020 |
High frequency of azole resistant Candida spp. colonization among presumptive multidrug resistant tuberculosis (MDR-TB) patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antitubercular Agents; Candida; Candidiasis; Child; Drug Interactions; Drug Resistance, Multiple, Fungal; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Rifampin; Species Specificity; Tuberculosis, Multidrug-Resistant; Young Adult | 2020 |
Effects of CYP3A inhibitors ketoconazole, voriconazole, and itraconazole on the pharmacokinetics of sunitinib and its main metabolite in rats.
Topics: Administration, Oral; Animals; Cytochrome P-450 CYP3A Inhibitors; Itraconazole; Ketoconazole; Male; Rats, Sprague-Dawley; Sunitinib; Voriconazole | 2021 |
Itraconazole inhibits nuclear delivery of extracellular vesicle cargo by disrupting the entry of late endosomes into the nucleoplasmic reticulum.
Topics: Active Transport, Cell Nucleus; Antifungal Agents; Cell Line; Cell Movement; Cholestenones; Endocytosis; Endosomes; Extracellular Vesicles; Fatty Acid-Binding Proteins; Humans; Itraconazole; Ketoconazole; Models, Molecular; Nuclear Envelope; rab7 GTP-Binding Proteins; Saponins; Vesicular Transport Proteins | 2021 |
In Vitro-In Vivo Correlation in Cocrystal Dissolution: Consideration of Drug Release Profiles Based on Coformer Dissolution and Absorption Behavior.
Topics: 4-Aminobenzoic Acid; Adjuvants, Pharmaceutic; Administration, Oral; Animals; Chemistry, Pharmaceutical; Crystallization; Drug Compounding; Drug Liberation; Gastrointestinal Absorption; Itraconazole; Ketoconazole; Male; Rats; Solubility; Triazoles | 2021 |
Activity of antifungal drugs and Brazilian red and green propolis extracted with different methodologies against oral isolates of Candida spp.
Topics: Antifungal Agents; Candidiasis, Oral; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Plant Extracts; Propolis; Stomatitis, Denture | 2021 |
In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus oryzae; Clotrimazole; Econazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Terbinafine; Tolnaftate; Voriconazole | 2022 |
Malassezia species: the need to establish epidemiological cutoff values.
Topics: Amphotericin B; Animals; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Voriconazole | 2022 |
Feline sporotrichosis caused by Sporothrix schenckii sensu stricto in Southern Thailand: phenotypic characterization, molecular identification, and antifungal susceptibility.
Topics: Amphotericin B; Animals; Antifungal Agents; Calmodulin; Cat Diseases; Cats; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Phylogeny; Sporothrix; Sporotrichosis; Thailand; Tubulin | 2022 |
Otomycosis caused by the cryptic and emerging species
Topics: Antifungal Agents; Aspergillus; Humans; Itraconazole; Ketoconazole; Otomycosis | 2022 |
ERG11 Gene Variability and Azole Susceptibility in Malassezia pachydermatis.
Topics: Animals; Antifungal Agents; Azoles; Drug Resistance, Fungal; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests | 2023 |
Stimulatory and Inhibitory Effects of Steroid Hormones and Human Cytochrome P450 (CYP) 3A Inhibitors on Cortisol 6β-Hydroxylation Catalyzed by CYP3A Subfamilies.
Topics: Antifungal Agents; Catalysis; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dehydroepiandrosterone; Humans; Hydrocortisone; Hydroxylation; Itraconazole; Ketoconazole; Steroids; Testosterone | 2023 |